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SUMMARY
There is a great need for an in vitro model for studying aqueous humour 
dynamics. A large number of antiglaucoma drugs| is currently in clinical use or 
are in various stages of development, and in some cases their underlying 
biochemical mechanisms of action are unclear. The present work was 
undertaken to find out whether the easily obtainable inexpensive bovine eye 
could be established as such a model to study the physiology and pharmacology 
of ocular hypotensive drugs. The specific objective was to try to explore the 
mechanism of action of the extensively used p-blocker, timolol, to determine 
whether it acts through the conventional p-adrenoceptor-adenylate cyclase 
mechanism, as is often assumed.
The isolated arterially perfused bovine eye has been proved to be a valid model 
for studying aqueous humour dynamics and the pharmacology of various 
antiglaucoma drugs. Its usefulness has been shown by significant effects of 
standard and well-established ocular hypotensive agents, such as timolol and 
MK-927, a carbonic anhydrase inhibitor, on both intraocular pressure and 
aqueous humour formation. MK-927 produced a dose-dependent decrease in 
intraocular pressure and aqueous humour formation with moderate doses of 1, 10 
or 100 nmol.
In addition to the responses to the standard drugs, the viability and metabolic 
activity of the isolated perfused eye has been shown by significant consumption 
of C>2 and elaboration of CO2  during the course of perfusion. This was achieved 
by comparing the two parameters between the perfused living and dead eyes.
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The bovine perfused eye has been shown to offer the opportunity to study the 
effect of ocular hypotensive drugs upon intracellular mechanisms, especially 
upon second messenger pathways. It allows rapid and convenient sampling of 
substantial amounts of target tissue for biochemical analysis after drug challenge.
The usefulness of the perfused eye has also been shown for isolating and 
culturing ciliary epithelial cells. Two new methods of isolating and culturing 
ciliary epithelial cells have been developed. One by aseptic and consecutive 
perfusion of the isolated eye with DMEM, calcium-free buffer and collagenase 
and the other by incubating the excised ciliary processes with collagenase. The 
cells were successfully propagated up to 10 passages without any obvious sign of 
change of growth characteristics. In first passage cells cultured in this way, 
there occurred highly significant and concentration-dependent increases in cyclic 
AMP and cyclic GMP in response to terbutaline and atriopeptin, respectively, 
indicating that these cells retain functional receptors. This will open up broad 
opportunities for physiological, pharmacological and biochemical studies on 
specific target cells responsible for aqueous humour production.
To explore the mechanism of action of timolol, we studied four different drugs 
which are known either to alter aqueous humour formation or intracellular cyclic 
AMP content. The drugs used were timolol, a [3-adrenoceptor antagonist; 
terbutaline, a P-adrenoceptor agonist; forskolin, a potent direct stimulator of 
adenylate cyclase and 8-bromo cyclic AMP, a membrane permeable analogue of 
cyclic AMP.
Both timolol (10 nmol) and terbutaline (30 nmol) were found to cause a 
significant reduction of intraocular pressure and aqueous humour formation by 
bolus injection into the perfusate, but neither of them had any effect on levels of
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ciliary epithelial cyclic AMP. Even in the case of terbutaline, a three times 
higher dose also failed to alter ciliary cyclic AMP content.
However, when excised ciliary processes from fresh bovine eyes were incubated 
with terbutaline, concentrations of 10~4 to 10"6 M produced a graded increase in 
cyclic AMP . The same concentrations of terbutaline also produced a more 
pronounced and concentration-dependent increase in cyclic AMP in cultured 
ciliary epithelial cells. 10“4 M terbutaline produced about 800% increase in 
ciliary epithelial cyclic AMP content.
Forskolin (30 nmol) on the other hand, produced a highly significant increase in 
ciliary cyclic AMP in the perfused eye, but had no effect on aqueous humour 
production. A 100 nmol dose of 8-bromo cyclic AMP also failed to produce 
any effect on aqueous humour formation. Finding no relevance of ciliary cyclic 
AMP levels to aqueous humour formation in all these experiments, we turned to 
specific inhibitors of cyclic nucleotide-dependent protein kinases. A 10 nmol 
bolus dose of KT-5720 (protein kinase A inhibitor) completely blocked the effect 
of terbutaline (30 nmol) on intraocular pressure and aqueous humour formation. 
In contrast, KT-5823 (protein kinase G inhibitor) was unable to block the 
intraocular pressure-lowering effect of terbutaline.
Thus experiments with timolol, terbutaline, forskolin and 8-bromo cyclic AMP 
showed that there is no correlation between the aqueous humour formation rate 
and the ciliary epithelial content of cyclic AMP. On the other hand, 
experiments with protein kinase A and protein kinase G inhibitors indicate that 
cyclic AMP may be an important modulator of aqueous humour formation. 
From the convincing irrelevance in the former case and an apparent relevance in 
the latter case we were led to suggest the following possibilities: that cyclic
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AMP may be an important modulator of aqueous humour formation but at 
changes in concentration which are too low to be measured by 
radioimmunoassay; that functional compartmentalization of cyclic AMP may be 
involved in ciliary epithelial cell function; that the increase in cyclic AMP in 
some critical foci of ciliary epithelial cells may be important to modulate cell 
function, yet this change is not sufficient to affect the total cyclic AMP content 
of the cells.
The vasodilator cardiac peptide, atriopeptin and the nitrovasodilator, sodium 
azide, were found to be highly effective in reducing aqueous humour formation 
| and intraocular pressure in the perfused bovine eye. Atriopeptin at
| concentrations of 10"6 to 1(H* also produced a concentration-dependent increase
EI
in cyclic GMP in cultured ciliary epithelial cells.
The intraocular pressure-lowering effect of a 10 nmol bolus dose of sodium 
azide was found to be completely abolished by the specific inhibitor of protein 
kinase G (KT-5823). In contrast, protein kinase A inhibitor (KT-5720) was 
unable to block this effect of sodium azide. It was concluded that both 
atriopeptin and sodium azide lower intraocular pressure by reducing aqueous 
humour formation and that cyclic GMP may be an important 2nd messenger 
involved in aqueous humour formation.
The calcium-channel blocker verapamil in bolus doses of 1, 10 or 100 nmol 
produced a dose-dependent decrease in intraocular pressure in the bovine 
perfused eye. On this basis future work on drugs which can modulate 
intracellular Ca?+ is suggested.
INTRODUCTION
INTRODUCTION
General Consideration
The supply of nutrients to the avascular structures of the eye, such as the cornea, 
the lens and the trabecular meshwork is accomplished by aqueous humour (AH). 
The existence of two systems of blood vessels - the retinal and the uveal - 
together with the blood-retinal and blood-aqueous barrier and the complex 
mechanism of AH formation and drainage! make it possible to supply nutrition to 
the intraocular tissues without blood interference in transmission of light 
through the eye. This complex arrangement for ocular nutrition contributes to 
good optical properties of the eye.
AH is a transparent fluid contained in the anterior and posterior chambers of the 
eye and is formed by the ciliary epithelium (CE) of the ciliary processes 
projecting from the ciliaiy body. As the aqueous is formed it enters the 
posterior chamber from which it flows in three different directions: (1) most of 
the aqueous flows forward between the lens and iris and through the pupil into 
the anterior chamber, (2) a small portion flows into the vitreous to be absorbed in 
the posterior part of the eye and (3) some of the aqueous apparently is 
reabsorbed at the ciliary body. Apart from supplying nutrition to the ocular 
tissues AH has other functions including draining of metabolic wastes into the 
venous system and maintaining optimum pressure in the eye, which is important 
to give the rigidity necessary for optical alignment of the cornea, lens and the 
retina. The intraocular pressure (IOP) is also responsible for the bulk flow of 
aqueous out of the anterior chamber through the two major outflow pathways - 
the trabecular and the uveoscleral. Such pressure is inherent in a system where 
fluid is to flow through passive routes. IOP is determined by the relationship
2between the rates of AH formation and drainage. In the normal eye the rate of 
production is equal to the rate of outflow of AH. Any deviation from the 
normal relationship will affect the IOP. If, for example, the rate of production 
of AH is more than the rate of its drainage, IOP will increase. Increased IOP 
can also occur in eyes with normal AH production but defective drainage, such 
as complete or partial blockage to the outflow pathways. A high IOP is the 
important cause of chronic open-angle glaucoma (COAG), a condition in which 
IOP rises to the point of damaging the retina and its nervous outflow. Reduction 
of IOP by various means to a level at which optic nerve damage ceases, is 
currently the only available and clinically acceptable treatment of COAG which 
is the most common cause of blindness throughout the world (Leopold and 
Duzman, 1986; Everitt and Avom, 1990).
The IOP can be reduced by two basic mechanisms: (1) decreasing the
production of AH from the ciliary processes, (2) increasing the outflow of AH 
through the trabecular (conventional) and/or uveoscleral (unconventional) 
pathways (Hurvitz. et al., 1991)
One of the important contemporary issues in glaucoma research is to determine 
which of the two basic mechanisms of reducing IOP (decreasing the inflow and 
increasing the outflow) is the preferable therapy. There is widespread belief that 
COAG is invariably associated with an increased resistance to the outflow of 
AH. Also there is apprehension that the secretory suppressant may have long 
term side effects on some of the avascular structures in the eye which depend 
upon adequate nutrition from the AH. Thus it follows that rational therapy 
should be directed at decreasing the resistance to outflow. The paradox is that 
drugs most commonly used in treating glaucoma in fact suppress secretion. The 
following may throw light on this paradox:
31. Decreasing outflow resistance is often resistant to drugs.
2. The pathological changes in the outflow channel, whether in the superficial 
trabecular meshwork nearer to the anterior chamber angle or deep in the 
juxtacanalicular tissue, have always been poorly understood. Ocular 
hypertension is due to an increased resistance to outflow but what happens to 
the trabecular meshwork to cause this is totally unknown (Epstein, 1987). 
Treatment to increase outflow is not aimed at the actual pathological changes 
in the outflow channel. Most of the available treatments, e.g. pilocarpine, 
are aimed at activating the ciliary muscle. But there is no evidence to 
suggest that in COAG, cholinergic tone is defective or the cholinergic 
transmitter or its receptors is in any way lost or altered (Sears, 1991).
3. Several classes of secretory suppressants are in extensive use in the treatment 
of glaucoma, such as carbonic anhydrase inhibitors and beta blockers. Very 
few ocular side effects have been reported to result from these drugs despite 
their substantial reduction of the rate of AH formation (Gilmartin et al., 1984; 
Bron et al., 1989; Higginbotham et al., 1989).
4. In the context of secondary glaucoma, the goal is to eliminate the cause. 
Medication aimed at improving outflow may not work at first and may have 
effects that aggravate the resolution of the primary inflammatory process. In 
such cases IOP must be kept at a reduced level by reducing AH flow, until 
the cause is eliminated (Sears, 1991).
5. Increased resistance to outflow as a result of compression of the trabecular 
meshwork or the apposition of the inner wall of the Schlemm's canal to the 
outer wall, has a deleterious effect on the outflow channels. Under such
4conditions the effectiveness of the outflow medication is lessened (Sears, 
1966).
6. In acute angle-closure glaucoma where there is ischaemia to the irisl sphincter, 
the reduction of IOP can usually be achieved either by a drug which 
suppresses secretion or, temporarily, by an osmotic agent. Ischaemia 
renders the tissue unresponsive to pharmacologic agents (Sears, 1991).
For all these reasons, reducing IOP by reducing AH inflow is as logical as 
increasing the outflow of AH.
The present study is concerned with the mechanisms of action of drugs which 
decrease the production of AH from the ciliary process. Thus a brief review of 
the structures responsible for AH production, AH physiology (its composition, 
production, drainage etc.) as well as a discussion on the pharmacology of the 
agents which may influence AH dynamics deserve worth attention.
Gross Structures of the Eye
In shape the eyeball is a sphere, with the segment of a smaller sphere, the cornea, 
in front. It is composed of three coats or tunics. The outermost protective coat 
is made up of the sclera posteriorly and the cornea anteriorly. The middle coat 
is mainly vascular, consisting of the choroid, ciliary body and iris. The 
innermost coat is the retina, containing the essential sensory elements 
responsible for vision - the rods and cones. Within the three coats are the 
refractory media - namely, the AH, the crystalline lens and a clear jelly, the 
vitreous humour (Fig. 1).
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Fig. 1. Horizontal section of the eye. P.P., posterior pole; 
A.P., anterior pole; V.A., visual axix (Wolff, Anatomy of the 
Eye and Orbitj, 1968).
5The cornea, the first and the most powerful refracting surface of the optical 
system of the eye, occupies the anterior sixth of the outermost coat. The 
crystalline lens is a double convex transparent body positioned between the iris 
and AH in front and the vitreous humour behind and is supported by an elastic 
capsule and the ciliary zonule (the suspensory ligaments) which is itself attached 
to the ciliary body. The iris, a pigmented membrane, is the most anterior 
portion of the vascular tunic of the eye made up of a flat bar of circular muscle 
fibres surrounding the pupil and a thin layer of smooth muscle fibres by which 
the pupil is dilated, thus regulating the amount of light entering the eye. It is 
covered by two layers of epithelia which are continuous forward extensions of 
the pigmented and nonpigmented layers of the ciliary body. The ciliary body is 
the middle thickened portion of the vascular tunic anterior to the ora serrata (the 
terminating point of the retina at the ciliary body), connecting the choroid with 
the iris. It is composed of corona ciliaris (the ciliary processes and folds), 
ciliary ring, ciliary muscle and a basal lamina. The ciliary processes are finger 
like projections, approximately 70 in number in man and 90 to 110 in bovine 
(Prince et al., 1960), projecting from the ciliary body. Contained in them is a 
mass of capillaries which are covered by a double layer of epithelium, which has 
an extraordinary apex to apex arrangement. The ciliary epithelia are thought to 
be the key structures responsible for AH production. The choroid is the thin 
portion of the vascular coat extending from the ora serrata to the optic nerve. It 
furnishes blood supply to the retina and conducts arteries and nerves to the 
anterior structures of the eye. The retina is the innermost layer of the three 
tunics of the eyeball surrounding the vitreous body and continuous posteriorly 
with the optic nerve. It is divided into pars optica, which rests upon the choroid, 
pars ciliaris which rests upon the ciliary body, and pars iridica which rests upon 
the posterior surface of the iris. Grossly, the retina is composed of an outer 
pigmented layer (pars pigmentosa), and an inner transparent layer (pars nervosa)
6which make up the pars optica. The rods and cones layer in the latter forms the 
percipient element of the retina (i.e., the element that responds to visual stimuli 
by a photochemical reaction) and is connected with the nerve fibre layer by 
nerve fibres which join to form the optic nerve. The optic nerve in turn carry 
the impulse to the brain.
The AH and vitreous body are contained in the two spaces within the eyeball. 
The larger space is situated between the lens and retina and contains the vitreous 
humour. The smaller space, termed the aqueous chamber, is the space between 
the internal surfaces of the cornea and lens. The aqueous chamber is itself 
divided into the anterior and posterior chambers. The anterior chamber contains 
most of the aqueous and is the space between the anterior surface of the iris and 
the internal surface of the cornea. The posterior chamber is the name given to 
the smaller space between the lens and the iris.
The vitreous is a clear mass and physiologically a hydrogel bounded by a 
hyaloid membrane. Forward extensions of the hyaloid membrane form the 
suspensory ligaments supporting the lens, known as the zonule. The vitreous is 
probably not a tissue in proper sense, but rather a product of the surrounding 
tissue, the neuroretina, the water content being extremely high, between 98% 
(Redslob, 1932) and 99.7% (Sullmann, 1951). It allows light to reach the retina 
and nutrients to diffuse from the ciliary body to the retina. The cornea and lens 
are nourished by a process of diffusion from the vitreous and AH of dissolved 
oxygen and nutrients, derived from the various capillaries. The cornea also 
absorbs oxygen by diffusion directly from the atmosphere.
7The Ciliary Epithelium
AH is formed by the CE of the ciliary processes projecting from the ciliary body 
( Fig. 2). The bulk of the ciliary body consists of unstriated muscle arranged in 
three bundles: longitudinal, radial and circular. The inner surface of the body 
can be divided into two parts: the anterior third consists of ciliary processes
and is termed the pars plicata, while the smooth posterior two thirds is termed 
the pars plana (fig. 2). Projecting inwards from the pars plicata region into the 
posterior chamber are approximately 70 radial ridges - the ciliary processes. 
Each process is 1 mm high, 2 mm long antero-posteriorly and 0.5 mm wide. In 
the bovine these processes are particularly well developed. The ciliary 
processes have a rich blood supply and are probably the most heavily 
vascularised part of the eye. Each process contains a mass of capillaries, so 
arranged that each comes into close relationship, at some point in its course, with 
the surface of the CE covering the ciliary processes.
The CE consists of two layers of cells, the columnar non-pigmented (NPE) and 
the cuboidal pigmented epithelial (PE) cells. The inner, NPE layer is next to 
the AH or vitreous. The outer layer is heavily pigmented and represents the 
forward continuation of the retinal pigment epithelium whilst the NPE layer is 
the forward continuation of the neuroepithelium from which the retinal cells are 
derived. The cells of this epithelium are considered to be responsible for AH 
secretion and show characteristic features of secretory epithelia under the 
electron microscope, i.e. interdigitations of the lateral surfaces of adjacent cells 
and basal infoldings (Pappas and Smelser, 1958, 1961). The relations of the 
epithelial cell layers are of importance, since the secreted aqueous must be 
derived from the blood in the capillaries of the ciliary stroma and thus secretion 
must occur across both layers. The bases of the NPE cells line the posterior
Fig. 2. Posterior view of the ciliary body and lens, showing 
ciliary processes (Wolff, Anatomy of the Eye and O rbit, 1968).
8chamber whereas the bases of the PE cells rest on the ciliary body stroma (Fig. 
3). The apices of the PE and NPE cells are thus in contact with one another. 
This unusual arrangement is the result of the invagination of the neuroepithelial 
layer during embryogenesis. Despite this arrangement, the secretory process is 
directed from apex to the base of the non-pigmented cells along the lateral 
intercellular canals which are 'closed' at the apical ends by dense junctional 
complexes (Cole, 1977) (Fig. 3).
Tight junctions are always present at the apices of the NPE cells. Many gap 
junctions usually are found between the lateral surfaces of the PE cells and less 
frequently between the lateral surfaces of the NPE cells. Gap junctions and 
puncta adherentia are located between the PE and NPE cells (Fig. 4). This 
highly integrated epithelium is responsible for secretion of AH and affords 
attachment to the ciliary zonules (Fig. 5). All ancillary functions to maintain 
proper transport activity, diffusional characteristics, mechanical stability of the 
epithelium etc. depend upon the properties of these specialized intercellular 
junctions. (Raviola and Raviola, 1978). AH production is only possible if the 
transport activity of the multitude of epithelial cells is precisely coordinated and 
is not dissipated by free diffusion of water and solutes along the intercellular 
clefts of the epithelium. On the other hand, mechanical stability is an essential 
prerequisite for the epithelium to withstand the tensile force of the elastic 
zonular fibres. The tight junctions between the NPE cells and nonfenestrated 
iris capillaries exclude large molecules from the AH (Green, 1984; Novack and 
Leopold, 1988). Thus these specialized junctions constitute the most important 
part of the blood-aqueous barrier.
Tight junctions between NPE cells represents the permeability barrier which 
prevents diffusion of blood-borne macromolecules into the AH (Shiose, 1970;
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the ciliary epithelium (Davson, Physiology of the Eye , 1990).
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Fig. 4. Diagram of the intercellular junctions in the ciliary 
epithelium (Raviola, 1977).
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Fig. 5. Diagram showing ciliary zonules and direction of flow 
of AH from the posterior to the anterior chamber (from Kolker, 
A. E. and Hetherington, J., Jr.: Becker-Shaffer’s diagnosis and 
therapy of the glaucomas, ed. 4, St. Louis, 1976, The C. V. 
Mosby Co.).
9Vegge, 1971; Smith and Rudt, 1973; Raviola, 1974, 1977; Raviola and Raviola, 
1978). Zonula occludens (tight junction) are impermeable to macromolecules 
and restrict the paracellular movement of ions and small molecules without 
preventing it altogether.
A large number of gap junctions between both the NPE and PE cells with greater 
concentration at the interface between the two epithelial layers constitute a 
striking morphological feature of the CE. These junctions, less commonly 
referred to as nexuses or macula communicans, are membrane specializations 
containing channels that mediate movement of ions and small molecules (Saez et 
al., 1993). In electron micrographs of thin sections, they appear as regions of 
intercellular contact where apposed plasma membranes of adjacent cells are 
separated by a gap junction of 2 - 3 nm (Saez et al., 1993). Gap junctions 
mediate both electrical and metabolic coupling between cells (Revel and 
Karnovsky* 1967; Pappas et al., 1971; Gilula et al., 1972)
Desmosomes and their organization in the CE indicates that they are typically 
similar to other epithelia (Staehelin, 1974; McNutt and Weinstein, 1973). 
Desmosomes occur in small numbers throughout the CE of monkey but are 
absent between NPE of rabbit (Raviola and Raviola, 1978).
Puncta adherentia are large and numerous between pigmented cells and at the 
interface between the two epithelial layers (Raviola and Raviola, 1978). They 
are associated with cytoplasmic microfilaments and may anchor the contractile 
apparatus of the CE cells to the plasmalemma.
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The Blood-Ocular Barriers
The striking differences between the composition of plasma and the AH means 
that substances encounter difficulty in passing from one fluid to the other. And 
also there is no barrier between the posterior chamber and the vitreous body and 
between the vitreous humour and the retina. Horseradish peroxidase and even 
Thorotrast particles can pass from the vitreous into the intracellular spaces of the 
retina (Smelser et al., 1965). The movement of horseradish peroxidase is only 
stopped at the tight junctions of the PE of retina (Peyman and Apple, 1972; 
Peyman and Bok, 1972). Thus to maintain the normal composition of AH, 
which is distinct from the plasma, some kind of barrier must be imposed in all 
the associated structures separating the AH, vitreous and the retina from the 
plasma. All such structures have either endothelial and/or epithelial barriers. 
In the mammalian eye, endothelial barriers are localized in the vessels of the 
retina, optic nerve, ciliary muscle and the iris. Epithelial barriers are present in 
the PE of retina, the NPE of the ciliary body and the posterior layer of the iridial 
epithelium (Raviola, 1977). All these constitute the two important barrier 
systems, namely the blood-vitreous or the blood-retinal barrier and the blood- 
aqueous barrier. Both these barriers thus have endothelial and epithelial parts 
and prevent almost all protein movement and they are effective even with respect 
to low molecular weight solutes, such as sucrose and fluorescein (Bill, 1975).
Blood-Vitreous or Blood-Retinal Barrier
The endothelial cells of the retinal capillaries and the PE of the retina represent 
respectively the endothelial and epithelial parts of the blood-retinal barrier. The 
endothelial cells of the retinal capillaries are relatively thick, without 
fenestrations and attached to each other by tight junctions. They prevent both
11
outward and inward movement of horseradish peroxidase as examined by 
injecting intravenously and into the vitreous. However, after intravenous 
injection, horseradish peroxidase was observed in pinocytic vesicles both in the 
retinal and optic nerve capillaries but absence of the material outside the vessels 
even after 2  hours indicated that in these vessels pinocytosis did not cause any 
appreciable outward transport (Peyman and Apple, 1972; Peyman and Bok, 
1972). The epithelial part of the barrier, i. e. the PE separates the choroidal 
fluid from the retinal tissue fluid and is very important because choroidal tissue 
fluid is likely to be very similar to plasma.
The Blood-Aqueous Barrier
The ciliary and the iridial epithelia constitute the epithelial part of the barrier and 
protect the posterior chamber from circulating macromolecules. The other is the 
endothelial part and is constituted by the non-fenestrated iris capillaries. This 
prevents movement of macromolecules from the lumen of the iris vessels into the 
iridial stroma. Horseradish peroxidase does not pass through the walls of iris 
capillaries (Vegge, 1971).
The double layer CE is in fact a forward continuation of the retina. It is the 
; NPE which constitutes the barrier. These cells are attached to each other by tight 
junctions and several studies have shown that penetration of horseradish 
peroxidase from the stroma of the ciliary processes into the posterior chamber is 
prevented by these junctions (Shabo and Maxwell, 1972; Vegge, 1977)
Since the blood-ocular barriers are largely impermeable even to small water 
soluble substances, such as glucose and amino acids, important metabolic 
substrates have to be transported through these barriers by means of carrier-
mediated transport systems. The blood-aqueous barrier contains transport 
systems for glucose and several amino acids (Reddy, 1979) and transport system 
for glucose, amino acids, lactate and choline have been identified in the blood 
retinal barrier (Dollery et al., 1971; Millar and Steinberg, 1976; Tomquist, 1979; 
Aim et al., 1981; Tomquist and Aim, 1982; Karlsson et al., 1984; Aim and 
Tomquist, 1985)
Blood Supply to the Eye
The blood vessels of the choroid supply many of the internal structures of the 
eye. The choroid, ciliary body and iris are supplied by the ciliary system of 
arteries, comprising the medial and lateral long posterior ciliary arteries, the 
short ciliary and the anterior ciliary arteries. These are often referred to as the 
uveal vessels. They arise from the main arterial supply to the eye, the 
ophthalmic artery, which is itself derived from a branch of the internal carotid 
artery in the human. Venous blood from the uvea drains into the episcleral 
veins, fine veins running through the sclera, and from there into the four vortex 
veins, finally leaving the eye by way of the superior and inferior ophthalmic 
veins. The nervous components of the retina are supplied from the central 
retinal artery, a branch of the ophthalmic artery arising proximal to the ciliary 
arteries. The venous blood from the retina drains into the retinal veins and then 
into the ophthalmic veins.
Special Features of Ocular Blood Supply in Bovine
The bovine eye has a unique vascularization in which the ciliary artery provides 
most of the blood flow to the eye (Prince et al., 1960). Also in respect of 
anterior uvea, the greater arterial circle, formed by the anastomosis of the two
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long posterior ciliary arteries and the anterior ciliary arteries, is very well 
developed in this animal (the greater arterial circle in the human has been named 
the major circle of the iris, inappropriately, because the circle is actually located 
in the ciliary body and also formed by the ciliary system of arteries). Thus 
cannulating one of the long posterior ciliaiy artery in bovine eye allows 
circulation to the anterior uvea; and catheterizing the ciliary artery before its 
division into medial and lateral ciliary arteries, the whole eye can be kept viable 
for a considerably longer period of time and indeed a very recent attempt by de 
Coo et al. (1993) has proven to be successful in keeping the eye metabolically 
active for up to 9 days.
In bovine, orbital blood supply is provided largely by the external ophthalmic 
artery. This is a branch of the internal maxillary artery, which itself is a 
continuation of the external carotid artery. A smaller artery, the internal 
ophthalmic artery, arising from the internal rete, also contributes to the orbital 
supply by entering the orbit through the optic foramen and then joining with the 
medial long posterior ciliary artery.
The ciliary artery originates from the external rete (an arterial network formed by 
the arborization of the external ophthalmic artery) (Fig. 6 ), and it passes superior 
to the optic nerve. It then divides usually into the larger medial and smaller 
lateral ciliary arteries which travel parallel to each other, both loosely attached to 
the optic nerve. Both arteries bifurcate before reaching the globe and each 
further breaks up into several short posterior ciliary arteries at the globe. Two 
branches of the large medial ciliary artery each form a long posterior ciliary 
artery, penetrate into the globe, one along its medial side and the other along its 
lateral side, well before the equator is reached. These two long posterior ciliary 
arteries form the chief supply to the major arterial circle and hence to the ciliary
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processes of the ciliary body. The short posterior ciliary artery penetrates the 
sclera at a variable distance from the optic nerve entrance. The retinal arteries 
in bovine are branches of some of the short posterior ciliary arteries and they 
enter the globe near where the optic nerve penetrates the globe. A schematic 
diagram of the orbital arterial system in ox is shown in fig. 6 .
The four vortex veins, as a rule one vein in each quadrant of the posterior pole 
of the eye, drain all the blood from the ciliary body and the iris. Most of the 
blood is drained by the vortex veins although there are minor anastomotic 
communications with anterior episcleral vessels. AH is drained into these 
episcleral vessels from the collector channels leaving the canal of Schlemm. 
Prince et al. (1960) noted that the ox has a true canal of Schlemm. The vortex 
veins, after leaving the globe, join to the supraorbital vein, inferior orbital vein 
and to the external rete which, after multiple anastomotic communications 
among them, are finally drained by the orbital vein.
Ocular Nerve Supply
The eye has a very rich nerve supply. Apart from the optic nerve, there are 
sympathetic nerves which are branches of the cervical sympathetic chain, and 
parasympathetic nerves from the oculomotor and facial nerves. Additionally, 
there are sensory nerves which are branches of the trigeminal nerve. These 
nerves are distributed only within the uvea and the extraocular parts of the retinal 
blood vessels (Bill and Sperber, 1990)
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Sympathetic nerves originate in the superior cervical ganglion, and 
parasympathetic nerves in the pterygopalatine and ciliary ganglia. With the 
exception of the visual apparatus, sensory impulses are conveyed through the 
long and short ciliary nerves. The long ciliary nerves are composed mainly of 
axons of nerve cells in the Gasserian ganglion - the ganglion of the trigeminal 
nerve. These nerves convey impulses from the iris, ciliary body and cornea. 
The short ciliary nerves also contain axons of the trigeminal; they pass through 
the ciliary gangion into the naso-ciliary nerve. These fibres carry impulses from 
all parts of the eyeball, but principally from the cornea. Preganglionic 
parasympathetic motor fibres to the ciliary muscle and iris run through the lower 
division of the oculomotor as the motor root of the ciliary ganglion; the 
postganglionic fibres supplying the muscles are contained in the short ciliary 
nerves.
Sympathetic fibres from the superior cervical ganglion enter the orbit as the 
sympathetic root of the ciliary ganglion and run into the short ciliary nerves to 
supply the vessels of the globe and the dilator pupillae of the iris. Other 
sympathetic fibres avoid the ciliary ganglion, passing through the Gasserian 
ganglion and entering the globe in the long ciliary nerves, whilst still others enter 
the globe in the tunica adventitia of the ciliary arteries.
Composition of Aqueous Humour
AH has a unique composition that differs from plasma in many respects. 
Several laboratory studies suggest that AH is not simply a filtrate. Rather it is 
an intraocular fluid whose production is homeostatically controlled and some of 
whose individual components are in a state of rapid turnover. The complex 
composition of AH is modulated by many factors, and changes and/or
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imbalances in its carefully tuned chemical composition are thought to be both the 
cause and consequences of pathological condition in the anterior segment of the 
eye. For example, biochemical analysis of AH has identified high molecular 
weight lens protein as a cause of elevated IOP in phacolytic glaucoma (Epstein et 
al., 1978) and ascorbic acid concentration in AH differs in normal subjects and 
in COAG patients (Lam and Lee, 1975). Several studies have shown that AH 
can act in tissue culture to promote proliferation (Albrink and Wallace, 1951; 
Benezra and Sachs, 1974; Herschler et al., 1980; Herschler and Tucson, 1983) or 
to inhibit cellular growth (Komblueth and Tenenbaum, 1956). While these 
opposing findings can be explained by the different experimental conditions and 
procedures, the possibility of AH being a growth modulator should be 
considered. Thus AH may be a growth medium in which stimulatory agents and 
cytotoxic factors act in a concerted manner to affect changes in cell number, 
morphology and function. Understanding the nature of these modulators and 
their functions may provide a clue to solving the problems of glaucoma. It is 
possible that derangement of such a modulator system in the AH may lead to 
changes in the proliferative capacity, biosynthetic properties and ultimately the 
survival of the cells of the trabecular meshwork resulting in an increased 
resistance to outflow.
The AH has a wide range of chemicals in its composition including ions (Na+, 
K+, Ca2+, Mg2+, Cl", HCO3" etc.), crystalloid or low molecular weight 
substances (glucose, ascorbate, lactate, pyruvate, urea, H2 O2 , amino acids etc), 
colloidal or high molecular weight substances (proteins, lipids), biologically 
active substances ( catecholamines, eicosanoids, hormones etc.) as well as some 
miscellaneous substances such as hyaluronic acid, hyaluronidase etc.). These 
chemical components derive from a number of sources, the principal ones being 
the plasma (by passive diffusion) and the CE (by active secretion). Specific
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substances also enter the AH by diffusion or secretion from surrounding tissues: 
comeal endothelium, the crystalline lens, trabecular meshwork, iris and the 
vitreous. These tissues also utilize a number of nutrients present in the AH, e.g. 
the main source of glucose for the cornea and the lens is the AH. Thus the 
composition of AH depends on the nature of the freshly secreted fluid from the 
CE plus the subsequent passive and active exchange across adjacent tissues. 
The rate of turnover of AH also contributes to modulation of the composition by 
way of accumulating waste products of the surrounding tissues. The metabolic 
requirements of tissues such as cornea, lens and trabecular meshwork are met by 
the continuous flow of AH through the posterior and anterior chambers of the 
eye. Diffusional and metabolic alterations of the AH occur continually. For 
example the lens alters the AH by using glucose, amino acids and other solutes, 
releasing metabolic wastes, such as lactic acid and may act as homeostatic 
reservoir for amino acids. Normal composition of AH reflects the normality of 
all the associated structures contributing in AH production and drainage. Tables 
1, 2 and 3 show normal concentration of important components of AH in 
comparison to the plasma.
Table 1. Biologically active substances in AH and plasma.
Components Aqueous Humour (ng.ml'l) Plasma (ng.mH)
Prostaglandins 2 —
Cyclic AMP 8 —
Catecholamines
Noradrenaline *0.8-1.14 0.311
Adrenaline 0-0.13 0.097
Dopamine 0 .12 0.037
Adapted from Cooper et al. (1984); aTrope and Rumley (1985).
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Table 2. Protein composition of AH in comparison to plasma.
Components AH (pg.ml- !) Plasma (jng.ml“l)
Protein (total) a12.4 + 2.0 7000
Albumin b5.5 - 6.5 3400
Transferrin b1.3- 1.7 —
Prealbumin b0.3 - 0.4 —
Fibronectin c0.25 29
Immunoglobulins
IrG c3.0 1270
IgE (Iu.ml'l) c<0.75 16-218
Sources: aTripathi et al. (1989); b Inada et al. (1984); cBerman (1991).
Table 3. Concentration of electrolytes and low molecular weight solutes in 
human AH and plasma.
Components Aqueous Humour Plasma
Electrolytes (mM)
Na+ 142 130 - 145
K+ 4 3.5-5.0
Ca2+ 1.2 2 .0  - 2.6
Mg2+ 1 0.7- 1.1
ci- 131 92 - 125
HCO-3 20 24-30
Organic solutes(mM)
Ascorbate 1.1 0.04 - 0.06
Lactate 4.5 0.5 - 0.8
Citrate 0.1 0.1
Glucose 2.7-3.9 5.6 - 6.4
Urea 4.1 3.3 -6.5
Glutathione 0 .0 0 1 - 0.01 —
aH?0? 0.024 - 0.069 —
bAmino acids (total) 0.17 0 .1 2
Adapted from Riley (1983); aSpector and Gamer (1981); bDavson (1969).
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Aqueous Humour Formation
There is now general agreement that AH is produced by the double-layered CE 
and enters the posterior chamber in the first instance. There are three basic 
mechanisms by which materials may cross an epithelial barrier, namely 
diffusion, ultrafiltration and active transport.
All three basic processes contribute to the formation of AH at one step or other. 
Two major steps are implicated in the formation of AH. The first step is the 
development of plasma filtrate within the stroma of the ciliary processes by 
means of ultrafiltration. Due to the fenestrated nature of the ciliary capillaries 
this ultrafiltrate contains a higher percentage of plasma proteins. Still the 
capillary wall is a considerable barrier for the plasma proteins. Studies on the 
dynamics of extravascular plasma proteins in the ciliary processes indicate that 
the net filtrate from the capillaries contain about 4% of the albumin and 3% of 
the y-globulin in the plasma (Bill, 1968). Protein content in the ciliary stroma 
may be extremely high in some species, e.g. in rabbit it is about 75% of that in 
the plasma (Bill, 1968). The high protein concentration in the ciliary stroma 
reduces transcapillary difference in the oncotic pressure, which in turn is very 
important for filtration from the capillaries. The second step is the extraction of 
materials (electrolytes and other substances) by the CE into the AH, against a 
concentration gradient, by means of active secretion of solutes followed by 
osmotic flow of water to form the AH (Cole, 1977)
The presence of tight junctions between the NPE cells and the non-fenestrated 
iris capillaries is considered to be morphological basis of the blood-aqueous 
barrier. Blood-borne large molecules, such as proteins cannot pass this barrier 
(Green, 1984b; Novack and Leopold, 1988) The ocular barriers are effective
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even with respect to low molecular weight solutes, such as sucrose and 
fluorescein (Bill, 1975)
AH formation was once considered a simple process of diffusion or 
ultrafiltration of fluid from the plasma across the CE. However, the 
concentration of certain solutes in the plasma was inconsistent with the view 
(Davson, 1955; Reddy, 1957) and it is now well accepted that active transport is 
the most important factor in AH formation and that transepithelial ultrafiltration 
by hydrostatic pressure may not occur (Sears, 1991). The rate of AH formation 
depends on the rate of active transport by the CE (Cole, 1977). The arguments 
against transepithelial ultrafiltration are: First, Bill's (1975) calculation indicates 
that the value for the transciliary epithelial difference in hydrostatic pressure is 
less than the oncotic pressure of the stromal tissue fluid. The stroma of the 
ciliary processes has oncotic pressure (approximately 14 mmHg) as a result of 
protein leakage through the fenestrated capillaries. Assuming an IOP of 15 
mmHg, Bill showed that a capillary hydrostatic pressure greater than 29 mmHg 
would be necessary for the formation of any ultrafiltrate. The value of capillary 
hydrostatic pressure has been estimated to be 27 to 28 mmHg (Bill, 1973) and 25 
to 33 mmHg (Cole, 1977). Green and Pederson (1972) calculated that a 
capillary pressure greater than 50 mmHg would be necessary to promote 
ultrafiltration through the CE. Thus, the estimated values of capillary 
hydrostatic pressure in the CE and a consideration of the hydrostatic and oncotic 
pressures involved do not favour ultrafiltration at all. Second, a good deal of 
formation of AH in subhuman primates continues at a very low arterial blood 
pressure. Third, although AH formation is oxygen dependent, there is an 
independence of AH flow from increments of ciliary blood flow (Chiou et al., 
1990; Chiou and Chen, 1993). In a recent study Hong and Chiou (1993) 
showed that the extensively used p-adrenergic antagonists, timolol, levobunolol
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and betaxolol, which reduce IOP by reducing AH formation, all increased ocular 
blood flow considerably (up to 55%). A systemic carbonic anhydrase inhibitor, 
ethoxzolamide, was also shown to cause an increase of blood flow up to 56%. 
Increased blood pressure should increase the ultrafiltration. Hence an increase 
in AH formation would be expected with these drugs if ultrafiltration were a 
contributing factor in AH formation. Finally, Brodwall and Fischbarg (1982) 
showed that the hydraulic conductivity of the rabbit CE was too low to be 
compatible with the production of AH by transepithelial ultrafiltration.
Active secretion by the CE is accomplished by the transport of one or more ions, 
such as Na+ (Kinsey, 1971; Cole, 1977; Pesin and Candia, 1983; Krupin et al., 
1984; Helbig, et al., 1989a, 1989b; Sears et al., 1991b), Cl" (Cole, 1969; Holland 
and Gipson, 1970; Kishida et al., 1983; Pesin and Candia, 1983; Helbig et al., 
1989a) and HCO3 - (Cole, 1977; Maren, 1977; Helbig et al., 1989b; Wolosin et 
al, 1991)).
The membrane bound enzyme complex Na+,K+-ATPase is an energy-dependent 
active transport system present predominantly in the basolateral membranes of 
the NPE but also on the PE (Cole, 1964; Cole, 1984; Riley and Kishida, 1986; 
Coca-Prados and Lopez-Briones, 1987; Flugel and Lutjen-Drecoll, 1988; 
Usukura et al., 1988). Na+,K+-ATPase is an enzyme that catalyses the 
hydrolysis of ATP (ATP —> ADP + P) whilst energizing the Na+»K+-pump. A 
marked decrease in AH formation occurs after poisoning of Na+,K+-ATPase 
with ouabain (Cole, 1977; Bonting and Becker, 1964). Vanadate also blocks 
Na+,K+-ATPase activity and its topical administration reduces AH formation in 
rabbit (Becker, 1980; Krupin et al., 1980a) and in monkeys (Podos et al., 1984). 
It is likely that Na+ is the actively transported ion, with Cl" or HCC>3" following 
to maintain electroneutrality. Measurement of electric potential across the CE
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indicates that the aqueous is positive with respect to the stroma and ouabain 
reduces this potential (Cole, 1961; Pesin and Candia, 1983; Krupin et al., 1984). 
It is clear from these studies that sodium is the transported ion and its pump 
generates the transepithelial potential difference. In a recent study (Sears et al., 
1991) in intact isolated ciliary processes, free of vascular and connective tissue 
components but in which tight junctions and gap junctions of the epithelial 
bilayer were preserved, ouabain has been shown to reduce the transepithelial 
potential difference virtually to zero, confirming the singular importance of the 
sodium pump to generate the potential difference required for transport.
Active transport of C1‘ may also occur, although the magnitude of this transport 
is probably small compared to that of Na+ (Cole, 1969). Although there is no 
strong evidence to suggest Cl" as a primary secreted ion coupled to cell 
metabolism, there appears to be a role for chloride transport in the CE. Some of 
the short circuit current and transepithelial potential difference across isolated 
iris-ciliary body has been shown to be chloride-dependent (Cole, 1969; Holland 
and Gipson, 1970; Kishida et al., 1983). Net chloride fluxes towards the 
aqueous by active transport have been reported (Saito and Watanabe, 1979; Saito 
et al., 1980). Presence of chloride channels has been demonstrated in shark CE 
and intracellular chloride activity in these cells has been shown to be greater than 
that predicted from considerations of electrochemical equilibrium (Wiederholt 
and Zadunaisky, 1986). Single chloride channel activity have been 
demonstrated in rabbits (Yantomo et al., 1987).
Formation of HCO3 " by the carbonic anhydrase, which catalyzes the reaction 
H2 O + CO2  -> HCO3 " + H+ is important in the formation of AH. There exists 
substantial evidence that acetazolamide (a carbonic anhydrase inhibitor) directly 
affects the transport mechanisms in the CE (Cole, 1977). The exact mechanism,
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however, is not known. The existing hypotheses are (i) inhibition of carbonic 
anhydrase causes a decrease in HCO3 " available for diffusion into the 
intercellular channels to maintain electroneutrality, (ii) a change in intercellular 
pH may inhibit Na+,K+-ATPase, (iii) decreased availability of H+, produced by 
the carbonic anhydrase-catalysed reaction, decrease the exchange of H+ for Na+ 
and reduces the availability of intracellular Na+ to be transported into the 
intercellular channel, (iv) HCC>3" dependency of sodium pump (Sears et al.,
1991). Acetazolamide decreases the rate of Na+ and HCO3 ’ transport into the 
posterior chamber by equimolar amounts, suggesting a linkage of the accession 
of these two solutes (Maren, 1976; 1977).
Among other mechanisms recently uncovered for transport of HCC>3" across the 
CE, in cultured bovine PE, is a chloride-dependent uptake (Helbig et al., 1988; 
1989a). Uptake is not the same as vectoral transport; nonetheless, it has been 
demonstrated that a sodium-bicarbonate cotransporter and a chloride-bicarbonate 
exchanger are present in bovine PE.
Other ions and low molecular weight solutes, such as amino acids, glucose, 
inositol, ascorbic acid etc. are also reported to be secreted by the CE, but the 
exact mechanism of their transport into the posterior chamber is not clearly 
known (Berman, 1991). There appears to exist an independent transport system 
for many of them. A statistical study of the covariation of the concentrations of 
amino acids and related compounds in the human AH suggested existence of six 
transport systems in the CE: three independent mechanisms for neutral amino 
acids and independent mechanisms for basic amino acids, acidic amino acids and 
urea (Ehlers, 1978). The concentration of ascorbic acid in the aqueous is about 
20  times that in the plasma and there is evidence that it is transported actively to 
the AH (Becker, 1967; Chu and Candia, 1988; Helbig et al., 1989).
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In view of the greater concentration of certain enzymes including Na+,K+- 
ATPase, adenylate cyclase and carbonic anhydrase etc. (Tsukahara and 
Maezawa, 1978; Mishima et al, 1982a) and greater development of intracellular 
organelles and greater metabolic activities of NPE compared to PE 
(Shantaveerappa and Bourne, 1964; Caprioli and Sears, 1983), it has been 
suggested that the NPE plays the dominant role in AH formation.
The mode of action of fluid formation by the transporting epithelium (CE) has 
been best described by the standing-gradient osmotic flow model (involving 
active transport of solutes) proposed by Diamond and Bossert (1967). A steady 
state, standing osmotic gradient is maintained in the lateral intercellular channel, 
with the greater concentration of solute occurring proximally in the channel 
adjacent to the tight junction (Fig. 7). This hypertonic fluid in the
COj+HjO ^A-^HCOyt-U
d .
PC
Osmcl ie watat p  ux
Fig. 7. A diagram of the hypothetical standing-gradient osmotic flow model 
(Diamond and Bossert, 1967). Na+K+-ATPase is located in higher 
concentration along lateral cellular interdigitations. PC = posterior chamber.
proximal region of the channel forces an osmotic flow of water into the channel. 
The solute concentration decreases from the proximal to the distal end of the 
channel as water enters; slightly hypertonic fluid flows into the posterior 
chamber as nascent AH. The success of this model in explaining AH
production requires the restriction of fluid and solute entry into the intercellular 
channel by the tight junction, i. e. there should be no ultrafiltration and in fact 
this may be the case.
Drainage of Aqueous Humour
AH enters the posterior chamber from the ciliary process flows around the lens 
and through the pupil into the anterior chamber (Fig. 5). From the anterior 
chamber it leaves the eye and enters the general venous circulation, by bulk flow 
via two pathways, both commencing at the anterior chamber angle. One 
pathway runs through the trabecular meshwork across the inner wall of 
Schlemm's canal and then into collector channels, aqueous veins and the general 
venous syetem. This is called the anterior, trabecular or conventional route. 
There are three layers of meshwork between the anterior chamber and the inner 
wall of Schlemm's canal. The fisrt layer is the uveal meshwork, which is the 
forward extension of the ciliary muscle inserting in the cornea (Bill and 
Svedberg, 1972). The second layer is constituted by several sheets of 
connective tissue extending between the scleral spur and the cornea. The third 
layer, called the juxtacanalicular tissue, is an endothelial meshwork between the 
corneoscleral meshwork and the inner wall of Schlemm's canal. It contains 
collagen and elastic fibres, a ground substance and several layers of endothelium 
enmeshed in a matrix of glycosaminoglycans, proteoglycans and other 
macromolecules. The major resistance to outflow resides at the juxtacanalicular
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tissue (also called cribriform plexus) and the inner wall of Schlemm’s canal. 
The second pathway is the posterior, uveoscleral or unconventional route. 
Aqueous flows from the chamber angle across the iris root and the anterior face 
of the ciliary muscle, through the connective tissue spaces between the muscle 
bundles of the ciliary body. These spaces in turn open into the suprachoroid 
from which fluid can pass through the scleral substance or through the 
perivascular spaces into the episcleral tissue and then into the venous circulation. 
The pressure in the suprachoroid is lower than in the anterior chamber, the 
difference being at least a few mmHg under normal conditions, thus favouring 
the uveoscleral outflow.
In primate most of the drainage occurs through the trabecular route and a small 
portion is drained via the uveoscleral route. A small part of the AH flows into 
the vitreous to be absorbed into the posterior part of the eye; some of the 
aqueous apparently is absorbed at the ciliary body (Moses, 1990). Lower 
animals have no well developed canal of Schlemm, but a sinus structure having 
the same function (Bill, 1975). In human eyes, the uveoscleral outflow accounts 
for about 5 to 20 percent of total outflow (Bill and Phillips, 1971; Bill, 1975), 
while in monkey outflow is fairly equally distributed between the two routes 
(Bill, 1966a, 1971). In rabbit and cat, there is comparatively little uveoscleral 
drainage (Bill, 1966b; Cole and Monro, 1976).
Intraocular Pressure
The contents of the eye are under a pressure, which is larger than in most other 
tissues, due to continuous formation of AH. Mean normal IOP in man is about 
15 mmHg with the highest and lowest accepted values of 21 mmHg and 10.5 
mmHg respectively (Davson, 1990; Hurvitz et al., 1991). IOP can vary between
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species, individual and even between eyes of the same individual. This pressure 
is governed by several factors, such as the rate of secretion of AH, resistance to 
outflow (by at least 2  pathways) and episcleral venous pressure.
Dynamics of Aqueous Humour
The flow of aqueous through the different compartments and outflow pathways 
of the eye is one of typical hydraulic flow where the source of energy is the 
difference of pressure at the ends of the passage of flow; the pressure at the 
upstream end is of course greater. The difference of upstream and downstream 
pressure is called pressure head (AP). The rate of hydraulic flow is related to 
Poiseuille's law. It has been incorporated into the Goldman equation:
F = C (Pi - Pe) or F = AP.C 
This equation relates aqueous flow (F) to facility of outflow (C) and AP. The 
pressure head in case of AH drainage is the difference between IOP (Pj) and the 
episcleral venous pressure (Pe), i.e. the pressure in the vessels into which AH 
drains. The mean normal value for outflow facility in human is estimated as 
0.25 plmin’l. mmHg'l applied pressure (Davson, 1990)
Glaucoma
The term glaucoma encompasses a group of eye diseases characterised by 
progressive defects in the visual field and ultimately loss of vision. It is 
usually, though not necessarily, associated with an increase in IOP. The loss of 
visual field is associated with damage to the optic nerve which is manifested 
clinically as cupping of the optic disc. The boundaries between glaucoma, low 
tension glaucoma and ocular hypertension are often indistinct. However, 
glaucoma is often associated with an IOP of greater than 21 mmHg. Low
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tension glaucoma is the condition whereby the pathological changes associated 
with glaucoma and loss of visual field are present, but with a normal IOP. 
Ocular hypertension is defined as the condition whereby IOP is greater than 21 
mmHg, but there are no pathological changes present associated with glaucoma, 
although this condition frequently heralds the development of glaucoma and 
should be treated accordingly (Jay, 1992). This is because IOP is the most 
important risk factor of glaucoma; the greater the IOP the greater the risk. A 
patient with an IOP >24 mmHg is 10.5 times more likely to develop subsequent 
field loss than a patient with an IOP <16 mmHg (Sommer, 1989).
The disease may be caused by a number of factors, such as: (i) the bowing of the 
iris over the drainage angle, thus partially occluding the passage of aqueous 
through the trabecular meshwork into the canal of Schlemm (narrow angle 
glaucoma, NAG). This leads to an elevated IOP which stretches the scleral 
layer and further leads to cupping of the optic disc. IOP may rise as high as 
diastolic pressure in the retinal vessels, thus giving rise to progressive retinal 
ischemia and detachment, with concomitant increasing loss of visual field 
(scotoma), (ii) Complete occlusion of the trabecular meshwork by bulging of 
the peripheral iris (closed angle glaucoma, CAG). (iii) Partial occlusion of the 
trabecular meshwork by build-up of cellular debris or glycosaminoglycans in the 
juxtacanalicular tissue (chronic open-angle glaucoma, COAG), thus increasing 
the resistance to outflow of AH and consequently IOP. This is the most 
common form of glaucoma all over the world. Again all these types of blockade 
can be caused either from intrinsic ocular problems (primary glaucomas) or in 
relation to other ocular or systemic problems (secondary glaucomas). Further, 
the conditions may be acute, presenting with a sudden increase in IOP and a 
rapid development of visual loss secondary to optic neuropathy and corneal 
oedema; or chronic, developing insidiously over a long period of time, with a
29
comparatively lower IOP, sometimes even in the normal range, presumably 
caused by the optic nerve being particularly susceptible to the development of 
glaucomatous optic neuropathy. While much has been written about the 
predisposing factors, such as family history of damage from glaucoma (Heilman 
and Richardson, 1978; Schottensten, 1989), diabetes mellitus, high myopia, 
systemic vascular diseases, age etc., the immediately recognisable causative 
factor is the insufficient drainage of AH leading to an elevated IOP in most types 
of glaucomas. Reduction of IOP by various means, to a level at which optic 
nerve damage ceases, is still the only available and clinically acceptable 
treatment of the most commonly occurring COAG.
GENERAL OUTLINE OF SIGNAL TRANSDUCTION MECHANISMS
AND CELLULAR FUNCTIONS
The unique conceptual framework and the central event for the regulation of 
most, if not all, cellular functions is the reversible phosphorylation of specific 
substrate proteins in specific tissues, mediated by hundreds of extracellular and 
intracellular messenger molecules through their association or interaction with 
various protein phosphorylation systems (Cohen, 1988, 1989; Hardie, 1990; 
Walaas and Greengard, 1991). All protein phosphorylation systems have at 
least three components. The central ones are the phosphoprotein themselves, 
whose biological properties change during phosphorylation-dephosphorylation. 
The other components are the two classes of enzymes which are needed for 
phosphorylation and dephosphorylation reactions. One class includes protein 
kinases which biochemically are phosphoryltransferases. These enzymes 
catalyze the transfer of the y-phosphate group of ATP to the hydroxyl group of a 
serine, threonine or tyrosine residues of the acceptor substrate proteins (Krebs 
and Beavo, 1979; Walaas and Greengard, 1991). Another class includes the
30
phosphoprotein phophatases, which dephosphorylate the phosphoproteins, 
thereby returning the specific phosphorylation system to its basal state (Cohen, 
1989; Hardie, 1990; Shenolikar and Naim, 1991; Garg, 1992). Additional 
components are the associated modulators (Naim et al., 1985b). Thus a 
substrate protein is converted from dephosphorylated to phosphorylated form by 
a protein kinase, and the phosphorylated form is converted back to the 
dephophorylated form by a protein phosphatase. Physiological activity depends 
on the state of phosphorylation of the substrate protein. So the relative activities 
of protein kinase and protein phosphatase determine the state of phosphorylation 
and physiological activity of the specific substrate protein concerned.
Protein Phosphatases
There are hundreds of protein (serine/threonine) kinases in mammalian cytosol 
and nucleus (Hunter, 1987), and also there are certainly hundreds of target 
phosphoproteins. In contrast dephosphorylation appears to be catalysed by a 
relatively smaller number of protein phosphatases. A protein phosphatase is a 
phosphoesterase which catalyses the removal, by hydrolysis, of a phosphate 
group from a hydroxylated amino acid residue of a protein. The protein 
phosphatases involved in the dephosphorylation of serine and/or threonine 
residues appear to be only four in number ( Cohen, 1989; Ingebritsen and Cohen, 
1983a,b; Shenolikar and Naim, 1991).
Mechanism of Phosphorylation of Substrate Proteins
Activation of protein kinases represents the most common and direct causal 
activation mechanism of substrate proteins, although increases in the state of 
phosphorylation can be brought about indirectly either by inhibition of protein
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phosphatases (Walaas and Greengard, 1984; Naim et al., 1988; Hemmings et al., 
1984a, 1990) or by changes in the properties of the protein itself as a substrate 
for distinct protein kinases or phosphatases. Changes in the state of 
phosphorylation of substrate proteins mediate, either directly or through 
additional steps, the generation of biological responses.
Protein Kinases and Their Activation
As mentioned earlier, protein kinases are phosphoryltransferases activation of 
which causes the phosphorylation of specific substrate proteins. There are 
numerous protein kinases as there are hundreds of substrate proteins in various 
tissues (Hunter, 1987; Cohen, 1989). Two important ways have so far been 
identified for the activation of protein kinases:
One is the activation by autophosphorylation which is the intramolecular event 
within the protein kinase itself. A large number of protein kinases undergo 
autophosphorylation and the majority of such kinases have autophosphorylation 
sites, the phosphorylation of which may profoundly change the activity of the 
enzyme involved (Blackshear et al., 1988). Important examples are cyclic 
AMP-dependent protein kinase II (Erlichman et al., 1974; Rubin and Rosen, 
1975), cyclic GMP-dependent protein kinase (Gill, 1977; Lincoln and Corbin, 
1983), Ca2+-calmodulin-dependent protein kinase II (Lou et al., 1986; Lai et al., 
1986,1987).
The second and most important way of activation involves a large number of 
extracellular and intracellular messengers and their specific receptors on the cell 
surface or within the cytoplasm. This is extremely complicated and involves 
four basic mechanisms, known as signal transduction systems. These are:
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( 1) Cyclic nucleotide systems, mediated by the intracellular second messengers 
cyclic AMP, and in certain cases, cyclic GMP. Very recently some 
evidence in support of cyclic CMP [cytidine 3',5'-monophosphate] as a 
third intracellular nucleotide messenger has been put forward (Newton,
1992).
(2) The phosphoinositide system, mediated by the second messengers 
diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3 ), the ultimate 
effect of which is mediated by Ca^+.
(3) Ion channel systems (e.g. ligand-gated ion channels) whose effects are 
usually ultimately mediated by Ca^+.
(4) The tyrosine kinase system, mediated directly by the receptor-kinase 
complex without generation of any second messenger (Robert, Kirk and 
Venis, 1990; Nestler and Greengard, 1984; Walaas and Greengard, 1991).
Thus the large number of messenger molecules (hormones, neurotransmitters, 
local mediators, growth factors etc.) which act at cell surface receptors on 
mammalian cells, produce their effects on target cells through the above 
mentioned basic mechanisms.
It is customary to name a protein kinase after the name of the first or the second 
messenger which is responsible for its activation. Thus the protein kinase which 
is activated by the second messenger cyclic AMP is named as cyclic AMP- 
dependent protein kinase. Similarly cyclic GMP-dependent protein kinase,
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Ca2+-calmodulin-dependent protein kinase, insulin-dependent protein kinase, 
growth factor-dependent protein kinase and so on.
In addition to the above mentioned four basic mechanisms, there appear to be 
other means of regulation of protein kinases. Some first messengers appear to 
produce biological responses by regulating the total amount of specific protein 
kinases in target tissues, e.g. interferon which produce its effect by increasing the 
double stranded RNA-dependent protein kinase (Krust et al., 1982, Sen, 1982) 
and some oncogenic viruses increase the tyrosine kinases (Erikson et al., 1980; 
Hunter and Sefton, 1982) in target tissues. Haeme appears to regulate substrate 
protein phosphorylation by inhibiting rather than activating haeme-regulated 
protein kinase, although the mechanism by which this protein kinase is inhibited 
in the presence of haeme and activated in its absence remain unknown (Hunt,
1980). Still several other cellular messenger, including polyamines (Kuehn and 
Atmar, 1982; Sekar et al., 1982) and the steroid hormones have been shown to 
regulate protein phosphorylation in target tissues. Each of the three classes of 
steroid hormones, namely glucocorticoids, mineralocorticoids and gonadal 
steroids regulate the state of phosphorylation of type II cyclic AMP-dependent 
protein kinase in target tissues (Liu and Greengard, 1974, 1976; Liu et al., 1981). 
Thus with a few exceptions, protein phosphorylation appears to be a common 
pathway through which a large number of regulatory agents produce metabolic 
and physiological responses in diverse tissues.
Thus, the original protein kinase hypothesis (Kuo and Greengard, 1969) which 
states that all of the diverse effects on cell function in nervous and non-nervous 
tissues are mediated through the activation of only one enzyme - the cyclic 
AMP-dependent protein kinase - and the later extension of this hypothesis which 
states that a wide variety of biologically active molecules produce many of their
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metabolic and physiological responses through the regulation of specific protein 
kinases, of which cyclic AMP-dependent protein kinase is just one subclass 
(Greengard, 1978a) are still invaluable assets in understanding cellular function. 
Existence of numerous pathways for the activation of protein kinases supports 
the view that protein phosphorylation is a final common pathway of paramount 
importance in biological regulation.
According to the extended protein kinase hypothesis extracellular 1st messenger 
(hormones, neurotransmitters, local mediators etc.) through their association with 
specific receptors, in most cases also involving a membrane-associated guanine 
nucleotide binding protein (G-protein), stimulate some intermediary enzymes 
(such as adenylate cyclase, guanylate cyclase, phospholipases etc.) to produce a 
generation of second messengers (cyclic AMP, cyclic GMP, Ca^+). The newly 
formed second messengers activate their respective protein kinases, which in 
turn catalyse the phosphorylation of specific substrate proteins. This 
phosphorylation, then, through one or more steps, results in the metabolic or 
physiological response characteristic of the 1st messenger and the specific tissue 
involved. A simplified illustration of the overall process is shown in fig . 8 .
Receptors and Signal Transduction Mechanisms
The receptor can be defined as a molecular structure on the surface of a cell or 
within the cell, which binds with a specific substance, called the agonist or 
ligand, thereby producing a specific physiological response characteristic of the 
agonist and the cell/tissue involved. The basic requirement for a receptor is the 
ability to discriminate signal from 'noise'. To receive the signal, the receptor 
must have an affinity for the messenger (agonist). At the same time the receptor 
must have specificity, in other words, an appropriately low affinity for less
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Fig. 8 . Schematic diagram of postulated role played by protein 
phosphorylation in mediating some of the biological effects of a 
variety of regulatory agents. Abbreviations: EGF, epidermal 
growth factor; PDGF, platelet-derived growth factor; NGF, 
nerve growth factor; FGF, fibroblast growth factor; TGF, 
transforming growth factor; SC, somatostatin C (Nestler and 
Greengard, 1984)
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active agents. Examples of cell surface receptors are receptors for peptide 
hormones, neurotransmitters, local mediators (eicosanoids, histamine, 
bradykinin) etc. and the steroid hormone receptors constitute the examples of 
cytoplasmic receptors. Obviously there are numerous receptors (known or 
unknown) as there are numerous messenger molecules both endogenous 
(associated with and produced by the living body) and exogenous (synthetic 
chemicals such as drugs, allergens etc.)
Types of Receptor-Effector Linkages
The overall process illustrated in fig. 8 , i.e. starting from the extracellular 
messenger through its occupation of specific receptors (cell surface or 
cytoplasmic) to the ensuing physiological responses constitute the different steps 
and components of the signal transduction mechanism. Many different types of 
linkage between receptor occupation and the resulting physiological response are 
involved. Some of them involve a G-protein and other intermediates. 
According to the nature of signal transduction mechanism or receptor-effector 
linkage, four types of receptors have so far been recognised (Rang and Dale,
1991):
(1) Direct ligand-gated channel type. These are the receptors for fast 
neurotransmitters where coupling between the receptor and the ionic 
channel is a direct one not involving any biochemical intermediaries in the 
cell or within the membrane. Examples are the nicotinic acetylcholine 
receptor, the GABAa , glycine and glutamate receptors. The action of these 
transmitters reaches a peak in a fraction of a second, and usually decays 
within a few seconds.
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(2) G-protein-coupled type. Signal transduction by G-protein is a widespread 
mechanism used by a wide variety of hormones, neurotransmitters, and 
autocrine and paracrine factors, to regulate cellular functions. G-proteins 
modulate not only cyclic AMP formation, but also intracellular Ca^+ 
mobilization, arachidonic acid release and, very importantly, membrane 
potential. Membrane potential is not only trigger for neurotransmitter 
release and conduction of nerve impulses. In tissues, such as in some 
secretory cells, it is the main regulator of Ca^+ entry. The G-protein- 
coupled receptor family comprises most of the receptors that are familiar to 
pharmacologists, e.g. muscarinic acetylcholine receptor, adrenergic 
receptors, dopaminergic receptors, serotonin receptors, histamine receptors, 
opiate receptors, receptors for many peptides and many others. Most of 
these have a variety of subtypes on pharmacological grounds. A large 
number of G-proteins and their receptors have so far been identified. As 
many as 86  molecularly and/or pharmacologically defined G-protein- 
coupled receptors have been reported. These are coupled to a large variety 
of effectors by a family of up to 15 G-proteins (9 already cloned) in 
mammalian cells (Bimbaumer, 1990).
(3) Tyrosine kinase-linked type. These are quite different in structure and 
function fron either the channel-linked or the G-protein-coupled receptors. 
Examples are receptors for insulin and various other growth factors (Yarden 
and Ulrich, 1988; Carpenter and Cohen, 1990). In these cases, binding of 
the extracellular messenger to its receptor appear to directly activate the 
protein kinase, which often is an integral part of the receptor itself, without 
any intervening second messenger generation. In certain cases, of course, 
such tyrosine-specific protein kinases are distinct from the receptors
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themselves, although they are often associated with the membranes and 
functionally linked to membrane receptors through unknown mechanisms.
(4) Intracellular steroid/thyroid-type receptors. These are quite different from 
the other three types. They are soluble cytosolic or nuclear proteins, so the 
ligands must first enter the cells to produce their effects. The receptor- 
mediated regulation of DNA transcription is characteristic of steroid and 
thyroid hormones and these act by stimulating transcription of selected 
genes, leading to the synthesis of particular proteins and the production of 
cellular effects. Receptors of the first three categories are all membrane 
proteins whereas steroid receptors are soluble cytosolic or intranuclear 
proteins. Only the mechanisms which are involved or are reported to be 
involved in aqueous humour dynamics will de discussed further.
SIGNAL TRANSDUCTION SYSTEMS INVOLVED IN AQUEOUS
HUMOUR DYNAMICS
Several signal transduction systems appear to be involved in the tissues 
responsible for AH production (the CE) and drainage (the trabecular meshwork 
cells). These include (i) the adenylate cyclase/cyclic AMP system which is 
reported to be involved in decreasing AH formation (Caprioli and Sears, 1984; 
Sears, 1985; Bartels et al., 1987; Mittag et al., 1993), increasing AH formation 
(Mittag et al., 1987; Nilsson et al., 1990) and increasing AH outflow (Kaufman, 
1987; Erickson-Lamy and Nathanson, 1992); (ii) guanylate cyclase/cyclic GMP 
system which is reported to cause a decrease in AH formation and IOP 
(Nathanson, 1987; Korenfeld and Becker, 1989; Becker, 1990; Busch et al, 
1992); (iii) Phospholipase/inositol system which is recently reported to be
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present in the ciliary epithelium of different species, though its physiological role 
is yet to be elucidated, e.g. in rabbit (Yoshimura et al., 1989; Ohuchi et al.,
1992) and in man (Wax and Coca-Prados, 1987; Lee et al., 1989); (iv) Ion 
channel system, e.g. Ca2+ channel (Jacob, 1991).
All of the above systems are operated through G-protein-coupled receptors. The 
first three involve their respective second messengers such as cyclic AMP, cyclic 
GMP or inositol trisphosphate (IP3) and diacylglycerol (DAG). The ion 
channel functions do not appear to involve any second messenger; instead, the 
G-protein interacts directly with the channel macro-molecule to produce the 
effect.
G-proteins and Their Functions
G-proteins, so called because of their interaction with the guanine nucleotides, 
GTP and GDP. They are the crucial in cell-to-cell communications and act as 
molecular switches, regulating signal transfer from cell surface to effector 
mechanisms inside the cell. G-proteins are present in virtually all eukaryotic 
cells. They regulate a myriad of metabolic, hormonal, neural, sensory and 
developmental functions and at least 9 different heterotrimeric G-proteins have 
now been identified (Dolphin, 1991; Spiegel, 1990).
Mechanism of Activation and Deactivation of G-proteins
In the resting state , the G-protein exists as an unattached apy trimer, with GDP 
occupying the site on the a  subunit. On activation G-protein undergoes cyclical 
activation/deactivation under the influence of GTP and the agonist stimulated 
receptor. G-protein mediated signal transduction is initiated when an
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extracellular first messenger (a hormone, growth factor or neurotransmitter) 
binds to a specific receptor on the cell surface. The receptor configuration is 
temporarily altered, presumably involving the cytoplasmic domain of the 
receptor, causing it to acquire high affinity for apy. Association of apy with 
the receptor causes the bound GDP to dissociate and to be replaced with GTP 
(GDP/GTP exchange), which in turn causes the dissociation of a-GTP from the 
Py subunits. a-GTP is the active form of the G-protein, which diffuses in the 
membrane towards membrane-bound effectors (enzymes, ion channels) and can 
associate with them causing activation or inactivation as the case may be. This 
process is terminated and deactivation of G-protein initiated when the hydrolysis 
of GTP to GDP occurs through the intrinsic GTPase activity of the a  subunit. 
Both trimeric a-GTP-Py and monomeric a-GTP are assumed to be active 
GTPase (Brown and Bimbaumer, 1988). The resulting a-GDP dissociates from 
the effector and reassociates with py, completing the cycle.
The Adenylate Cyclase/Cyclic AMP System
Cyclic AMP is a nucleotide synthesized within the cells from ATP by the 
reaction of the enzyme adenylate cyclase. It is produced continually and 
inactivated by hydrolysis to 5-AMP, by the action of a family of enzymes known 
as phosphodiesterases. Many different drugs, hormones and neurotransmitters 
produce their effects by increasing or decreasing the catalytic activity of 
adenylate cyclase and thus raising and lowering the concentration of cyclic AMP 
within cells. Cyclic AMP regulates a large variety of cellular functions 
including, metabolism, cell division, cell differentiation, ion transport, ion 
channel function, contraction, secretion etc. All these functions are brought 
about by a common mechanism, namely the activation of various protein kinases 
by cyclic AMP. These enzymes catalyze the phosphorylation of serine and
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threonine residues in different cellular proteins, known as substrate proteins, 
using ATP as the source of phosphate groups and thereby regulate their function. 
The phosphorylated substrate proteins return to the basal state by the action of 
specific phosphatases. As described above, the adenylate cyclase is under the 
control of G-proteins and the specific receptors on the cell membrane. A 
schematic representation of the whole process is shown in Fig. 9.
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Fig. 9. Schematic representation o f  adenylate cyclase/cyclic AMP-mediated signal 
transduction mechanism.
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The Guanylate Cyclase/Cyclic GMP System
Cyclic GMP is now known to be a second messenger in diverse tissues including 
the cardiovascular system (Walter, 1989), other smooth muscle and neutrophils 
(Wolfe et al., 1989), brain (Levitt et al., 1984) and CE (Korenfeld and Becker, 
1989; Nathanson, 1987; Mittag et al., 1987). Thus cyclic GMP is receiving 
greater attention as an important second messenger in biological systems.
Unlike adenylate cyclase, which has only one form, there are two forms of 
guanylate cyclase:
(i) The Membrane Bound or Particulate Form
The activation and function of the membrane bound or particulate form of the 
enzyme is thought to be similar that of the adenylate cyclase/cyclic AMP system 
(Fig. 10).
(ii) The Cytoplasmic Form or Soluble Guanylate Cyclase
Nitric oxide (NO) is the only known activator of this enzyme (Murad et al., 
1978; Bohme et al., 1978). The purified guanylate cyclase is a haemoprotein 
and interaction of NO with the haeme moiety is considered as the mechanism of 
enzyme activation. NO has now been found to be synthesized in various tissues 
(Moncada et al., 1991) including the much studied vascular endothelium (Palmer 
et al., 1987).
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Fig. 10. Schematic representation o f  particulate guanylate cyclase/cyclic GMP-mediated 
signal transduction mechanism.
The cytoplasmic enzyme was found to be a heterodimer containing 2 subunits, of 
70 and 82 KDa, each having a carboxy-terminal catalytic domain and unable to 
function as a monomer (Schulz, et al., 1989; Nakane et al., 1990). They are 
shown to contain haeme as prosthetic group and modulate their activity after 
binding to NO or other nitrogen-containing gaseous molecules derived from
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arginine metabolism. In contrast, the plasma membrane form is a multidomain 
protein made from the association of a peptide receptor domain (e.g., atriopeptin 
receptor), a protein kinase-like domain and a guanylate cyclase domain 
(Chinkers et al., 1989).
Soluble guanylate cyclase-mediated signal transduction is initiated with the 
production of NO by the metabolism of L-arginine, the metabolic reaction being 
catalysed by nitric oxide synthase. NO then binds to the haeme moiety of the 
soluble guanylate cyclase, thereby activating it. Guanylate cyclase in turn 
produces cyclic GMP from GTP. The overall process can be shown as follows
(Fig. 11.).
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L-arginine
Guanylate cyclase
Phosphodiesterase
GTP cyclic GMP ■>- 5'-GMP
Protein Kinase G
Substrate Protein Protein P04
4. 
4 
4. 
4- 
4.
Phosphatase
Cellular response
Fig. 11. Schematic representation of signal transduction mechanism by soluble 
guanylate cyclase/NO system.
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Calcium-dependent Signal Transduction
Calcium-dependent receptor-mediated functions are regulated by a large number 
of messengers such as neurotransmitters, hormones and a wide variety of growth 
promoting factors. Calcium plays a more general and widespread role in cell 
function than do cyclic AMP and cyclic GMP and is now regarded as the most 
important signal transduction system.
Calcium mobilizing receptors affect intracellular Ca^+ levels via hydrolysis of 
phosphoinositol 4,5-bisphosphate (PIP2 ) into inositol 1,4,5-trisphosphate (IP3 ) 
and 1,2 -diacylglycerol (DAG). Phosphatidyl inositol 4-phosphate (PIP) and 
PIP2 , collectively called polyphosphoinositides (PPI) are a class of minor 
membrane phospholipids. PIP2  which has the phosphate group attached to the 
inositol ring plays a key role in their function. This phospholipid is the 
substrate for a membrane-bound enzyme, phospholipase C (PLC), which splits it 
into DAG and IP3 , both of which function as second messengers. The cycle is 
completed by the phosphorylation of DAG into phosphatidic acid (PA) and by a 
series of dephosphorylation reactions catalysed by intracellular phosphatases 
which dephosphorylate IP3 ultimately to form inositol. Recoupling of PA with 
inositol then occurs to form phosphatidyl inositol once again. The process of 
activation of PLC by various agonists turns out to involve a G-protein and to be 
essentially identical to the mechanism of adenylate cyclase activation, although 
different G-protein subtypes are involved.
IP3 and DAG synergistically mediate signal transduction in receptor mediated 
systems linked to Ca^+ mobilization. IP3 has been shown to be involved in the 
release of Ca^+ from intracellular stores and DAG activates protein kinase C, 
which phosphorylates specific substrate proteins. Many of the cellular actions
 \
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of calcium are mediated by its binding to specific calcium-binding proteins, such 
as troponin, calmodulin etc., forming Ca^+/Ca^+-binding protein complex which 
in turn activate their specific protein kinases. In addition to calcium-binding 
proteins, Ca^+ also exerts some of its cellular functions in conjunction with 
lipids, such as phosphatidylserine. This Ca^+/phosphatidylserine then activate 
the protein kinase. There are several Ca2+/calmodulin-dependent protein
kinases.
Possible Links Among Phospholipases
Recent evidence suggests that the same agonists which induce the hydrolysis of 
PI also induce hydrolysis of other phospholipids, particularly
phosphatidylcholine (PC) that also produces DAG at a relatively later phase in 
the cellular response, and a possible role of phospholipase D in prolonging this 
DAG elevation has been postulated (Exton, 1990; Billah and Anthes, 1990). 
Substantial evidence is now available that the sustained elevation of PK^ 
activity is essential for subsequent responses such as cell proliferation and cell 
differentiation (Davis and Lipsky, 1988; Asaoka et al., 1991). In addition, 
phospholipase A2  (PLA2 ) is activated by most of the agonists which induce PI 
hydrolysis (Nakamura et al., 1993).
Intracellular Ca^+
Intracellular signalling via changes in cytosolic free Ca2+, (Ca^+)j, plays a 
central role in cell regulation. Most (Ca2+)j signals are generated in part by 
enhanced Ca^+ influx. Furthermore, Ca^+ influx is required to maintain 
intracellular stores from which Ca^+ is mobilized for signalling. Ca^+ influx 
into cells can occur either during action potential or at resting potential.
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Ca^+ Influx During Action Potential
The most prominent route for Ca^+ entry consists of voltage-gated Ca^+
j con d uction ,
channels, opened in a concerted manner during action potential Ca^+ enters 
the cells predominantly via L-type voltage-gated Ca^+ channels (high voltage- 
gated Ca^+ channels). Phosphorylation of the L-type channels by cyclic AMP- 
dependent protein kinase (PKy\) and protein kinase C (PKq) (Chang et al., 1991) 
and direct receptor control of the same channel via G-proteins (Dolphin, 1991; 
Heschler et al., 1990) determine how much will enter during a single 
action potential, controlling, e.g. the number of channels which will open. 
Dihydropyridine-sensitive Ca^+ stimulation (through L-type channels) is 
achieved by the same a  subunit that stimulates adenylate cyclase (Yatani et al., 
1988; Brown and Bimbaumer, 1988)
Voltage Dependent Csfi+ Influx at Resting Potential
Ca2+ influx can be observed during! slight depolarization in the range of the 
normal resting potential. It was found that slight sustained depolarizations (<10 
mV) from resting potentials between -60 and -50 mV caused in part of the cell 
an inward current of minor amplitude (2 - 1 0  pA). This current was associated 
with a marked rise in (Ca^+)i in part of the cytosol.
Extrusion of Calcium from the Cytosol
Because a high concentration of ionised calcium is toxic (Rasmussen and Barret,
1984) the mobilized Ca^+ is subsequently extruded from the cells. Cytosolic 
Ca2+ levels are maintained by various regulatory mechanisms in the cell 
including: (a) the Ca^+-dependent plasma membrane ATPase pump, (b) the
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plasma membrane Na+/Ca^+ exchange mechanism, (c) the mitrochondrial Ca^+ 
pump and (d) the ATP-dependent Ca?+ pump in the ER.
Conclusion
The brief outline described above represents only a very straightforward and 
simple understanding of the various signal transduction pathways in the cellular 
arena. In fact the processes are highly complicated and there are numerous 
interactions between the individual as well as among the different transduction 
pathways. The very large number of extracellular 1st messengers, their cell 
surface or intracellular receptors, the heterotrimeric composition of G-proteins 
with each subunit occurring in multiple forms and existence of different isoforms 
of effectors (e.g. adenylate cyclase, phospholipases, channels), different 
protein kinases (specific or non-specific) etc. contribute to this enormous 
functional diversity and complexity.
PHARMACOLOGICAL REVIEW OF OCULAR HYPOTENSIVE
AGENTS
Ocular hypotensive agents used in glaucoma treatment and research can be 
divided into two broad divisions according to the nature of their effect in 
reducing IOP. One division include substances which decrease IOP by reducing 
AH formation, typical examples of which are the beta-adrenoceptor antagonists 
and carbonic anhydrase (CA) inhibitors. In addition to these, there are other 
types of drugs such as the experimental agents, forskolin (Caprioli and Sears, 
1983, 1984; Caprioli et al., 1984; Sears, 1985) and cholera toxin (Gregory et at., 
1981). The vasodilator hormone atriopeptin has been found to reduce IOP by 
reducing AH formation in rabbits (Korenfeld and Becker, 1989) and also
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reportedly reduces IOP in glaucoma patients (Diestelhorst and Krieglstein, 
1989). The cyclic AMP phosphodiesterase inhibitor, 8 -pivaloyloxymethyl ester 
(POM-ester) of griseolic acid also has been reported to decrease IOP by reducing 
AH formation (Kiuchi et al., 1991).
Another group includes substances which produce their effect by increasing the
outflow of AH. Well known examples are parasympathomimetic agents,
adrenergic agonists such as adrenaline and its prodrug, dipivefrin (dipivalyl
adrenaline), clonidine, apraclonidine and certain prostaglandins, especially PGF2 
a and its analogue, PhXA41 (Aim et al., 1993; Toris et al., 1993). The
relatively specific ot2 -adrenergic agonist, apraclonidine, however, is reported to 
reduce both AH formation and outflow resistance (Gharagozloo et al., 1988; 
Robin, 1988).
Beta-adrenergic Agents
There are a number of P-adrenergic agents, both agonists and antagonists 
(specific or non-specific), used in the field of glaucoma research, such as tazolol 
(Pi-agonist), metoprolol (Pi-antagonist), salbutamol, terbutaline (p2 -agonists), 
butoxamine (P2 - antagonist), isoprenaline (non-selective p-agonist), oxprenolol 
(non-selective p-antagonist) etc. p-adrenergic blocking agents are the most 
commonly prescribed drugs in glaucoma therapy. The agents currently in 
clinical use include timolol, levobunolol, metipranolol, carteolol and betaxolol. 
The first four are non-selective P-antagonists (i.e. have affinity to both Pi and P 
2 - adrenoceptors) while betaxolol is a cardio-selective (pi- selective) antagonist, 
cardioselectivity being highly dose-dependent (Lertora et al., 1975). All are 
used topically as eyedrops (Brooks and Gillies, 1992). There is now general 
agreement that they decrease IOP by reducing AH formation (Leopold and
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Duzman, 1986; Sugrue, 1989; Hurvitz et al., 1991; Brooks and Gillies, 1992), 
but the mechanism by which they reduce AH formation is a matter of great 
controversy as will be reviewed in detail. The most logical and widely believed 
mechanism is the classical p-adrenergic antagonism, which by definition is to 
inhibit competitively the binding of endogenous adrenergic transmitters at P- 
receptors, thus preventing agonist induced activation of adenylate cyclase, 
blocking the resultant increase in cyclic AMP levels. This, it is supposed, 
causes the reduction of AH flow.
Carbonic Anhydrase Inhibitors
CA inhibitors are the next major group of antiglaucoma drugs affecting AH 
formation. Clinically they are used orally for long term treatment of primary 
and secondary open angle glaucoma (OAG). Examples of oral drugs are 
acetazolamide, methazolamide, ethoxzolamide and dichlorfenamide, which have 
been in use to treat glaucoma for over 3 decades (Woltersdorf et al, 1989). 
Recently, topical preparations of some novel CA inhibitors have been 
introduced. These include MK-927, MK-417, MK-507 (L-671, 152), L-662583, 
AHR-16329 (Lippa et al., 1988, 1992; Pfeiffer et al., 1990; Hurvitz et al., 1991; 
Sears et al., 1991; Brechue and Maren, 1993a,b). In general, the topically 
applied drugs are ampholytes with a basic amine and acid sulphonamide group, 
delivered as their hydrochloride salts. These drugs have relatively high water 
and lipid solubility which facilitate corneal penetration and reaching the ciliary 
process in concentrations sufficient to saturate the enzyme binding sites. CA 
inhibitors decrease the formation of AH, with no effect on outflow. The exact 
mechanism, however, is not known, but may involve decreasing sodium efflux 
into the AH, secondary to decreased formation of bicarbonate (Cole, 1977). All 
CA inhibitors contain a ring structure attached to a sulfonamide group (R-
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SO2NH2 ); the sulfonamide moiety competes with carbonic acid for its site on 
CA (Maren, 1976) which catalyses the reaction, CO2  + H2 O —> HCC>3" + H+ 
and thus plays an essential role in ion transport across the CE by supplying these 
two ions.
Cholinergic Agents
Cholinergic agents are the oldest, effective, non-surgical therapy for glaucoma 
(Leopold and Duzman, 1986). They can be divided into two groups according 
to their mode of action - direct acting and indirect acting. The former act 
directly on muscarinic receptors, e.g. pilocarpine and carbachol. The indirect 
acting drugs block the enzyme acetylcholinesterase, allowing acetylcholine to 
accumulate at the parasympathetic nerve endings. Examples of this group of 
drugs include physostigmine, demecarium, echothiophate and isofluorophate. 
Physostigmine is short acting and the other three elicit a long-lasting inhibition 
of the enzyme. Among the cholinergics, pilocarpine is the most commonly used 
and extensively studied drug for the treatment of glaucoma. These drugs exert 
their IOP lowering effect by increasing the facility of outflow of AH through the 
trabecular meshwork, which occurs by causing contraction of the ciliary muscle, 
which pulls on the scleral spur (Kaufman and Barany, 1976; Zimmerman, 1981).
Adrenaline and Other Adrenergic Agonists
The mechanism whereby adrenaline lowers IOP appears to result from a 
combination of several factors none of which are unequivocally established. A 
key factor is that it activates both alpha and beta-adrenoceptors. Experimental 
evidence suggests that adrenaline increases outflow of AH (Sonntag et al., 
1978; Townsend and Brubaker, 1980). Contradictory reports are available in
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respect of AH formation - both an increase (Townsend and Brubaker, 1980; 
Nagataki and Brubaker, 1981; Schenker et al., 1981) and a decrease (Lamble, 
1977). The outflow effect was originally attributed to the activation of a- 
adrenoceptors (Richardson, 1972) but the observation that this action of 
adrenaline can be attenuated by timolol indicates involvement of 13- 
adrenoceptors (Cyrlyn et al., 1982; Erickson-Lamy and Nathanson, 1992). That 
these are p 2 -adrenoceptors *s supported by the fact that betaxolol (pi-selective) 
failed to blunt the outflow effect of adrenaline (Allen and Epstein, 1986), and the 
highly specific P 2 -antagonist, ICI118,551, completely blocked adrenaline's 
effect (Erickson-Lamy and Nathanson, 1992). The precise mechanism, 
however, is still unknown. Some experimental evidence suggests implications 
of prostaglandins or other cyclooxygenase products in the mechanism of action 
of adrenergic agonist (Camras et al., 1985; Anderson and Wilson, 1990) which is 
further supported by the fact that repeated administration of adrenaline is 
associated with an increase in the content of prostaglandin E in AH of rabbits 
(Miyake et al., 1988) and monkeys (Camras et al., 1987).
Recently-introduced selective a 2 -adrenergic agonists, apraclonidine (Robin et 
al., 1987; Abrams et al., 1987; Brown et al., 1988; Hurvitz et al, 1991), B-HT 
920 and UK 14304 (Burke and Potter, 1986; Steidle et al., 1987; Serle et al, 
1991) have proved to be very potent ocular hypotensive agents. These drugs 
lower IOP mostly by reducing AH formation rather than increasing outflow 
(Krieglstein et al., 1978; Lee et al., 1984; Serle et al., 1991). However, 
clonidine decreases blood flow to the limbal blood vessels (Ralli, 1975; Bill and 
Heilmann, 1978) which could alter episcleral venous pressure. Although it does 
not alter tonographic outflow facility (Robin, 1988), it may have an effect on 
uveoscleral outflow. It has been shown that 1% apraclonidine decreases AH 
flow by approximately one-third in normal volunteers (Gharagozloo et al.,
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1988), but about 50% of normal volunteers tested with 0.5% apraclonidine have 
IOP below presumed episcleral venous pressure of 8 mmHg (Abrams et al., 
1989; Coleman et al., 1989a). Also no volunteer tested with 0.5% timolol 
attains such a low IOP (Coleman et al., 1989b). Apraclonidine's effect on AH 
formation is believed to be mediated by a 2 -adrenergic receptors. Radioligand 
binding studies point to the presence of a j  and a 2  adrenergic receptors in the 
iris-ciliary body, with the latter being more prevalent (Mittag and Tormay, 
1985a; Mittag et al., 1985; Jumblatt et al., 1987; Mallorga et al., 1988). In 
functional studies it has been shown that stimulation of a  \-adrenoceptors in the 
rabbit ciliary process results in increased phosphatydylinositol turnover 
(Mallorga et al., 1988) whereas a 2 -adrenoceptors are negatively coupled to 
adenylate cyclase in the rabbit iris-ciliary body (Mittag and Tormay, 1985b) and 
ciliary processes (Bausher et al., 1987; Kintz et al., 1988).
Prostaglandins
Lower doses of certain prostaglandins, especially PGF2 a  and its analogue
PhXA41, have a dramatic IOP-lowering effect in many species (Lee et al., 
1984b; Goeneboer et al., 1989; Camras, 1993; Toris et al., 1993) including 
normotensives (Kerstetter et al., 1988; Lee et al., 1988; Villumsen and Aim,
1989), glaucoma patients (Camras et al., 1989; Villumsen et al., 1989) and 
subhuman primates (Camras and Bito, 1981; Crawford et al., 1987). These 
drugs lower IOP by increasing uveoscleral outflow (Crawford and Kaufman, 
1987; Nilsson et al., 1989; Gabelt and Kaufman, 1989). The mechanism 
involved is a slow enzymic lysis of the connective tissue between the ciliary 
muscle bundles (Tamm et al., 1989) thus widening the connective tissue spaces 
through which AH leaves the anterior chamber by this route (Lutjen-Drecoll and 
Tamm, 1988).
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Dopaminergic Drugs
Dopamine agonists, Hal 17 (Potter et al,., 1993), bromocriptine and antagonists, 
haloperidol, moperol, metoclopramide and trifluperidol lower IOP while few 
agonist and antagonist increase IOP in laboratory animals (Chiou et al., 1989). 
Bromocriptine and pergolide have been demonstrated to lower IOP in normal 
(Mekki et al., 1983, 1984; Al-Sereiti et al., 1989) and glaucomatous humans 
(Lusting, 1983; Geyer et al., 1987). The function of dopaminergic drugs in 
lowering IOP remains largely unexplained. De Vries et al. (1986) reported that 
adenylate cyclase-linked dopamine receptors are present in both human and 
bovine ciliary body. Lograno et al. (1990) showed both functional and 
biochemical evidence for the presence of dopamine D\ receptors in bovine 
ciliary body. However, the definitive presence and characterization of these 
receptors in the CE remains elusive (Wax, 1993).
Calcium Channel Blockers and Vasodilator Drugs
Systemic calcium channel (L-type) blockers such as verapamil and nifedipine 
have been shown to lower IOP, (Payne et al., 1990). The ocular hypotensive 
effect of topical verapamil and nifedipine (Segarra et al., 1986, 1993; Abelson et 
al., 1988) upon the human eye have also been demonstrated. Several 
nitrovasodilator drugs which mediate an increase in intracellular cyclic GMP 
concentration via activation of soluble guanylate cyclase, e.g. nitroglycerine 
(Nathanson, 1988), sodium nitroprusside and sodium azide (Kamezis and 
Murphy, 1988) have been reported to have an ocular effect.
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Other IOP Lowering Agents
There is a wide variety of other agents which reportedly lower IOP in 
experimental animals or in man by various mechanisms. These include the 5- 
HT-antagonist, ketanserin (Costagliola et al., 1991), a-adrenoceptor antagonists, 
such as prazosin (Krupin et al., 1980b), yohimbine (Mittag et al., 1985), 
dibenamine, phentolamine, phenoxybenzamine and thymoxamine (Mittag, 
1983), Hi-antihistaminines, such as antazoline and pyrilamine (Krupin et al., 
1980c), topical corticosteroid (Becker, 1965) steroid blocker (Phillips et al., 
1984; Tsukahara et al, 1986) etc.
Beta-adrenoceptor Antagonists
Since the introduction of timolol maleate for clinical use in 1978, after studies 
showed its efficacy as an ocular hypotensive agent (Zimmerman and Kaufman, 
1977a, 1977b; Coakes and Brubaker, 1978; Sonntag et al., 1978), beta blockers 
have become the most popular therapeutic agents in the medical treatment of 
glaucoma. Phillips et al. (1967) were the first to report that topical 
administration of the beta-blocker propranolol reduced IOP. Since then many (3 
-blockers have been introduced. The first preclinical evidence that timolol 
lowers IOP was reported by Vareilles et al. (1977) who demonstrated that 0.5% 
and 1.5 % solution of (-)-timolol significantly lowerd IOP in rabbits with an 
experimentally induced form of open angle glaucoma (OAG), utilizing a- 
chymotrypsin. This form of OAG is most likely due to impaired outflow facility 
(Sears and Sears, 1974). Also the pathological changes of this type of glaucoma 
resemble those of CO AG, i.e. progressive cupping of the optic nerve head (Best 
et al., 1975). The effects of this group of drugs upon AH dynamics has been 
well established both clinically (Zimmerman, 1977b; Keats and Stone, 1984; The
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levobunolol study group, 1989; Brooks and Gillies, 1992) and experimentally in 
several species in vivo (Vareilles et al., 1977; Nathanson, 1981a; Potter, 1981; 
Schenker et al., 1981; Liu et al., 1983; Bar-Ilan, 1984; Sugrue et al., 1985; 
Alkondon et al., 1986). Their IOP lowering effect is known to be due to a 
reduction of AH secretion (Liu and Chiou, 1981; Schenker et al., 1981; Vareilles 
and Lotti, 1981; Brubaker et al., 1982; Miichi and Nagataki, 1983; Bartels, 
1988). The subcellular mechanism by which they lower AH formation is still a 
matter of controversy (Leopold and Duzman, 1986; Sugrue, 1989). Most of the 
existing data support the notion that the reduction of AH flow is a local action of 
the drug upon the eye, because the reduction in IOP is greater in the treated than 
in the contralateral, untreated eye following topical administration of a beta- 
adrenergic antagonist (Katz et al., 1976; Zimmerman and Kaufman, 1977a). It 
has been suggested that the effect in the treated eye is a local phenomenon and 
that the effect in the untreated eye is a result of systemic absorption. On the 
other hand, the drugs may act at a site either within or via the CNS (Neufeld et 
al., 1983). It has also been suggested that timolol may act to reduce AH 
secretion by reducing the levels of melatonin in the iris and ciliary body (Rhode 
et al., 1985). Indeed, orally administered melatonin reportedly lowers IOP of 
healthy volunteers (Sample et al., 1988). However, levels of melatonin in the 
iris and ciliary body of rabbits and chicks are unaltered by topical timolol 
(Rhode and Chiou, 1987). There is also some indication that timolol may 
antagonise dopaminergic function resulting in reduction of blood flow to the 
ciliary body and hence a reduction is AH secretion (Watanabe and Chiou, 1983). 
Macri and Cevario (1978a) studied AH and blood flow dynamics in the cat eye 
and concluded that various pharmacologic agents decrease AH formation by 
producing vasoconstriction of afferent ciliary process vessels, which might 
consequently decrease AH ultrafiltration. However, the hypothesis of 
ultrafiltration through the CE has now been almost abandoned (Bill, 1975; Sears,
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1991). Also, no correlation has been found between ocular blood flow and 
changes in IOP using dopamine agonists and antagonists and various other 
antiglaucoma drugs including p-blockers (Chiou et al., 1989, 1990; Chiou and 
Chen, 1992). In a recent study it has been shown that most antiglaucoma drugs 
including the P-antagonists, timolol, levobunolol and betaxolol, enhance ocular 
pulsatile blood flow (Hong and Chiou, 1993). However, Chiou and Chen 
(1993) reported that the p-blockers L-timolol, levobunolol, metipranolol and 
betaxolol all decreased ocular blood flow in ocular hypertensive rabbits.
Attempts have been made to explain the ocular action of p-blockers on the 
basis of presence and distribution of p-adrenergic receptors in the CE. 
Radioligand and enzymatic studies showed presence of p-adrenoceptors in the 
anterior segment of the eye (Neufeld and Page, 1977; Bromberg et al., 1980). 
The vast majority of these receptors in man and animals have been shown to be 
p2 -subtype (Trope and Clark, 1982; Schmitt et al., 1984; Elena et al., 1984b; 
Mittag and Tormay, 1985a; Wax and Molinoff, 1987). p2 -adrenoceptor 
radioligand binding sites have been found in the NPE cells of the bovine ciliary 
process (Polansky et al., 1985). p2 -adrenoceptors have also been visualized in 
rabbit ciliary process epithelial cells by in vitro autoradiographic technique 
(Elena et al., 1987). Presence of adenylate cyclase with pharmacological 
characteristics indicative of p2 -adrenoceptor linkage has been found in the 
epithelial cells of the rabbit (Nathanson, 1980) and human (Nathanson, 1981b) 
ciliary process. Others confirmed the presence of p2 -adrenoceptor-adenylate 
cyclase system both in rabbit ciliary process (Cepelic and Cemohorsky, 1981; 
Patkama et al., 1986) and in the NPE cells of the bovine ciliary process (Elena et 
al., 1984a). Adenylate cyclase on the plasma membrane of rabbit NPE has been 
visualised by electron microscopy (Tsukahara and Maezawa, 1978).
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In spite of the convincing evidence of the presence of predominantly p2" 
adrenoceptors and adenylate cyclase in the CE of both man and animals, results 
of a large number of experiments show that the p-antagonists may not act on AH 
dynamics through P2 -adrenoceptor blockade (Liu and Chiou, 1981; Chiou, 1983; 
Watanabe and Chiou, 1983; Lotti et al., 1984b; Chiou et al., 1985). At present a 
considerable body of experimental evidence has been accumulated in support of 
the hypothesis that P-adrenoceptor antagonists reduce AH formation via 
antagonism of conventional p-adrenoceptors and also in support of the 
hypothesis that they may act by mechanisms other than through conventional p- 
adrenoceptors.
Evidence Supporting Classical p-adrenoceptor Mechanisms
A large number of studies on AH dynamics (reviewed by Potter, 1981; Potter 
and Rowland, 1981) suggest that AH secretion by the ciliary process epithelial 
cells is modulated by p-adrenergic receptors. The p-agonist isoprenaline 
stimulates cyclic AMP synthesis and increases AH formation and timolol blocks 
this effect and decreases AH secretion in the monkey eye suggesting the effect is 
mediated by p-adrenoceptors (Nathanson, 1881a; Miichi and Nagataki, 1983). 
The relatively selective p2 -agonist, terbutaline, increases AH formation by about 
100% in cynomolgus monkey, whether the drug is administered intravenously or 
intracamerally and this effect was completely abolished by timolol given by 
either route (Nilsson et al., 1990).
Timolol is a potent non-selective P-adrenoceptor antagonist (Scriabine et al., 
1973) which is not, however, noted for any other pharmacological activities 
shown by a number of p-adrenergic antagonists, such as intrinsic 
sympathomimetic activity, membrane stabilizing activity or local anaesthetic
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activity (James, 1989; Chrisp and Sorkin, 1992). It has also been reported that 
the ocular hypotensive effect of timolol is not elicited by CA inhibition (Liu et 
al., 1980), ATPase inhibition (Watanabe and Chiou, 1983) nor prostaglandin 
blockade (Rowland and Potter, 1981). However, timolol is one of the most 
effective and widely studied agents known to affect AH secretion and IOP. The 
drug is a very effective displacer of radioligand binding to p2 -binding sites in 
membrane fractions of both iris-ciliary body from humans (Wax and Moniloff, 
1987) or rabbits (Neufeld and Page, 1977; Schmitt et al., 1984) or ciliary 
processes from rabbits (Bromberg etal., 1980), sheep (Trope and Clark, 1982) or 
bovine (Elena et al., 1984b). Comparable activity was observed for inhibition 
of adenylate cyclase in ciliary process from human (Nathanson, 1980) and 
rabbits (Nathanson, 1980; 1985a) and NPE cells of the bovine ciliary process 
(Elena etal., 1984a).
For a compound to be active as a pharmacological antagonist, there must be 
tonic agonist-induced stimulation to block. Thus, the ability of timolol to 
reduce AH formation and IOP implies that endogenous adrenergic tone 
stimulating P-adrenoceptors exists in the eye. It has been observed that the rate 
of AH flow in humans undergoes a circadian rhythm characterised by a higher 
flow during working hours (highest being in the morning) and lower flow during 
sleep (Reiss et al., 1984). AH formation in human volunteers is decreased by 
approximately 45% during sleep (Reiss et al., 1984) and, in contrast to day time, 
0.5% timolol is devoid of any ocular hypotensive effect (Topper and Brubaker,
1985). These observation suggest that endogenous adrenergic activity during 
the day stimulates AH formation and that this stimulus subsides during sleep. 
Supportive evidence for this comes from experiments in which the topical 
application of isoprenaline failed to alter AH formation in volunteers during the 
day, but significantly increased during sleep (Larson and Brubaker, 1988). AH
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flow stimulation during sleep has also been found with adrenaline (Topper and 
Brubaker, 1985) and terbutaline (Gharagozloo et al., 1988). These observations 
along with obliteration of the circadian cycle in human by timolol (Topper and 
Brubaker, 1985) can be best explained by classical P-adrenergic blockade. The 
melatonin release during sleep which was previously reported to be the cause of 
reduced production of AH during sleep (Samples et al., 1988) has been 
contradicted by Koskela and Brubaker (1991) by comparing aqueous flow during 
nocturnal sleep in the dark and during nocturnal sleep under bright light and by 
measuring aqueous flow during a short period of sleep in a dark room during the 
day.
Rabbits have also a circadian pattern of AH flow being highest during the dark 
and lowest during the light phase of the cycle (Rowland et al., 1986; Smith and 
Gregory, 1989). Yoshitomi et al. (1991) measured concentrations of 
catecholamines and cyclic AMP in the AH of rabbits entrained to 12h dark and 
12h light. Aqueous nor-adrenaline and cyclic AMP were significantly higher in 
the dark. Superior cervical ganglionectomy reduced the aqueous noradrenaline 
concentration during both light and dark phases and superior cervical 
ganglionectomy or pretreatment with 0 .1% timolol totally eliminated the dark 
phase increase in cyclic AMP. Thus increased adrenergic activity during the 
dark is the cause of increased cyclic AMP production and timolol antagonised its 
production. Linner and Prijot (1955) noted that cervical sympathetic 
ganglionectomy resulted in reduced AH flow. Superior cervical ganglionectomy 
or preganglionic section of the cervical sympathetic trunk blunted the dark phase 
increases in IOP (Gregory et al., 1985; Braslow and Gregory, 1987; Liu and 
Dacas, 1991), AH flow (Yoshitomi and Gregory, 1991), AH nor-adrenaline 
concentration (Liu and Dacas, 1991; Yoshitomi et al, 1991) and AH cyclic AMP 
(Yoshitomi et al, 1991).
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Evidences Against the Involvement of Conventional p-adrenergic Receptors 
in AH Formation
Topically applied timolol can block P-adrenoceptors in the eye as evidenced by 
the attenuation of the ability of topical isoprenaline to increase both the IOP 
following water loading and the enhancement of production of cyclic AMP in 
the AH of rabbit (Vareilles et al, 1977; Schmitt et al., 1981b). The doses of 
timolol required to block both responses to isoprenaline are much less than those 
required for ocular hypotensive activity, thus implying that different mechanisms 
are involved in both phenomenon. This is supported by the observation that the 
effectiveness of various P-antagonists in lowering IOP in rabbit models of ocular 
hypertension did not correlate with their ability to block p-adrenoceptors 
(Bonomi et al., 1979).
Studies with specific Pi and p2 -adrenergic agonists and antagonists for their 
effects on AH dynamics in cat showed that tazolol (Pi-agonist) reduce formation 
of AH more than outflow, while metoprolol (p i-antagonist) reduce outflow more 
than formation, both salbutamol (P2 *agonist) and butoxamine ^-antagonist) 
inhibited AH formation and outflow to an equal extent (Chiou et al., 1985). The 
relatively selective P2 -agonists, salbutamol, terbutaline and soterenol which are 
used systemically for the treatment of asthma, have also been shown to lower 
IOP in monkeys (Langham and Biggs, 1974) and humans (Paterson and 
Paterson, 1972; Wettrell et al., 1977). Their IOP lowering effect accounted to 
be mainly a result of reduction of AH production; however, an increase in 
outflow might also play an important role (Kaham, 1981). It is an obvious 
paradox that both p-agonists and antagonists lower AH production.
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Betaxolol is a Pi-specific adrenergic antagonist. Like timolol, it also has no partial 
agonist activity (Boudot et al., 1979) and has little or no local anaesthetic or 
membrane-stabilizing activity (Cavero and Lefevre-Brog, 1983). Betaxolol 
reduces IOP by reducing AH formation without affecting outflow (Reiss and 
Brubaker, 1983; Allen et al., 1986). Although p2 -adrenoceptors greatly 
predominate in the ciliary processes, the ocular hypotensive activities of 
betaxolol and timolol, both at 0.5%, in glaucoma patients were viewed as being 
comparable (Berry et al., 1984; Levy et al., 1985; Stewart et al., 1986). More 
recent studies, however, suggest that the ocular hypotensive effect of betaxolol is 
rather less than that of timolol (Allen and Epstein, 1986; Feghali et al., 1988; 
Vogel et al., 1989; Collignon-Brach, 1992), but both drugs are in common 
clinical use (Brooks and Gillies, 1992).
Both D-and L-isomers of timolol are almost equipotent in decreasing AH flow 
and IOP in various species including man (Liu and Chiou, 1981; Liu et al., 1983; 
Keats and Stone, Richards and Tattersfield, 1987; 1984; Mills et al., 1988). But 
in vivo and in vitro experiments show adrenergic receptors have specific affinity 
toward L-isomers. From direct receptor binding studies it has been 
demonstrated that L-isomers of timolol and propranolol have much higher 
affinity (40 fold and 281 fold, respectively) than D-isomers toward p-adrenergic 
receptors in iris-ciliary body preparations (Chiou et al., 1985).
Timolol and other P-adrenoceptor antagonists inhibit the production of 
intracellular cyclic AMP and lower AH production and IOP. However, agents 
such as cholera toxin (Gregory et al., 1981) and forskolin (Caprioli and Sears, 
1983; Caprioli et al., 1984; Sears, 1985; Bartels et al., 1987; Shibata et al., 1988) 
both stimulate the production of cyclic AMP, yet they also lower IOP by
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reducing AH flow and without affecting outflow facility (Caprioli et al., 1984; 
Lee et al., 1984a).
The (3-adrenoceptor antagonist sotalol reportedly inhibits the production of 
intracellular cyclic AMP, as do all other P-adrenoceptor antagonists. Sotalol, 
however, when applied topically at 2% concentration to patients with COAG, 
has no effect upon IOP (Merte and Styz, 1983). Alprenolol effectively lowered 
IOP but exhibited no activity in antagonizing the effect of isoprenaline on either 
IOP or cyclic AMP. Oxprenolol, on the other hand, had little or no ocular 
hypotensive activity but was very effective in antagonizing both actions of 
isoprenaline. All of these agents penetrate the anterior chamber readily (Schmitt 
etal., 1981a).
Another p-adrenoceptor antagonist, carteolol, which is used to lower IOP in 
patients with COAG, reportedly has 1.67 times potency of timolol for its 
extraocular P-adrenoceptor binding response (Ishizaki et al., 1983). However, 
carteolol is only 0.25 times as potent as timolol as an ocular hypotensive agent in 
the human eye (Horie et al., 1982).
The fact that topically applied (+)-timolol can lower IOP of both rabbits (Share 
et al., 1984) and man (Keats and Stone, 1984; Mills et al., 1988) has been used 
to support the contention that the ocular hypotensive action of timolol is not 
mediated via P-adrenoceptors (Liu and Chiou, 1981; Chiou et al., 1985). Both 
timolol and its (+)-enantiomer were found to be equally effective in reducing AH 
production when perfused intracamerally in the anaesthetized cat eye. 
However, only one concentration of each agent was employed (Liu and Chiou,
1981). Both enantiomers were also found to be equipotent after topical 
administration in a model which indirectly measured AH secretion in conscious
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rabbits (Chiou, 1983b). The ability of topically administered (+)-timolol to 
lower the elevated IOP of a-chymotrypsin-treated rabbits is somewhat less than 
that of timolol (Share et al., 1984). Timolol is slightly more potent than its (+)- 
enantiomer in blunting the water-load induced increase in IOP in pigmented 
rabbits (Liu et al., 1983). (+)-timolol is effective at 1% in lowering the IOP of 
glaucoma patients (Keats and Stone, 1984). The instillation of solutions of (+)- 
timolol ranging from 0.25 to 2% has been found to lower IOP of glaucoma 
patients but all these concentrations of (+)-timolol were less effective than 
0.25% timolol (Mills et al., 1988).
In contrast to all these observations relating to ciliary p-receptors, (+)-timolol, at 
1%, has some extraocular p-adrenoceptor blocking activity in human volunteers 
although it is reportedly 13 times less potent than (-)-timolol at human bronchial 
p2 -adrenoceptors, and additionally is 49 times less potent than (-)-timolol at 
extraocular p2 -adrenoceptors in animal studies (Richards and Tattersfield, 1985, 
1987). This observation is further supported by the finding that (+)-timolol has 
only 3% of the potency of (-)-timolol in blocking the isoprenaline-induced 
synthesis of cyclic AMP in iris-ciliary body preparation (Liu et al., 1983). (+)- 
timolol is about one-third as potent as timolol in displacing ^H- 
dihydroalprenolol binding to iris-ciliary body tissue, reducing AH formation and 
lowering IOP of a-chymotrypsin-treated hypertensive eyes (Share et al., 1984). 
The (+)-enantiomer is fifty to ninety times less potent than the (-)-enantiomer in 
antagonizing the effects of isoprenaline on pulmonary and atrial P-adrenergic 
receptors (Share et al., 1984). The inhibitory effects of both enantiomers of 
timolol upon isoprenaline-induced stimulation of adenylate cyclase in the rabbit 
ciliary process are also comparable (Nathanson, 1988c). In water-loaded 
pigmented rabbits both enantiomers blunt the peak increase in IOP, the (-)- 
enantiomer is only slightly more effective (Liu et al., 1983).
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Homer's syndrome is the clinical equivalent of superior cervical ganglionectomy 
and can occur spontaneously in humans or secondary to an underlying disorder, 
for example, migrainous neuralgia, or a tumour (such as lymphoma). AH 
secretion in such patients is normal however. The suppression of AH flow 
following 0.5% timolol is the same in such individuals as in the normal 
population (Wentworth and Brubaker, 1981). This suggests a post synaptic 
locus of action for timolol and the lack of a need for intact adrenergic 
innervation. However, the results of this study contrast with preclinical 
findings. The ability of 4% timolol to lower the IOP of cats was completely 
prevented by superior cervical ganglionectomy (Colasanti and Trotter, 1981, 
1983). The fact that the effect of 2% timolol was only j partially suppressed 
makes these observations difficult to interpret . Adrenergic innervation is 
required for timolol to block the increase in IOP following water loading of 
normotensive, pigmented rabbits, as indicated by the lack of effect in 
denervated eye (Liu et al., 1984). Thus a paradox exists between clinical and
i
preclinical findings, possibly resulting from species differences.
Timolol reduces AH formation in the bovine arterially perfused eye preparation 
(Wilson et al., 1993) which lacks intact adrenergic innervation and therefore has 
no sympathetic tone for a P-adrenergic antagonist to block, further suggesting 
the mechanism of action of timolol upon AH formation is not mediated via a 
classical p-adrenoceptors. In the same preparation, it has also been shown that 
no correlation existed between the levels of ciliary cyclic AMP and AH 
production using timolol, terbutaline, forskolin and 8 -bromo cyclic AMP 
(Shahidullah and Wilson, 1992). Thus the available experimental and clinical 
evidence suggests that the p-adrenoceptors in the ciliary body are 
unconventional in some ways. Much work requires to be done to resolve these 
paradoxes and to fully explain the mechanism of action of timolol in the eye.
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Atrial Natriuretic Peptides
Atrial natriuretic peptides (AP), also called atriopeptins or cardiopeptins, are a 
family of closely related peptides containing 21 to 28 amino acid residues which 
are synthesized and released by atrial myocytes (de Bold, 1985; Needleman and 
Greenwald, 1986) in response to distension of the atria (e.g., by an increase in 
blood volume). The AP have a number of functions, which have the effect of 
powerful vasodilatation and an increase in renal sodium excretion (Currie et al., 
1983; Maack et al., 1986). Extra-atrial sites of AP synthesis have been 
described (McKenzie et al., 1985; Gardner et al., 1986). However, no mRNA 
transcripts of AP have been localized in ocular tissues (Stone, 1987).
AP receptors are associated with the membrane-bound form of the enzyme 
guanylate cyclase (Winquist et al., 1984; Waldman et al., 1984; Hamet et al., 
1986) and are found in high concentrations in rabbit CE (Bianchi et al., 1986). 
There are several reports of decreasing IOP after intravitreal (Sugrue and Viader, 
1986; Nathanson, 1987; Mittag et al., 1987a; 1987b), intravenous (Sasaki et al., 
1986) and intracameral (Sugrue and Viader, 1986) administration of AP. 
Intravenous injection of human AP also reported to lower IOP in glaucomatous 
patients (Diestelhorst and Krieglstein, 1989). There is evidence that a decrease 
in basal and stimulated adenylate cyclase activity occurs (Bianchi et al., 1986) 
and an increase in guanylate cyclase activity results when ciliary processes are 
exposed to physiological concentrations of AP (Nathanson, 1987; Mittag et al., 
1987a, 1987b). These observations have been supported by Korenfeld and 
Becker (1989) who demonstrated that intravitreal injection of AP reduces AH 
formation and IOP and increases cyclic GMP in the iris-ciliary body preparation.
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It has been proposed that the biochemical mechanism by which AP reduces AH 
formation and IOP is the activation of particulate guanylate cyclase and 
consequent increase in intracellular cyclic GMP (Korenfeld and Becker, 1989; 
Fawcett and Wilson, 1989). This was supported by the finding that 8 -bromo 
cyclic GMP (an analogue of cyclic GMP, more resistant to hydrolysis by 
phosphodiesterases than cyclic GMP) lowers IOP when given topically in albino 
rabbits (Becker, 1990) and subconjuctivally in pigmented rabbits (Busch et al.,
1992). It has been shown that AP decrease IOP in isolated arterially perfused 
bovine eye (Millar et al., 1990).
Nitrovasodilators
The evidence for the effects of this class of drugs upon IOP is much less 
abundant. However, there are reports that certain nitrovasodilators, such as 
sodium nitroprusside (Nathanson, 1987; Nathanson, 1992) and nitroglycerine 
(Nathanson, 1988, 1992) caused a marked decrease in IOP in rabbits. Sodium 
nitroprusside and sodium azide are shown to lower IOP in bovine perfused eye 
(Millar and Wilson, 1991). These agents are activators of soluble guanylate 
cyclase.
Sodium azide is also thought to directly stimulate intracellular soluble guanylate 
cyclase and also promotes release of endothelium-derived relaxing factor - 
EDRF (Furchgott and Zawadzki, 1980) from blood vessel endothelia. EDRF is 
now thought to be NO (Palmer et al., 1987). Sodium nitroprusside stimulates 
guanylate cyclase but has no effect upon secretion of EDRF. Topical 
administration 1% or 2% solution of sodium azide or sodium nitroprusside to 
rabbits, however, was found to increase IOP in a dose-dependent manner 
(Krupin et al., 1977). The same experiments also showed that the AH outflow,
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systemic blood pressure and heart rate were not affected by these drugs, 
suggesting an increase in AH flow as the mechanism of increasing the IOP. By 
contrast in arterially perfused bovine eye, however these drugs reduce IOP 
(Millar and Wilson, 1991). In a recent study, soluble guanylate cyclase has 
been characterized in transformed human NPE and sodium nitroprusside had 
been shown to increase cyclic GMP by about 40 to 60 fold in these cells 
(Danziger et al., 1993) supporting possible involvement of soluble guanylate 
cyclase in mediating AH formation.
Calcium Channel Blockers
The calcium ion has now been established as an important second messenger 
which modifies a variety of cellular functions, such as secretion, contraction and 
proliferation (Rasmussen, 1986; Carafoli, 1987). Recently the subject of 
possible roles for Ca?+ in the CE has attracted the attention of many researchers. 
Using spectrophotometry, Lee et al. (1989) reported calcium changes in SV40 
transformed human ciliary non-pigmented (8-SVHCE) cells with various 
agonists. Ca^+-calmodulin and protein kinase C-dependent phosphorylation 
have been reported in rabbit ciliary process and 8-SVHCE cells (Yoshimura et 
al., 1989; Lopez-Briones, 1990). The presence of a calcium signalling system in 
cultured non-transformed human and rabbit NPE cells has been confirmed by 
Ohuchi et al. (1992). Recently, Mittag et al. (1993) reported a calmodulin- 
activated adenylate cyclase in rabbit ciliary process. Jacob (1991) identified a 
low-thresold T-type calcium channel in bovine CE cells. With regard to 
outflow apparatus, it has been shown that removal of Ca^+ from the anterior 
chamber of the eye of rabbit and cynomolgus monkey by intracameral infusion 
with both calcium-free aqueous-like solutions or calcium-chelating agents, such 
as EDTA or EGTA, causes a marked increase in outflow facility and a large fall
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in IOP (Kaye et al., 1968; Bill et al., 1980). This presumably reflects the fact 
that calcium has a role in maintaining the structural integrity of many tissues, 
probably including the trabecular meshwork and the inner wall of Schlemm's 
canal.
It seems obvious from all this experimental evidence that both the AH inflow 
and outflow pathways have calcium-dependent components. Consequently, 
drugs like verapamil or other calcium channel blockers could be used to 
manipulate AH inflow or outflow to lower IOP , particularly in view of the fact 
that these drugs have the ability of causing generalized vasodilatation and an 
improvement of blood supply to the organ concerned. Discovery of drugs 
which can lower IOP as well as improve ocular blood flow is an important 
strategy in glaucoma research. Improved blood supply to the optic nerve and 
retina is an important therapeutic aim to reverse or at least to stop the progressive 
damage of the retina and the optic nerve - the principal pathology of glaucoma 
which renders the eye blind.
Despite these promising aspects, little work has so far been done on ocular 
effects of calcium channel blockers. Also the few available reports are 
disappointingly conflicting. Garrido (1984) and Segarra et al. (1986; 1993) 
suggest that topical application of verapamil and nifedipine lower IOP in 
conscious normotensive rabbits. Green and Kim (1977) showed that intravenous 
perfusion of verapamil causes a fall in IOP in anaesthetized rabbit and more 
recently Payne et al. (1990) have shown that intravenous verapamil and 
nifedipine caused a significant reduction of IOP in conscious rabbits. On the 
contrary, the results of Beatty et al. (1984) suggest that verapamil, nifedipine or 
diltiazem cause an increase in IOP in conscious rabbits and men. Similary, 
Schnell (1975) found that although a single dose of nifedipine causes a reduction
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of IOP in glaucomatous men, repeated oral doses have no effect on these patients 
or normal subjects. On the other hand, Kelly and Walley (1988) found that oral 
or intravenous nifedipine had no effect at all on IOP in normal human 
volunteers. In a recent study, Netland et al. (1993) showed that calcium channel 
blockers have no effect in open angle glaucoma but are useful in preventing 
visual field loss in patients with low-tension glaucoma.
The mechanism of ocular effect of verapamil is not known. From data on the 
pharmacological interactions between verapamil and prostaglandins, Green and 
Kim (1977) have proposed that verapamil reduced AH formation by acting on 
the uveal vessels, by a vasodilator effect on the efferent uveal vessels. 
However, the actions of prostaglandins on the eye are complex and recently it 
has been shown that they reduce IOP by increasing uveoscleral outflow 
(Crawford and Kaufman, 1987; Nilsson et al., 1989; Gabelt and Kaufman, 
1989). Consequently, conclusions based on interactions between verapamil and 
prostaglandins can not be utilized to infer the sites and mechanism of action of 
verapamil. In any case, the dilatation of efferent vessels is unlikely, because it 
is now well established fact that Ca^+-channel blockers cause generalized 
vasodilation, but do not affect the veins much (Soward et al., 1986). However, 
relaxation of afferent ciliary vasculature may cause local reduction of blood 
pressure and comcomitant improvement in blood flow. Again it has been shown 
that the effects of drugs on ocular blood flow are not likely to cause changes in 
the IOP (Chiou et al., 1989, 1990; Chiou and Chen, 1992, 1993). Tonographic 
data from Seggara et al. (1993) suggest that both verapamil (3.85±0.18 to 1.85±
0.19 jil.min“l) and nifedipine (3.63±0.23 to 1.24±0.44 pl.min'l) reduce outflow 
of AH in rabbits when applied topically. Beatty et al. (1984) found a small 
insignificant increase in outflow facility and an apparent increase in AH inflow 
after the topical use of verapamil in rabbits and human. The discrepancy
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between these two reports using the same drug in the same species and utilizing 
the same route of administration is difficult to explain. Different doses and 
technique used might be accounted.
Isolated Arterially Perfused Eye
The isolated arterially perfused eye has become a frequently used model in the 
investigation of ocular functions (Niemeyer, 1981). The earliest efforts to 
establish such an in vitro model was made by Seaman and his coworkers 
(Seaman et al., 1965; Tazawa and Seaman, 1972; Tazawa et al., 1971) utilizing 
bovine eye and subsequently by Macri and Cevario utilizing cat eye (Macri and 
Cevario, 1973; 1974a; 1974b; 1975). Since then considerable success has been 
demonstrated in studying physiology and pharmacology of AH dynamics using 
isolated perfused eye either from cat (Macri and Cevario, 1978a, 1978b; Macri et 
al., 1980; Van Alphen and Macri, 1981) or from rabbit (Kodama et al., 1983, 
1985; van Pinxteren and van Alphen, 1985). The isolated outflow pathway 
from bovine (Erickson-Lamy et al., 1988) and human eye (Erickson-Lamy et al., 
1991; Erickson-Lamy and Nathanson, 1992) have also been adapted for 
physiological studies. The whole bovine eye was perfused by Kishida et al. 
(1985), who rejected it as unsuitable for the study of AH dynamics. The 
benefits of its size, unique vascularization and ready availability led us to 
investigate the bovine perfused eye further and to establish it as a useful model 
for studying AH dynamics (Wilson et al.,1993). This model also allows rapid 
sampling of substantial amounts of tissues for biochemical analysis (Shahidullah 
and Wilson, 1992) and for culturing the CE cells in vitro for subcellular studies 
(Shahidullah and Wilson, 1993). It is very encouraging to note that recently de 
Coo et al. (1993) succeeded in keeping the isolated arterially perfused bovine 
eye metabolically viable for up to 9 days.
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Aims of the Project
It has been noted, while reviewing the various antiglaucoma drugs, that none of 
the important and widely used drugs has been established on a firm molecular 
basis of their mechanism of action on AH formation. In the case of adrenergic 
drugs, particularly the extensively used P-blockers, no correlation has been 
found between their physiological response and underlying biochemical effect
tw  y-
either using glaucoma patients or normal volunteers or experinemtal animals. 
Recently, there have been some interesting new developments in the 
biochemistry of ciliary tissues, such as demonstration of the presence of 
serotonergic (Tobin et al., 1988; Tobin and Osborne, 1989; Barnett and Osborne, 
1993) and purinergic receptors (Wax et al, 1993) in the iris ciliary-body 
preparation and CE respectively. Activation of ciliary process adenylate cyclase 
by calmodulin (Mittag et al., 1993), demonstration of soluble guanylate cyclase 
in human NPE cells (Danziger et al., 1993), T-type Ca^ "*" channel in bovine CE 
(Jacob, 1991) have been reported. There are also promising new agents to 
investigate, such as 5-HT receptor antagonists, atriopeptin and nitrovasodilators 
(which produce their effect by activating soluble guanylate cyclase) which 
reportedly lower IOP.
Extensive study of these agents, to relate their physiological and biochemical 
effects on the target tissues is necessary. This demands an effective in vitro 
experimental model in which AH dynamics and their pharmacological 
manipulation can be studied. In vivo work involves the influence of the CNS as 
well as hormonal and cardio-vascular systems which often complicate the 
interpretation of results. With this general end in view, the aims of the present 
project were:
1. To develop the isolated arterially perfused eye as an in vitro model for 
studying AH dynamics and their pharmacological manipulation, including 
the development of a fluorescein dilution method for measuring AH 
formation rate. To achieve this and to prove the validity of the model three 
approaches were undertaken.
a) Testing the model using standard antiglaucoma drugs, timolol and 
a carbonic anhydrase inhibitor (MK-927), both known to reduce 
AH formation.
b) Testing the model by using a wide range of arterial flow rates and 
correlating the observed IOP and perfusion pressures. This may 
confirm that AH formation in this preparation results from active 
secretion and not by some passive filtration process.
c) Testing the metabolic activity of the perfused eye by measuring the 
O2  consumption and CO2 elaboration.
2. To study the mechanism of action of timolol by measuring the relative 
effects on IOP, AH formation and ciliary cyclic AMP accumulation of a 
variety of agents.
3. To confirm whether AP and sodium azide lower IOP in the bovine perfused 
eye by reducing the AH formation rate and to test the involvement of cyclic 
GMP in the mechanism of these agents.
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4. To extend the study of cyclic nucleotides as putative ciliary second 
messengers to the next biochemical level by using selective inhibitors of 
protein kinase A and protein kinase G.
5. To develop a method of culturing bovine CE, in order to open up further 
possibilities of pursuing these post receptor mechanisms to the ultimate 
conclusion; in particular to study the possible involvement of intracellular 
calcium ions.
METHODS
MATERIALS AND METHODS
The Bovine Perfused Eye Preparation
Bovine eyes obtained from the abattoir were transported to the laboratory at 
ambient temperature and maintained at room temperature for usually about 10 to 
15 min (needed for dissection and cannulation) until the start of arterial 
perfusion at 37°C. The ambient temperatures during transportation were in the 
range of 2 to 17°C depending on the season. The eyes were not transported on 
ice since the resulting solidity of the orbital fatty tissues seriously hampered 
dissection and cannulation. It was also felt that the return of the eyes' core 
temperature to 37°C on commencing perfusion, would be slowed considerably 
by cooling the whole eye in ice. Immediately after transportation to the 
laboratory, the excess adnexal tissue was trimmed away from the eye but care 
was taken not to damage blood vessels running over the posterior surface of the 
globe. A few mm of each extraocular muscle was left attached to the globe. 
One of the long posterior ciliary arteries (medial or lateral) was cleared of 
connective tissue and cannulated at a point proximal to the heavy pigmentation 
which appears in the arterial wall before it pierces the sclera. This portion of 
the artery is quite elastic, offers easy cannulation and withstands the necessary 
manipulation.
After cannulation, the eye was placed in a warming jacket maintained at 37°C 
(Fig. 12). The exposed surface of the eye was kept moist by wrapping with 
surgical gauze soaked in Krebs' solution at 37°C and then covered with an 
insulated plastic cup. The cannulated long posterior ciliary artery and thus the 
blood vessels of the choroid, ciliary body and iris were then perfused with a 
Krebs' solution comprising (mM): NaCl, 118; KC1, 4.7; CaCl2 , 2.5; KH2 PO4 ,
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Fig. 12. The bovine isolated eye, showing perfusion of the 
uveal vasculature through one long posterior ciliary artery under 
conditions of constant flow rate. Perfusion pressure and IOP 
were both monitored as shown.
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1.2 ; MgSC>4 , 1.2; NaHCC>3 , 25; glucose, 11.5; ascorbate, 0.05. The pH of the 
solution was adjusted to 7.4 by bubbling with O2  containing 5% CO2 . The 
flow was induced by using a Watson-Marlow peristaltic pump fitted with either 
a 502S or a 503S pumphead. Arterial perfusion pressure was recorded via a 
tranducer and Linseis pen recorder (Fig. 12). Flow was commenced at 
approximately 0.2 ml.min'l and increased usually in 10 increments to 2.25 - 2.5 
ml.min"!, over a period of approximately 50 min. However, in some eyes 
which showed low perfusion pressure, optimum flow rate was reached much 
earlier than this, sometimes within 30 min of the start of perfusion. During this
period perfusion pressure often fluctuated, usually due to poor alignment of the 
cannula with the artery, but was not allowed to exceed 100 mmHg. This was 
achieved either by correcting the arterial alignment with the cannula or by 
adjusting the flow rate or by both. After approximately 50 min, when AH 
secretion had started and the globe had become firm, the anterior chamber was 
cannulated with a 23G needle and connected via silicon rubber tubing (i.d. 0 .8  
mm) either with a water manometer or via a T-piece with both a water 
manometer and the cuvette of a fluorimeter for the purpose of determining either 
IOP (Fig. 12) or AH flow rate respectively (Fig. 13).
Measurement of IOP
For this purpose the anterior chamber was cannulated with a 23 gauge needle 
and connected via a fine silicon rubber tube to a water manometer of internal 
diameter 1 mm (Fig. 12). Observations of IOP were usually made at 5 min 
intervals throughout the remainder of the experiment. Only eyes maintaining a 
stable IOP within the range of 95 to 165 mmH20 (7 to 12 mmHg), and a stable 
arterial perfusion pressure within the range of 20 to 60 mmHg, after an 
equilibration period of a further 30 to 60 min, were accepted for study. At this
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Fig. 13. Anterior chamber perfusion system used for 
determination of AH formation rate. Fluorescein dissolved in 
aqueous humour substitute was pumped from the anterior 
chamber through a circuit consisting of fine tubing and a 
cuvette, where fluorescence was monitored.
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point bolus doses of drugs or the appropriate vehicle were injected, in volumes 
of 3 to 10 pi using a microsyringe, into the perfusate immediately proximal to 
the arterial cannula, and their effects on IOP or arterial perfusion pressure were 
measured and recorded. Before injecting the drug or the vehicle, it was 
ascertained that the IOP did not fluctuate by more that 1 mmH2 0  for a period of 
at least 15 min. The time of injection was designated as zero time.
Measurement of AH Formation Rate
The anterior chamber was cannulated first with one 23 gauge needle. This was
connected by a thick-walled silicon rubber tubing (i.d., 0 .8  mm; wall thickness
1.8 mm) through a Watson-Marlow peristaltic pump (Model 502S and 503S) to
the cuvette of a spectrophotofluorimeter (Aminco-Bowman or a Perkin-Elmer
LS-3), returning to the anterior chamber via a second 23 gauge needle and a T- 
i (was -
piece (Fig. 13); the latter connected to a water manometer. The points of the 
needles in the anterior chamber were kept widely separated to optimise mixing.
The system of tubing and cuvette was filled with a known volume (1.06 ml in 
case of Aminco-Bowman spectrophotofluorimeter and 1.34 ml in case of Perkin- 
Elmer LS-3 spectrometer) of an aqueous humour substitute (AHS) comprising 
(mM): NaCl, 110 ; KC1, 3.0; CaCl2, 1.4; MgCl2, 0.5; K2HP04, 0.9; NaHC03, 
30; glucose, 6.0; ascorbate, 3.0 (Barany, 1964); and fluorescein sodium 2.7 pM. 
The AHS was bubbled with 0 2  containing 5% C02, before mixing with 
fluorescein, for 8 min, at which time the pH was 7.6. After recording the initial 
fluorescence of this solution, the pump was started and the fluid was circulated 
through the anterior chamber at a rate of 0.25 ml.mhrl. With the 
establishment of the circulation, AH from the anterior chamber started mixing 
with the AHS and fluorescein in the cuvette and tubing system. As aqueous
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passed through and mixed with the fluorescein, its concentration fell and was 
recorded from the fluorimeter every 5 min. The fluorescence was recorded at an 
excitation wavelength of 470 nm and an emission wavelength of 515 nm. When 
mixing was completed (which never took more than 2 0  min), a steady state was 
established, and from then on dilution of fluorescein in the cuvette was only due 
to newly formed AH.
Emission by fluorescein varies considerably with pH. Aqueous pH was 
measured at the end of some of the 2-3 hour experimental periods and compared 
to the pH of the mixture of AH plus AHS and fluorescein at the start of the 
experiment. IOP was also monitored from the water manometer to exclude eyes 
showing exceedingly high pressure (above 165 mmH2 0 ), which was taken as a 
sign of breakdown of the blood-aqueous barrier (Wilson, Shahidullah and Millar,
1993).
The AH formation rate was estimated by the fluorescein dilution technique, with 
the usual assumption that the marker leaves the anterior chamber only by bulk 
flow. When the rate of formation is constant, a plot of loge of fluorescein 
concentration against time is a straight line whose slope gives the rate constant 
for AH formation (Kouj;.min-l). The rate constant for AH formation is a 
function of the rate of disappearance of fluorescein from the anterior chamber 
and at a steady IOP and constant anterior chamber volume, is directly 
proportional to the rate of formation of AH. Regression lines representing the 
decay of fluorescence in the aqueous were constructed using the ANOVA 
statistical package provided by Minitab. The Kout value for a period of 30 min, 
after initial 20  min of mixing time, was used as the "same eye" control value to 
compare against any subsequent drug-induced change. For this, the appropriate 
vehicle was injected into the perfusate immediately behind the arterial cannula,
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as in the case of IOP, just after completion of the 20 min mixing period. In 
most experiments, however, drugs or vehicle were injected into separate eyes.
The Kout value was also used to find, by extrapolation, the fluorescence value 
(Fm) at zero time, corresponding to the value which would have pertained if 
complete and hypothetical instantaneous mixing had occurred. This 
extrapolation allowed estimation of the anterior chamber volume. For this 
calculation it was assumed that the rate of AH formation, i.e. the Kout.min“l 
value, for the 30 min control period was similar to that for the preceding 20 min 
mixing period.
Anterior chamber volume at the beginning of each experiment was thus 
measured by extrapolation of the decay curve for fluorescence. At the end of 
some experiments, the chamber volume was also measured by withdrawal of AH 
through a lateral corneal puncture, using a preweighed disposable plastic syringe 
fitted with 23 gauge needle as described by Vogh et al. (1989). The rate of AH 
formation, in terms of absolute units, could them be calculated as the product of 
(Vac + Vs) and Kout.min"l. The relationship which allows this calculation is:
F0 x Vs = Fm (Vs + Vac) where,
F0  represents the initial fluorescence in the cuvette and tubing system prior to 
cannulation, Fm is the fluorescence at the start of anterior chamber perfusion if 
instantaneous mixing were achieved, Vs is the volume of cuvette and tubing 
system, Vac is the volume of anterior chamber and, as mentioned above, Fm was 
obtained by extrapolation and thus:
VsCFo-Fm) 
Vac = ---------------
Fm
79
Testing the Integrity of Blood-aqueous Barrier of the Isolated Eye Perfused 
with Krebs' Solution
As one of the procedures used to validate the perfused eye preparation, various 
arterial flow rates ranging from 1.5 ml.min" 1 to 3.5 ml.min" 1 were used. 
Preparations were set up and arterial perfusion carried out at the standard flow 
rate of 2.25 ml.min" 1 (which was used throughout all other experiments). Upon 
establishing that IOP and perfusion pressure were stable, the recordings were 
continued up to 40 min. Then the flow rate was changed to 1.5 ml.min-l and at 
this new flow rate the IOP and perfusion pressure were recorded for another 40 
min. Similar observations of 40 min duration were also made for each flow rate 
of 2.5 ml.min"! and 3.5 ml.min-! respectively on the same eye. Variation of 
perfusion pressure and IOP were then statistically analysed using Student's t-test.
Measurement of O2 and CO2 Tension
In an effort to determine that the tissues of the isolated perfused eye are 
metabolically active, an estimate was made of O2  consumption and CO2  
production by fresh perfused eyes. These were compared with corresponding 
data from bovine eyes which had been stored at 4°C for at least 24 hour (after 
intially perfusing with non-oxygenated Krebs' solution for 30 min in order to 
remove blood from the vasculature which may interfere with subsequent 
perfusion). Both fresh and dead eyes were arterially perfused for 90 min at 37° 
C as described above and comparison was made of the gas tensions of the 
perfused fluid and the perfusate emerging from the vortex veins. O2  and CO2  
were measured using a pH/Blood Gas Analyzer (Instrumentation Laboratory 
Systems, 1302).
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Effects of Timolol and MK-927 on AH Formation
In order to confirm that it is possible to demonstrate significant and reproducible 
ocular effects of standard drugs, on the bovine isolated perfused eye preparation, 
a single bolus dose of timolol, and 3 different doses of the CA inhibitor, MK- 
927, were tested in respect of AH formation. In these experiments separate eyes 
were used for studying control and drug effects. Both the drugs were dissolved 
in freshly prepared Krebs' solution. The dose used for timolol maleate was 10 
nmol and for MK-927 was 100, 10 or 1 nmol. After drug or vehicle (in these 
cases Krebs' solution) injection, the fluorescence reading were monitored for 120 
min. The volume of the bolus injection was 10 pi in both cases. Statistical 
comparison of values of Kout.min~l were made by analysis of variance 
(ANOVA) and for values of pl.min’l by two-tailed Student's t-test for unpaired 
data using Minitab.
Effects of Terbutaline, Forskolin and 8-bromo Cyclic AMP on AH 
Formation
Terbutaline, forskolin and 8-bromo cyclic AMP were tested for their effects on 
AH formation. The dose used for terbutaline and forskolin was 30 nmol and for 
8-bromo cyclic AMP was 100 nmol. The vehicle for terbutaline and 8-bromo 
cyclic AMP was Krebs' solution. Forskolin was dissolved in dimethylsulfoxide 
(DMSO). Drug solution or vehicle in volumes of 3 to 10 pi was injected into 
the arterial perfusate as before. The fluorescence readings after drug injection 
were taken for 120 min in case of terbutaline and 90 min for the other two 
agents. Kout.min‘ l values were calculated and analysed statistically as before 
using analysis of variance (ANOVA).
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Effects of Terbutaline and Sodium Azide on IOP
Single bolus doses of 30 nmol of terbutaline and 10 nmol of sodium azide, were 
also investigated for their effect on IOP. The vehicle for each drug was Krebs’ 
solution and a group of vehicle-treated eyes was used as control for both drugs. 
Upon establishing the stable IOP for 15 min as described above, the drug or the 
vehicle (both in a volume of 10 pi) was injected. IOP was monitored for 90 min 
after injection of drug or vehicle. The regression line for IOP values at 5 min 
intervals was constructed for each eye and the statistical comparison was made 
on the mean slope of control or treated group by ANOVA.
Effect of Verapamil on IOP
Three doses of verapamil, were investigated to observe any dose-dependent 
response. The drug was dissolved in 50% DMSO. The doses used were 1, 10 
and 100 nmol. Volume of the bolus injection was 10 pi for each of the doses. 
Statistical comparison between the control and treated groups was made by 
ANOVA.
Effect of Atriopeptin on AH Formation
A 50 pmol dose of atriopeptin, was also investigated in respect of AH formation. 
Same-eye as well as different-eye controls were used for the vehicle (water). 
The drug solution or vehicle was injected in a volume of 5 pi. In the case of 
the group where same-eye controls were used, after the initial 2 0  min of mixing, 
vehicle was injected and then after a further 30 min, the drug was injected. For 
the different-eye control group the same protocol was maintained as for other
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drugs. Calculation of Kout values and statistical analysis was done as described 
for timolol.
Effect of Specific Inhibitors of Cyclic AMP-dependent (KT-5720) and Cyclic 
GMP-dependent (KT-5823) Protein Kinases on Terbutaline and Sodium 
Azide-Induced Reduction of IOP and AH Formation
Determination of Effect on IOP
After the establishment of 15 min of stable IOP, the specific protein kinase 
inhibitor (KT-5720 in case of terbutaline and KT-5823 in case of sodium azide) 
was injected as a bolus dose of 10 nmol. After 15 min the second drug (30 nmol 
of terbutaline and 10 nmol of sodium azide) was injected. IOP was monitored 
for 105 min from the time of first injection. A similar but cross over study on 
IOP was also conducted to investigate the effect of KT-5823 (cyclic GMP- 
dependent protein kinase inhibitor) on terbutaline's response and KT-5720 
(cyclic AMP-dependent protein kinase inhibitor) on the effect of sodium azide.
Determination of Effect on AH Formation
The effects of KT-5720 on the reduction of AH formation by terbutaline and of 
KT-5823 on the suppression of AH formation by sodium azide were studied. 
Here also same-eye and different-eye controls were used. After 2 0  min of 
aqueous mixing, the appropriate vehicle in appropriate volume was injected into 
the arterial perfusate. After 30 min of control period the specific inhibitor of 
protein kinase (KT-5720 in case of terbutaline and KT-5823 in case of sodiun 
azide) was injected. After another 15 min 30 nmol of terbutaline or 10 nmol of
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sodium azide was injected. Measurement of Kout values and statistical anlysis 
were made as before.
Determination of Ciliary Cyclic Nucleotides Concentrations (Cyclic AMP 
and Cyclic GMP).
In order to determine the effects of timolol, terbutaline and forskolin upon cyclic 
AMP and the effect of atriopeptin on cyclic GMP in the CE, three types of tissue 
preparation were used. These were (1) the superficial scrapings of the CE 
obtained after drug challenge from the eyes perfused as in the case of IOP and 
AH formation experiments, (2) incubation with the drug of the ciliary process 
tips excised from fresh eyes and (3) incubation with drug of the CE cells 
obtained by tissue culture in the laboratory. In the case of terbutaline, all three 
types of tissue preparation were used for determining its effect on cyclic AMP. 
In the case of atriopeptin, only the cultured CE cells and in all other cases the 
scrapings of CE cells from the perfused eye were used.
Collection of Tissue Samples from Perfused Eyes
Perfused eye preparations were set up as in the case of IOP experiments and 
allowed to achieve stability. Eyes showing stable IOP and perfusion pressure 
were then challenged with either the drug or the vehicle in appropriate doses and 
volume into the perfusate through the rubber tubing immediately behind the 
arterial cannula. The perfusion was subsequently allowed to proceed for 
precisely 3 min, whereupon the eye was taken off the perfusion system and 
rapidly dissected through the posterior pole to remove the vitreous, lens and lens 
capsule. A portion of the sclera along with choroid and retina was also 
dissected out to facilitate manipulation. The remaining anterior portion of the
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eye was then inverted over a plasticine sphere, which filled the curvature of the 
depressed cornea in the anterior chamber, and was immediately immersed in 
liquid nitrogen for precisely 2 0  s in order to freeze the ciliary processes and stop 
any chemical or enzymically catalysed reaction. This dissection and subsequent 
procedures took approximately 3 min, giving a total drug exposure time of 
approximately 6 min. After removal from the liquid nitrogen, the anterior eye 
portions were placed in a freezer at -30°C for about 30 min. They were then 
removed from the freezer and the CE cells were scraped very superficially from 
the processes along the region of the pars plicata by means of a sharp stainless 
steel spatula. While scraping, care was taken to harvest as little as possible of 
the underlying stromal tissue. The scraped tissue was collected into 0.5 ml of 
TCA (6 %, w/v) in Eppendorf tubes. Scrapings from each eye were collected in 
separate Eppendorf tubes and stored at -30°C until required for analysis.
Collection of Samples from Fresh Eyes
Fresh eyes were dissected from the posterior pole as described above. After 
removal of vitreous, lens and lens capsule, the tips of the ciliary processes were 
cut with fine scissors and harvested in Eppendorf tubes containing 1 ml of 
saline. Unlike the ciliary processes in rabbit and human, the bovine processes 
are well developed and project freely for a distance of about 3 mm over the iris, 
the so-called operculum or corpora nigra. Thus the tips of the processes can be 
cut without any contamination from the adjacent tissues. The Eppendorf tubes 
with the cut ciliary processes were incubated at 37°C. After about 10 min, 
when the temperature of the contents in the Eppendorf tubes was equilibrated at 
37°C, drug solutions or vehicle were added. Drug solutions were added to the 
Eppendorf tubes to the desired concentrations. After addition of drugs or 
vehicle the incubation was continued for a further 12 min. The fluid in the
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Eppendorf tubes was then removed with a Pasteur pipette and 0.5 ml of 6% TCA 
was added to stop any enzymic reaction. The tubes were then stored at -30°C 
until required. Cut tips were used only for terbutaline experiments. Four 
concentrations of terbutaline (10"4, 10" ,^ 10“6 and 10"^M) were used.
Collection of Samples in Case of Cultured CE Cells
Bovine CE cells were cultured and maintained as described in page 92-95. Only 
the 1st and 2 nd passage cells were used for investigating drug effects on cyclic 
i nucleotides. For this purpose, cells were grown in 25 cm^ GIBCO culture
| flasks. At confluence, the culture medium was decanted and the cells were
| washed two times with normal saline (pH 7.4). The cells in each flask were
i
! then incubated with 5 ml of the same saline solution for about 10 min tol
i
| equilibrate the temperature at 37°C. After addition of drug or vehicle, the flasks
j were incubated for another 6 min. The fluid from the flask was decanted and
i
0.5 ml of 6% TCA was spreaded over the cell layer to stop enzymic reaction. 
The cells were then scraped with a cell scraper and collected along with the TCA 
into Eppendorf tubes using a Pasteur pipette. Cells from separate flasks were 
collected in separate Eppendorf tubes and stored at -30°C until needed.
[it
Preparation of Cyclic Nucleotide Extract for RIA
The previously collected raw samples in the Eppendorf tubes (for all three types) 
were thawed in a water bath at 50°C for 10 min, then sonicated for 5 - 1 0  min in 
a Camlab Transsonic T310 sonicator bath, mixed well with a vortex mixer and 
frozen again at -30°C for 2 0  min. The above sequence of procedures (ffeeze- 
thaw-sonication-vortexing) was carried out 5 times altogether. The purpose of 
this was to break open all of the cells in the tissue. At this stage, either ^H-
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cyclic AMP for cyclic AMP RIA or ^H-cyclic GMP for cyclic GMP RIA (e.g., 
0.072 pmol of ^H-cyclic AMP, equivalent to 4440 dpm) was added to each 
sample in order to determine the recovery efficiency of the extraction process. 
This amount was subtracted while calculating the total amount of cyclic 
nucleotide in the samples.
The homogenate in Eppendorf tubes was then spun in a microcentrifuge (10,000 
g, for 5 - 10 min). The supernatant was transferred to a 3 ml glass test tube 
containing 1.6 ml of 0.5 M (22.5%, v/v) tri-N-octylamine (TNO) in Freon. The 
resultant immiscible layers were mixed thoroughly on a vortex mixer for 4 x 5s 
and centrifuged briefly (1000 g, 3 min) to break the emulsion and to clarify the 
separate phases. The top layer was transferred to a 4cm column of well washed 
(with distilled water, 10 times) Dowex-50W cation exchange resin (dry mesh 
200 - 400 in case of samples for cyclic AMP assay; and 50 - 100 for cyclic GMP 
assay). The resin columns were made using 155 mm disposable Pastern pipettes 
with a glass wool plug. While transferring the supernatant, great care was taken 
to avoid contamination of the aqueous layer from the underlying Freon layer. 
This was very important because it was observed that a slight contamination 
seriously hampered the recovery of nucleotides through the column. This was 
conveniently done using a glass Pasteur pipette and suction bulb. A further 0.2 
ml of 6% TCA was added to each pellet remaining in the Eppendorf tubes which 
were then vortex mixed to break up the pellets. A micro-homogenizer pestle 
was used at this stage, when needed, in order to assist in disrupting the pellets. 
The washed pellets were then spun down once again (10,000 g, 5 min). The 
supernatant was transferred to the same 3 ml glass tubes containing TNO in 
Freon, vortex mixed, centrifuged and the aqueous layer transferred to the same 
resin column. The pellets in the Eppendorf tubes at this stage were stored at -30 
°C for protein assay. Cyclic nucleotide was then eluted from the column by
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washing 10 times with 0.5 ml of distilled water with minimum disturbance of the 
resin. The first three washings were discarded as dead volume of the column 
and 4th to 10th washings were collected as eluate in 10 ml glass test tubes. The 
eluates were dried overnight under a stream of air and were stored at 4°C for 
subsequent assay.
The dead volume and eluate volume of the column were previously determined 
using standard ^H-cyclic AMP or ^H-cyclic GMP in TCA and were found to be 
2.5 ml and 3.5 ml respectively. 0.5 ml of TCA was mixed with 0.1ml of ^H- 
cyclic AMP (concentration was 3.6 pmol.mH) and the mixture was then added 
to 1.6 ml TNO in Freon in a 3 ml glass test tube. The tube was vortex mixed for 
20 s and centrifuged for 2 min (10,000 g). 0.4 ml of supernatant was then
transferred to the Dowex-50W cation exchange resin column and the resulting 
eluate collected in a 25 ml plastic vial for liquid scintillation counting. The 
remaining 0.2 ml of supernatant in the tube containing the TNO in Freon was 
then transferred to the same column and the eluate collected in another counting 
vial. The column was washed 15 times with 0.5 ml of distilled water and the 
eluate of each washing was collected in separate counting vials. 10 ml of 
Ecoscint scintillation cocktail was added to each of the 17 vials and the p- 
radiation counted in a Packard 2000CA Tri-Carb Liquid Scintillation Counter. 
The liquid scintillation counter printout included an automatic correction for 
counting efficiency.
Determination of Recovery Efficiency of Nucleotide from the Extraction 
Process
The dried tissue extracts in 10 ml glass test tubes were redissolved in 500 pi of 
Na-acetate buffer (pH 6.2) supplied with the cyclic AMP or cyclic GMP
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radioimmunoassay kit. From each tube a 100 p.1 aliquot was taken in a 
scintillation counting vial and 10 ml of scintillation cocktail and 0.5 ml of 
distilled water were added to it. The contents were mixed well by shaking and 
the beta-radiation was counted by the Liquid Scintillation Counter (Packard 
TriCarb 2000A). Two empty vials containing only distilled water and 
scintillation cocktail and two total count vials containing 0.072 pmol of ^H- 
cyclic AMP (or in case of cyclic GMP assay 0.018 pmol of ^H-cyclic GMP) 
were also counted for use as background and total counts respectively. The 
recovery efficiency for each extraction was then calculated.
Radioimmunoassay (RIA)
The basic principle of RIA first described by Yalow and Berson (1971) consists 
of competition between radioactive and non-radioactive antigen for a fixed 
number of antibody binding sites. If increasing amounts of unlabelled antigen 
(i.e., in standards or unknown samples) and a fixed amount of labelled antigen 
(i.e., tracer) are allowed to react with a constant amount of antibody, a 
decreasing amount of labelled antigen is bound to the antibody. This 
relationship can be expressed as a standard curve and the amount of unlabelled 
antigen in a sample can be determined by interpolation from this curve. This 
reaction can be represented schematically as follows:
Labelled Antigen + Specific Antiboby Labelled Antigen-Antibody
Complex
Ag* Ab Ag*Ab
+
Unlabelled Antigen (In standard solutions or unknown samples)
Ag
4
Unlabelled Antigen-Antibody Complex 
_________________AgAb_________________
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RIA for Nucleotides (Cyclic AMP and Cyclic GMP)
Determination of nucleotides was adapted from the procedure of Steiner et al
(1972) using New England Nuclear RIA kits (DuPont). In their original work 
Steiner et al. (1972) reported that cyclic nucleotide substituted at 2'-0-position 
has a higher affinity for the antibody and thus displaces the [125I]-labelled 
derivative better than the unsubstituted cyclic nucleotide. Following this, Cailla 
et al (1973) described a procedure for succinylating tissue extract of cyclic AMP 
yielding 2'-0-succinyl cyclic AMP and increasing the sensitivity of the assay by 
100-fold. Harper and Booker (1975) and Fradson and Krishna (1976) showed 
that a similar result could be achieved by acetylating the sample with acetic 
anhydride to give 2'-0-acetyl cyclic AMP or 2'-0-acetyl cyclic GMP. Thus 
both standards and samples were acetylated with acetic anhydride to increase the 
sensitivity of the assay.
The experimental protocol for both cyclic AMP and cyclic GMP assay were as 
per instructions for acetylated samples included in the kits. All standards and 
samples were run in duplicate.
Analysis of Radioactivity
All tubes were counted for 5 min in a gamma counter (Packard Cobra Auto 
Gamma, 5003). The analysis of radioactivity in tubes was controlled by an 
IBM-computer with a user-defined RIA protocol. Each assay run included 
duplicates for total counts, blanks, standards and unknowns (samples). The 
standard curve was plotted with the characteristics of a bound fraction RIA curve 
with a negative slope. The concentration for each unknown sample was 
automatically calculated by interpolation from the standard curve and the values
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were printed. From the printed value, the total amount of nucleotide in each 
sample was calculated. The nucleotide added for recovery estimation was 
subtracted to find the actual amount of nucleotide present in the sample.
Protein Assay
The amount of protein in the pellets was determined by the Lowry (1951) 
method. The pellets in the Eppendorf tubes were transferred to 10 ml glass test 
tubes. This was achieved very conveniently by addition of 1 ml of N-NaOH to 
each Eppendorf tube allowing a few minutes to soften the pellets and then 
transferring with a disposable glass Pasteur pipette. Another 4 ml of N-NaOH 
was added to each tube and the tubes were heated in a water bath at 60° C with 
occasional shaking for about 2 h or until all pellets had dissolved. Three 
convenient aliquots from each samples were transferred to separate 10 ml glass 
test tubes and N-NaOH was added to each aliquot to yield a final volume of 300 
pi. A blank and 5 standards, each in duplicate were prepared in 10 ml glass test 
tubes using bovine serun albumin (BSA) solution in distilled water (lmg.ml'l) 
as follows (Table 4):
Then at 15 s intervals, 3 ml of solution C (Lowry et al., 1951) were added. The 
tubes were mixed and left at room temperature for 15 min. lN-Folin-Ciocalteu 
reagent was then added to each tube at 15 s intervals, mixed well and left for 30 
min. After this time and at 15 s intervals, absorbance of each aliquot was 
measured at 750 nm (E75 0 ) using a Cecil Spectrophotometer. A standard curve 
was constructed with values for protein (in micrograms) present in the standards 
plotted along the abscissa and the corresponding E7 5 0  values along the ordinate. 
The standard curve was constructed using the computerised statistical package 
Minitab. Protein in each aliquot was calculated from the regression equation
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obtained by using the Minitab package. The results were expressed as mg of 
protein per sample.
Table 4.
Tubes BSA (nl) N-NaOH (nl)
Blank 0 300
*S1 30 270
S2 60 240
S3 90 2 1 0
S4 120 180
S5 150 150
* S = Standard
The results for cyclic AMP were expressed as pmol.mg"! protein and for cyclic 
GMP as fmol.mg‘1 protein. All results were analysed using MINITAB and 
statistical significance was tested by using the two-tailed Students t-test for 
impaired data.
Culturing Ciliary Epithelial Cells
Two methods of isolation for primary cultures of CE cells have been adopted: 
one using the arterially perfused eye as described above and another by cutting 
the tips of ciliary processes from unperfused eyes.
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Isolation and Culture of Cells Using Perfused Bovine Eye
The perfusion procedure was essentially similar to that described for IOP 
experiments except that the system was sterile and 3 distinct perfusates were 
used instead of modified Krebs' solution. The eyes were initially perfused with 
Dulbecco's modification of Eagle's medium (DMEM) supplied with 100% O2  
(instead of previously used mixture of 95% O2  and 5% CO2 , because CO2  
influences the pH of the Hepes bufferred DMEM used) for about 30 min while 
raising the flow rate to 1.5 ml.min" 1 with a view to open up the ciliary 
vasculature as well as supplying nutrients and oxygen. The second perfusion 
was for exactly 12 min with a Ca^+-free buffer (pH 7.4) comprising (mM): 
NaCl, 142; KC1, 13.41; Hepes 4.82 and EDTA, 0.25. Finally, the eyes were 
perfused with collagenase A (Boehringer) solution (0.1%) in a buffer (pH 7.6) 
comprising (mM): NaCl, 66.73; KC1, 13.41; Hepes, 3.84 and CaCl2 , 4.82; for 20 
min, at a flow rate of 0 .2 2  ml.min‘ 1 (reduced to economize on collagenase). 
The eyes were immediately removed from the perfusion system and all 
subsequent operations were carried out in a flow hood (Flow Laboratories).
The remaining extraocular tissues were cleaned and the eyes were washed 3 
times with a sterile saline containing gentamycin (200 pg.ml‘1). The eyes were 
dissected from the posterior pole and the vitreous and lens along with its capsule 
were carefully removed. The partially digested CE sheets were then picked up 
with a round tipped wet Pasteur pitette and collected in sterile centrifuge tubes 
containing DMEM with newborn calf serum (NCS) and foetal calf serum (FCS) 
(10% of each). The sheets of cells thus collected were disrupted by squirting 
gently with the Pasteur pipette without allowing formation of air bubbles. 
Squirting was done in 3 other subsequent tubes transferring each time the 
sediment from the preceding tube. This helped to subject the isolated cells to a
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minimum of stress. The undisrupted sediment in the last tube was removed and 
cells in all the tubes were centrifuged (in an IEC Centra-8R Centrifuge, model 
100-240, at 700 rev.min'l for 4 min at 4°C) and resuspended for washing in 
DMEM. Finally, the cells were centrifuged and resuspended in 2 ml of DMEM 
containing 10% NCS, 10% FCS and gentamycin (2 0 0  pg.mH) - this will be 
referred to as complete medium throughout the rest of the text. The cells were 
then seeded in a 80 cm^ culture flask (GIBCO) containing 15 ml of complete 
medium and incubated at 37°C in an atmosphere of 5% CO2  and 95% air. The 
medium was changed the day following the initial isolation and every 2 - 3  days 
subsequently. Confluence was reached by 7 - 8 days. Cells from 2  perfused 
eyes were usually enough for an 80 cm^ flask.
Isolation and Culturing of Cells Using Unperfused Eyes
Both fresh eyes just after transportation to the laboratory at room temperature 
and eyes collected and maintained on ice were found to be equally suitable for 
this purpose. However, usually eyes maintained on ice were used in the present 
study. The extraocular tissues were cleared off and the eyes were washed 3 
times in saline containing gentamycin (200 pg.ml-!) before dissection. All 
work was then carried out aseptically in a flow hood. The eyes were dissected 
from the posterior pole as described before and inverted on a plasticine sphere 
which fits the curved space formed by the inverted cornea. The vitreous was 
first removed by pushing from the side with a curved forceps keeping the lens 
intact in its position. The lens along with its capsule was then removed by 
cutting the zonular fibres with fine sharp scissors. This revealed the ciliary 
processes lying on the iris. The free suspended portion of the tips were cut with 
fine scissors and collected in centrifuge tubes containing DMEM and 
gentamycin (200 jj.g.ml‘1). The cut tips were then tranferred to a large petri
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dish containing 20  ml of the same Ca^+-free solution used in the case of 
perfused eyes and incubated under constant and mild shaking (Luckham Rotatest 
Shaker, R100/WT) for 25 min. The tips were then picked up with a wet, sterile 
and round-tipped Pasteur pipette and transferred to another large petri dish 
containing 15 ml of the same 0.1% collagenase solution used for the perfused 
eye and incubated under constant shaking for a further period of 30 min. After 
30 min of incubation, 3 ml of a mixture of NCS and FCS (1:1) was added to the 
petri dish to neutralise the enzyme. The partially digested tips were then 
transferred to a centrifuge tube containing DMEM and gentamycin and disrupted 
by squirting with the Pasteur pipette. Squirting was done in 3 other subsequent 
tubes transferring each time the sediment from the preceding tube. This helped 
to subject the isolated cells to a minimum of stress. The undisrupted sediment 
in the last tube were removed and the cells in all the tubes were then centrifuged 
(in an IEC Centra-8R Centrifuge, model 100-240, at 700 rev.min-1 for 4 min at 4 
°C) washed with DMEM and finally centrifuged and resuspended in 2 ml of 
complete medium. The cells were then seeded in 80 cm^ flasks (one flask for 
cells from 2 eyes). Incubation and all other tasks were done as in the previous 
case. The cells reached confluence in 7 to 8 days.
Trypsinization and Propagation of Cells
At confluence the cells were washed 2 times with 20 ml of sterile saline solution 
and incubated with 10 ml of trypsin-EDTA solution (lx, prepared in modified 
Puck's saline, GIBCO) at 37°C for 3 - 4 min. The cells were easily detached 
upon gently shaking the flask 3-4 times. Trypsin was immediately neutralized 
with 3 ml of a mixture of NCS and FCS (1:1). The cells were centrifuged and 
supernatant discarded. Cells were suspended and washed with DMEM and 
finally centrifuged, supernatant discarded and resuspended in 5 ml of complete
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medium. Cells were passaged in 10 GIBCO culture flasks (25 cm^) each 
containing 5 ml of complete medium. Confluence was usually reached after 3 
to 4 days. Cells were propagated and maintained up to 10 passages without any 
obvious sign of change of growth rate but only cells from 1st and 2 nd passages 
were used in the present study.
Effect of Terbutaline on Cyclic AMP in Cultured CE
Four concentrations (10"4, 10“^ , 10"6 and 10“^ M) of terbutaline were tested for 
its effect on cyclic AMP content in the cultured CE cells. The vehicle was 
Krebs's solution. Only the 1st passage cells were used. The procedure was 
similar to that described for the collection of samples in case of cultured cells for 
RIA.
Effect of Atriopeptin on Cyclic GMP in Cultured CE
First and second passage cells were used. Three concentrations ( 10‘6 , 10'7 and 
lO’^M) were used for 1st passage cells and two concentrations (10"6 and 10" 
^M) for the 2nd passage cells. The drug was dissolved in distilled water. The 
procedure was similar to that described for collection of cultured cells for RIA.
RESULTS
RESULTS
Development of the Isolated Arterially Perfused Eye as a Model for Studying 
AH Dynamics
The isolated arterially perfused eye has been developed as a useful in vitro 
model for studying AH dynamics (Wilson, et al., 1993) in which the AH 
formation rate in terms of both rate constant (defined as Kout.min“l) and 
absolute units (ja.l.min‘1) can be determined directly by circulating the anterior 
chamber with a fluorescein solution. The slope of the regression line (a plot of 
loge of fluorescein concentration in the anterior chamber against time) 
representing the decay of fluorescein from the anterior chamber is the rate 
constant for AH formation, Kout.min"l. The anterior chamber volume can be 
determined by a simple formula as described in the Methods section. The rate 
of AH formation in absolute terms can then be calculated by multiplying the 
Kout.min"l value by the sum of the volumes of anterior chamber and tubing 
system.
The anterior chamber volume was determined in 54 eyes by the fluorescein 
dilution technique and also in 10 eyes by the direct method as described by Vogh 
et al. (1989). The mean volume with the fluorescein dilution technique was 
1.69 ± 0.03 ml (mean ± SEM) with a maximum of 2.10 ml and minimum of 1.23 
ml. The mean total (anterior + posterior) chamber volume was 2.0 +0.13 ml by 
the direct method. The mean normal Kout.min"l was found to be 0.0045 ± 
0.0001 (n=51), the mean normal AH formation rate was 12.9 ± 0.44 pl.min'l 
(n=l 1) and the mean normal IOP was 9.37 ± 0.14 mmHg (n=8 8 ).
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Effects of Different Flow Rates on IOP in Arterially Perfused Eye
The isolated eye was tested using four different arterial flow rates ranging from 
1.5 ml.min-! to 3.5 m in t in 'a n d  then correlating flow rates with the observed 
IOP and perfusion pressure. No correlation has been found between the flow 
rates and the IOP. The results are shown in table 5.
Table 5. Variation of Perfusion Pressure and IOP Due to Changes in Flow 
Rate During Perfusion of the Isolated Eye.
Perfusion Flow Rate 
(ml.min'l)
Perfusion Pressure 
(mmHg)
IOP (mmHg)
2.25 37.3 ±3.1 9.40 ± 0.44
1.50 28.4 ±2.7* 8.95 ±0.41
2.50 42.0 ±3.7 9.08 ± 0.34
3.50 50.0± 4.6* 9.97 ±0.41
Each eye was perfused with Krebs' solution for 40 min in turn at each of the 
flow rates shown. Each value is a mean ± SEM of the results from 8 
experiments. Significance of difference from pressure during perfusion at 2.25 
m intin '1: *p < 0.05.
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Metabolic Activity of Bovine Perfused Eye
Metabolic activity of bovine eye during perfusion was determined by comparing 
the C>2 consumption and CO2  elaboration by the living and the dead (frozen) 
eyes. The perfused eyes show a considerable metabolic activity as shown in 
table 6 .
Table 6. Metabolic Activity of the Bovine Isolated Perfused Eye.
n CO2 0 2
Fresh eyes 12 16.2 ±0.7 163 ± 7.4
Eyes stored at 4° C 15 10.1 ± 1.5** 129 ±8.0**
The O2  utilization and CO2  production of the bovine perfused eye, calculated by 
measuring O2  and CO2 tension (mmHg) in the perfusion fluid entering the 
ciliary artery and leaving the vortex veins. Each value is a mean ± SEM of the 
number (n) of experiments shown. Significance of difference from fresh eyes:
** 0 .0 1> p >  0 .0 0 1 .
Influence of pH on Fluorescence
It has been found that the pH of the solution of AH and fluorescein sodium has a 
tremendous influence on its fluorescence. There appears to be a direct 
proportionality of pH and fluorescence. Thus to exclude any variation due to 
pH, we measured the pH of a mixture of 2 ml (approximate anterior chamber 
volume) of fresh AH and 1.06 ml (vol. of the cuvette and the tubing system) of
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fluorescein solution after gassing as previously described. The pH of the 
chamber fluid after the end of some experiemts was also measured and compared 
with that of the mixture prior to perfusion. No variation of pH was observed 
(Fig. 14).
Before perf. After perf.
Fig. 14. Histogram showing pH of anterior chamber fluid 
before and after perfusion of the isolated bovine eye.
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Effects of P-adrenoceptor Drugs on AH Formation
The effects of a single bolus dose of terbutaline (30 nmol) or timolol (1 0  nmol) 
on AH formation were studied for a period of 2h. Both terbutaline and timolol 
caused a significant reduction of AH formation compared to the control group as 
shown in table 7.
Table 7. Effect of Timolol, Terbutaline or MK-927 on AH Formation
Treatment Dose
(nmol)
n Kout
(min^xlO4)
Vac
(ml)
Rate
(pj.min“l)
Control
(Krebs) 11 46 ± 1.2 1.75 ±0.05 12.9 ± 0.44
Timolol 10 14 40 ± 1.1** 1.67 ±0.05 10.9 ±0.30**
Terbutaline 30 7 38 ± 1.7** 1.73 ±0.05 10.7 ±0.54**
MK-927 100 9 35 ±2.8*** 1.67 ±0.07 9.4 ±0.54***
MK-927 10 7 39 ±2.2** 1.63 ±0.08 10.4 ±0.50**
MK-927 1 6 41 ± 1.0* 1.68 ±0.08 11.1 ±0.51*
The effects of timolol, terbutaline or MK-927 on AH formation in the bovine 
isolated perfused eye, shown both as Kout.min"l and rate (the product of 
j Kout.min“l and Vac + Vs). Vac = anterior chamber volume, Vs = volume of
j cuvette and tubing system. Each value is a mean ± SEM of the number of
j experiments shown (n). Significance of differences from control: * p < 0.05;
I
I ** 0 .001  < p < 0 .0 1 ; *** p < 0 .0 0 1 .
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Effect of CA Inhibitor, MK-927, on AH Formation
The effects of three doses, viz, 100, 10 or 1 nmol of MK-927, on AH formation 
were studied. All three doses caused a significant reduction in AH formation 
and also in a dose-dependent manner (Table 7)
Effect of Timolol, Terbutaline or Mk-927 on IOP
The IOP was found to be reduced sigficantly with all three drugs and in the same 
doses tested for AH formation. Table 8 shows the results in terms of mean 
slopes for treated and control groups.
Table 8 .
Treatment Dose (nmol) n Slopes (Mean ± SEM)
Control 11 0.0082 ±0.0018
Timolol 10 14 -0.0108 ±0.0019****
Terbutaline 30 7 -0.0086 ± 0.0017****
Mk-927 100 9 -0.0036 ±0.0021***
Mk-927 10 7 -0.0043 ±0.0023**
Mk-927 1 6 -0.0052 ±0.0032**
The effects of bolus doses of timolol, terbutaline and MK-927 on IOP in the 
bovine isolated perfused eye, shown as the mean slope of the regression lines 
drawn on IOP vs time (120 min). Each value is a mean ± SEM of the number of 
experiments shown (n). Significance of differences from control: ** 0 .001  < p
< 0.01; *** p < 0.001; **** p <0.0001.
102
Effect of Forskolin and 8-Bromo Cyclic AMP on AH Formation
Forskolin, which is a powerful stimulator of adenylate cyclase and 8 -bromo 
cyclic AMP, a cell permeable analogue of cyclic AMP both failed to influence 
AH formation in isolated arterially perfused eye (Table 9)
Table 9.
Treatment Dose (nmol) n Knilf (min-ixlO4)
Control (DMSO) — 10 40 ± 1.8
Forskolin 30 nmol 10 3 9  + 2 .0  n.s.
Control (Krebs) — 8 44 ± 1.5
8 -Bromo cAMP 100 nmol 7 43 ± 2.1 n-s-
Effects of forskolin and 8-bromo cyclic AMP on AH formation in the bovine 
isolated perfused eye, shown as Kout.min- l. Each value is a mean ± SEM of 
the number (n) of experiments shown. Significance of differences from control: 
n s- not significant; *** p < 0 .0 0 1 .
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Effects of Atriopeptin and Sodium Azide on AH Formation
The vasodilator drugs atriopeptin and sodium azide both caused a significant 
reduction of AH formation (Table 10)
Table 10.
Treatment Dose n Kn„t (min’lxlO 4)
Control A — 8 47 ±3.0
Control B — 8 48 ± 1.3
Atriopeptin 50 pmol 8 29 ± 1.9***
Control A — 6 45 ±3.8
Control B — 11 46 ± 1.2
Sodium Azide 10 nmol 6 24 ±2.2***
Effects of atriopeptin and sodium azide on AH formation in the bovine isolated 
perfused eye, shown as Kout.min"l. Each value is a mean ± SEM of the 
number (n) of experiments shown. Control A = same eye control; control B = 
different eye control. Significance of difference from control: *** p < 0.001.
Effect of KT-5720 on Terbutaline-induced Reduction of AH Formation
KT-5720, a specific inhibitor of protein kinase A caused abolition of the AH 
reducing effect of terbutaline (Table. 11).
Table 11.
Treatment Dose (nmol) n Kn„t (min’lxlO^)
Control (KT-5720 in 
DMSO)
10 7 48 ±2.9
T erbutaline+KT-5720 30+10 7 46 ± 2.3n s-
Blunting by KT-5720 of terbutaline's effect on AH formation in the bovine 
isolated perfused eye, shown as Kout.min"l. Each value is a mean ± SEM of 
the number (n) of experiments shown. Significance of difference from control 
(same eye): n s- not significant.
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Effects of KT-5720 and KT-5823 on IOP-Reducing Effect of Terbutaline
KT-5720, a specific inhibitor of cyclic AMP-dependent protein kinase, 
completely abolished the IOP-reducing effect of terbutaline while KT-5823, a 
specific inhibitor of cyclic GMP-dependent protein kinase, was ineffective in 
blunting terbutaline's effect on IOP. The results are shown in table 12.
Table 12.
Treatment Dose (nmol) n Slope (mean ± SEM)
Control (DMSO) __ 8 0.0067 ±0.0041
Terbutaline 30 7 -0.1822 ± 0.0248***
KT-5720 + Terbutaline 10 + 30 7 -0.0128 ±0.0133n s*
KT-5823 + Terbutaline 10 + 30 8 -0.2482 + 0.0216***
Effects of KT-5720 and KT-5823 on the IOP-reducing effect of terbutaline in the 
bovine perfused eye, shown as the mean slope of the regression lines drawn on 
IOP vs time (90 min). Each value is a mean ± SEM of the number (n) of 
experiments shown. Significance of differences from control: n s not
significant; *** p < 0 .0 0 1 .
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Effects of KT-5823 and KT-5720 on IOP-Reducing Effect of Sodium Azide
KT-5823, a specific inhibitor of cyclic GMP-dependent protein kinase abolished 
the IOP-reducing effect of sodium azide while KT-5720, the specific PK^ 
inhibitor, was ineffective (table 13).
Table 13.
Treatment Dose (nmol) n Slopes (mean ±  SEM)
Control (DMSO) __ 7 0.0192 ±0.0016
Sodium Azide 10 7 -0.2702 ±0.0223****
KT-5823 + Sodium Azide 10+10 7 -0.0167 ±0.0032n-s.
KT-5720 + Sodium Azide 10 +10 6 -0.2537 ±0.0195****
Effects of KT-5823 and KT-5720 on IOP-reducing effect of sodium azide in the 
bovine perfused eye, shown as the mean slope of the regression lines drawn on 
IOP vs time (90 min). Each value is a mean ± SEM of the number (n) of 
experiments shown. Significance of differences from control: n s not
significant; **** p < 0 .0 0 0 1 .
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Effect of Verapamil on IOP
Verapamil, a calcium channel blocker, produced a dose-dependent reduction in 
IOP (table 14).
Table 14.
Treatment Dose (nmol) n Slope (mean ± SEM)
Control (50% DMSO) . 10 0.0112 ±0.0045
Verapamil 100 8 -0.2321 ±0.0112****
Verapamil 10 6 -0.2108 ±0.0132****
Verapamil 1 7 -0.1505 ±0.0069***
The effects of bolus doses of verapamil on IOP in the bovine perfused eye, 
shown as the mean slope of the regression lines drawn on IOP vs time (120 min). 
Each value is a mean ± SEM of the number (n) of experiments shown. 
Significance of differences from control: *** p < 0 .0 0 1 ; **** p <0 .0 0 0 1 .
108
Effects of Timolol, Terbutaline or Forskolin on CE Cyclic AMP in the 
Perfused Eye.
In the perfused eye, at the same doses which produced a significant reduction in 
AH formation rate, neither timolol nor terbutaline produced any effect on ciliary 
cyclic AMP. Even at a higher dose level, terbutaline was entirely without any 
effect on ciliary cyclic AMP. Forskolin, on the other hand, produced a highly 
significant rise in ciliary cyclic AMP at a dose which produced no effect on AH 
formation. The results are shown in table 15.
Table 15.
Treatment Dose ( nmol) n Cyclic AMP ( pmol.mg"! 
Protein) (mean ± SEM)
Control (Krebs) — 20 9.8 ±0.5
Timolol 10 10 9.8 ± 0.4n s*
Terbutaline 30 9 8.7 ± 0.4n s-
Terbutaline 100 9 9.3 ± 0.9n s-
Control (DMSO) — 10 8.4 ±0.3
Forskolin 30 10 12.6  ± o .8 ***
Effects of timolol, terbutaline or forskolin on ciliary cyclic AMP in the bovine 
perfused eye shown as pmol of cyclic AMP.mg‘l of protein. Each value is 
mean ± SEM of the number (n) of experiments shown. Significance of 
differences from control: n s- not significant; *** p < 0 .0 0 1 .
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Effect of Terbutaline on Ciliary Cyclic AMP in Excised Ciliary Processes of 
Fresh Bovine Eyes.
When incubated with tips of ciliary processes cut from freshly collected eyes, 
terbutaline produced a dose-dependent increase in ciliary cyclic AMP as shown 
in table 16.
Table 16.
Treatment Dose (M) n Cyclic AMP (pmol.mg"! 
Protein)(mean ± SEM)
Control (Krebs) _ 6 9.4 ± 0.9
Terbutaline 10-7 6 9.6 ± 0.5n s -
Terbutaline 10-6 6 14.1 ± 1.2*
Terbutaline 10-5 6 15.1 ±1.1**
Terbutaline io-4 6 21.4 ± 1.6***
Effects terbutaline on cyclic AMP in the ciliary processes of bovine eye shown 
as pmol of cyclic AMP.mg'l of protein. Each value is mean ± SEM of the 
number (n) of experiments shown. Significance of differences from control: 
n s- not significant; * p < 0.05; ** p < 0.01; *** p < 0.001.
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Effect of Terbutaline on Cyclic AMP in Cultured CE of Bovine Eyes
In the cultured ciliary epithelial cells terbutaline also produced a marked and 
dose-dependent increase in ciliary cyclic AMP (Table 17).
Table 17.
Treatment Dose (M) n Cyclic AMP (pmol.mg"! 
Protein) (mean ± SEM)
Control (Krebs) -  . 12 48.9 ±2.6
Terbutaline 10-7 10 52.2 ± 6 .8n.s.
Terbutaline 10-6 10 85.8 ± 3.7***
Terbutaline 10-5 10 142.2 ±7.8****
Terbutaline io-4 12 357.0 ±21.5****
Effect of terbutaline on cyclic AMP in cultured CE (1st passage) cells of bovine 
eye shown as pmol of cyclic AMP.mg'l of protein. Each value is mean ± SEM 
of the number (n) of experiments shown. Significance of differences from 
control: n s- not significant; * p < 0.05; *** p < 0.001; **** p < 0.0001.
I l l
Effect of Atriopeptin on Cyclic GMP Levels in Cultured CE
Incubation (6  min) of cultured CE cells with atriopeptin produced a dose- 
dependent increase in cyclic GMP as shown in table 18.
Table 18.
| Treatment Dose (M) n First Passage 
Cells
Second Passage
Cells
Control (water) - . 9 64 ± 7 67 ±7
Atriopeptin 10-8 9 66  ± 5n s - - ____
Atriopeptin 10-7 9 135 ± 18** 78 + 8n-s-
Atriopeptin 10-6 9 174 ± 13*** 141 + 18**
Effects of atriopeptin on cyclic GMP in cultured CE (1st and 2nd passage) cells 
of bovine eye shown as fmol of cyclic GMP.mg’ l of protein. Each value is 
mean ± SEM of the number (n) of experiments shown. Significance of 
differences from control: n s- not significant; ** p < 0 .0 1 ; *** p < 0 .0 0 1 .
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DISCUSSION
Isolated Arterially Perfused Eye as a Model for AH Dynamics
Studies of isolated arterially perfused eye preparations are rare in the literature. 
Considerable success has been demonstrated in studying physiology and 
pharmacology of AH dynamics using isolated cat (Macri and Cevario, 1978a; 
1978b; Macri et al., 1980; van Alphen and Macri, 1981) or rabbit ( Kodama et 
al., 1983, 1985; van Pinxteren and van Alphen, 1985) eyes. Facility of outflow 
in the perfused anterior segment of bovine (Erickson-Lamy et al., 1988) and 
human (Erickson-Lamy et al., 1991; Erickson-Lamy and Nathanson, 1992) eyes 
has been measured.
Tazawa and Seaman (1972) described a technique for recording the 
electroretinogram utilizing the perfused extracorporeal bovine eye. In a 
preceding study the same group (Seaman et al., 1965) confirmed the viability and 
metabolic activity of the tissue of the perfused eye as evidenced by oxygen 
utilization, carbon dioxide elaboration, glucose consumption and the blockade of 
these activities by cyanide. The bovine perfused eye has also been described in 
a study of glutathione depletion and oxidative stress (Kishida et al., 1985) and in 
a preliminary communication on drug effects on IOP (Wilson, 1988). Although 
they recommended the bovine perfused eye for biochemical studies, Kishida et 
al. (1985) judged this preparation to be unsuitable for the investigation of AH 
dynamics. However, the delayed commencement of perfusion, within 2 h post 
mortem, may explain their dissatisfaction with their results. The present results 
indicate that delayed commencement of perfusion beyond 1 h after slaughter 
considerably reduces the probability of achieving a stable IOP and perfusion 
pressure. However, no correlation was found between success rate and
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postmortem time when not exceeding 50 min. In a very recent study de Coo et 
al. (1993) reported that using properly oxygenated serum-free MEM with full 
precautions for sterility, the bovine arterially perfused eye could be kept viable 
for 5 days. The same study also showed that with addition of some essential 
serum substitutes to the perfusate, viability could be extended up to 9 days.
We have demonstrated that the isolated arterially perfused eye is an effective, 
cheap, quick and humane model for studying the physiology and pharmacology 
of AH dynamics and the mechanisms of various antiglaucoma drugs (Wilson et 
al., 1993). Clearly any drug which affects IOP in isolated eye is doing so by a 
local mechanism and is unaffected by the absence of blood, hormones and CNS 
influences. The model showed its usefulness in all three different approaches 
undertaken to prove its validity. It showed a reduction in AH formation and 
IOP in response to two antiglaucoma drugs, namely timolol and MK-927, the 
latter producing a dose-dependent response with the use of very modest doses. 
Significant response to reasonable doses of standard drugs is of prime 
importance in any pharmacological studies.
The blood-aqueous barrier is an important anatomical and physiological entity 
involved in AH production. It is constituted by the tight junctions of the NPE 
cells and the nonfenestrated endothelium of iris capillaries. In an effort to 
determine the effectiveness of the blood-aqueous barrier in isolated perfused 
bovine eye we used four different flow rates: 2.25, 1.5, 2.5 and 3.5 ml.min"!. 
The resulting perfusion pressure and IOP were then compared. It was found 
that when perfusion pressure rose by 76%, IOP increased by less than 10% 
indicating that the barrier effectively prevents ultrafiltration. It was particulary 
important to establish this fact since the preparation is maintained with a 
perfusate having no oncotic pressure. This clearly implies that production of
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aqueous in the perfused bovine eye is an active secretory process. This 
conclusion is supported by the substantial arterio-venous differences measured 
for O2  and CO2  (Table 6). Estimation of O2  consumption and CO2  production 
by perfused fresh and dead eyes showed a significant net consumption of O2  and 
elaboration of CO2  only by the fresh eyes indicating that the perfused eyes were 
metabolically viable.
Attainment of steady-state IOP is another important criterion shown by the 
perfused eye. In the present study, the mean steady-state IOP in 88 eyes, 
measured in 12 different sets of experiments, was found to be 9.37 ± 0.14 
mmHg. In this preparation the episcleral venous pressure is probably not much 
above zero, since the vortex veins are cut. Assuming that all the episcleral veins 
drain into the vortex veins, the value is equivalent to 18.37 mmHg in vivo, if we 
also assume an episcleral venous pressure of 9 mmHg in the living animal. This 
value is in reasonable agreement with the report by Woelfel et al. (1964) that in 
the calf, IOP in vivo is 16.4 ± 0.6 mmHg. The steady-state IOP in these 12 sets 
of experiments was found to be very reproducible and were not statistically 
different among the different sets of experiments.
The water manometer was chosen as the method of measurement of IOP in this 
preparation since the movement of the manometer fluid column in m m ^O  is 
considerably greater than the corresponding change in mmHg (there is a 13.6 
fold difference). Superficial tonometry does not guarantee as reproducible 
results as anterior chamber cannulation. Electronic measurement and recording 
might well involve baseline drift in excess of 1 mmHg over a 1 to 2 h period and 
further would probably disturb the equilibration of the preparation at each 
attempt to take a reading. Additionally, tonometry would be less sensitive to the 
small changes of IOP being measured.
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The constant flow rate method of perfusion was adopted as the preferred method. 
Earlier work with the bovine perfused eye (Wilson, 1988) included a procedure 
whereby bovine eye preparations were perfused via a constant pressure method, 
while flow rate was monitored electronically. However, it was found that this 
method of perfusion resulted in significantly lower starting IOP values and a 
rather lower proportion of eyes whose IOP remained stable during the predrug 
part of the experiment. The mean starting IOP was 7.26 ±0.16 mmHg (n=26) 
when perfusion was carried out under conditions of constant pressure (Wilson et 
al., 1993), whereas in the constant flow method, the mean starting IOP was 
found to be 9.37 ± 0.14 (n=88).
After arterial cannulation, some eyes were rejected due to failure to achieve 
adequate perfusion. This was judged from the following criteria: that there 
should be at least two vortex veins flowing; that there should be no rise in 
perfusion pressure above 100 mmHg during any stage of the perfusion; that the 
perfusion pressure should not display major fluctuation (for example, due to an 
air bubble). Other eyes were rejected due to failure to achieve a stable IOP, or 
an IOP which rose by more than 0.1  mmH2 0 .min"l. Additionally, in the 
predrug part of the experiment, perfusion pressure and IOP should equilibrate 
within a period of 90 min after commencement of perfusion. In the case of 
anterior chamber perfusion, for estimation of AH formation rate, stability in IOP 
was sometimes not achieved, perhaps due to the turbulence. In these cases eyes 
showing IOP greater than 12.5 mmHg were rejected. The overall rejection rate 
on account of all criteria was found to be 34% (Wilson et al., 1993). While this 
rejection rate is high, only a very small number of eyes (less than 6%) were 
rejected after drug injection, usually due to sudden appearance of an air bubble 
in the perfusate. Hence, rejection did not significantly bias the pharmacological 
results. The high rejection rate in the predrug part of the experiment, can be
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accounted for at least in part by damage during enucleation at the abattoir by 
unskilled operators. Also from our experience, we found that a considerable 
percentage of bovine eyes are diseased - injury or infection of the cornea, 
cataract, and perhaps an abnormality in the outflow channels.
In the present experiments, there was no obvious correlation between post­
mortem interval and the success rate of the experiment when the interval 
between death and start of perfusion was within 50 min. Macri and Cevario
(1973), utilizing the perfused cat eye, showed that perfusion just 10 min after 
enucleation compared with perfusion 3-4 h after enucleation, had produced no 
significant difference in pharmacological responses. Thus, in the present 
preparation, starting perfusion within 50 min of slaughter of the animals seems 
quite reasonable.
Wilson (1988), describing the constant pressure perfusion of the bovine eye, 
inferred that addition of dextran and albumin to the Krebs' physiological saline 
solution was beneficial towards maintaining the integrity of the blood-aqueous 
barrier. However, it has been found subsequently that provision of oncotic 
pressure in the perfusate does not significantly protect the barrier, during the 
course of the perfusion procedure (Wilson et al., 1993). No provision was made, 
therefore, for oncotic pressure in the perfusate. The immediate benefit of this 
being the absence of dextran and albumin in the perfusate and therefore, the 
avoidance of any problems of drug binding and consequent diminution of 
pharmacological effect. Further, it has been shown that the provision of oncotic 
pressure in the perfusate via the addition of dextran and albumin does not 
significantly protect the barrier for the purpose of study of IOP. Wilson et al. 
(1993) reported that a correlation exists between a continually rising IOP and 
leakage of albumin into the chamber.
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In contrast to the two posterior ciliary arteries in living animals, only one long 
posterior ciliary artery was cannulated to perfuse the entire ciliary body. In 
mammals, the two posterior ciliary arteries (lateral and medial) anastomose and 
form the major iridic circle (Ruskell, 1964). From the circle, arteries run 
forward to supply the ciliary processes and iris. In the bovine the major iridic 
circle is called the greater arterial circle and is very well developed (Prince et al., 
1960). Thus cannulating one of the long posterior ciliary artery in the bovine 
eye allows physiological circulation to the anterior uvea. This has been 
confirmed by perfusing fluorescein into one long posterior ciliary artery while 
observing the ciliary body, exposed by dissection. If one ciliary process at the 
side opposite to that of the perfusing artery is now cut, fluorescein is 
immediately seen emerging from the incision (Wilson, personal communication). 
Kodama et al. (1983) conducted experiments in isolated rabbit eyes perfusing in 
one series through ophthalmic arteries and in another series one of the two long 
posterior ciliary arteries (the ophthalmic artery bifurcates to form the two long 
posterior ciliary arteries) and found no significant differences in results in the 
two series of experiments.
Tazawa and Seaman (1972) reported that the tissue of an enucleated bovine eye 
will gradually degenerate and lose all physiologic function, so an enucleated eye 
should be properly perfused with a flow rate providing sufficient nutrients. In 
the present study the constant arterial flow rate was 2.25 ml.min’ l. An 
estimation of total blood flow rate in the human eye is approximately 0 .6  
ml.min’ l (Silver et al., 1989). The literature about the perfusion flow rate of 
bovine eyes is ambiguous. Tazawa and Seaman (1972) used a flow rate of 1 
ml.min’ l. Imaizumi et al. (1976) used a flow rate of 2 ml.min’ l. Rover et al. 
(1978) used 2.5 ml.min’l and Kishida et al. (1985) used 2.0 - 2.5 ml.min’ l. 
Recently, de Coo et al. (1993) used a flow rate of only 0 .6 6  ml.min’ l and
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succeeded in keeping the eye metabolically viable for about 5 days. The 
literature shows that when the flow rate is changed, the perfusion pressure will 
change, as well as the physiological parameters of the eye (Niemeyer et al.,
1982). To determine an appropriate flow rate, we studied four different rates 
ranging from 1.5 to 3.5 ml.min“l and compared the IOP due to each of the flow 
rates. No significant variation of IOP was found using these rates. Thus 
consulting the literature and our experimental result we concluded that a flow 
rate of 2.25 ml.min"! would be an appropriate one.
Fluorescein was used as the marker for estimation of AH formation rate. The 
ideal marker should conform to at least 2  criteria: that it should be an inert 
compound with high molecular weight or ionization so that it leaves the anterior 
chamber only by bulk flow and does not diffuse into the ocular tissues and that it 
should produce fluorescence directly proportional to its concentration which is 
detectable by a fluorimeter. Fluorescein appears to be ideal in respect of both 
criteria and it has been used by other investigators for this purpose (Jones and 
Maurice, 1966; Nagataki, 1975).
Measurement of volume of the anterior chamber (Vac) from the fluorescence 
decay curve indicated that the volume of distribution of the marker was 1.69 ml. 
The chamber volume of 2.00 ml measured directly at the end of each experiment 
includes the posterior chamber contents, which presumably were little penetrated 
by fluorescein, since newly formed aqueous is continuously flowing toward the 
anterior chamber through the narrow slit under the iris. Since the bovine 
anterior chamber is quite deep, a posterior chamber contribution of 15% to the 
total chamber volume seems reasonable and in agreement with the reported 
values. Siedel (1921) found that the volume of posterior chamber fluid in the 
cat is about 14% of the volume of the anterior fluid. Copeland and Kinsey
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(1950) found that it is about 20% in the rabbit while Prince (1964) reported that 
in rabbit the posterior chamber contributes about 18% of the total chamber 
volume. If this is true, it confirms that little tissue adsorption of fluorescein 
occurred during the perfusion.
We have found that the mean rate constant for AH formation (Kout.min‘l) in 51 
control eyes drawn from 6 different series of experiments was 0.0045 ± 0.0001 
(mean ± SEM). A mean Kout.min‘l value of 0.0042 has been reported in 15 
human volunteers of which 3 were normal and 12 were ocular hypertensive 
without any visual field loss (Yablonski et al., 1978) which is quite in agreement 
with our result. In contrast the Kou  ^values in the isolated arterially perfused cat 
eye and rabbit eye were found to be 0.0088 (Macri and Cevario, 1973) and 0.018 
(Kodama et al., 1983) respectively. Other reported values of rate constant range 
from 0.0085 to 0.028 for the living rabbit eye and from 0.0092 to 0.015 for the 
living human eye (Cole, 1984). No reported data are available on Kout values 
either for the living or the enucleated and perfused bovine eye. The lower Kout 
value could be interpreted as a species difference, as a reflection of the much 
larger eye or it could be that the ciliary cells are in some way compromised by 
the perfusion process. Since the metabolic requirements of the aqueous are 
more a function of the internal surface area of the anterior chamber than of its 
volume, the lower surface/volume ratio of the large eye may only require a lower 
turnover of AH. In any event, this low Kout value will not affect the 
pharmacological studies with the system because it will apply to both the 
control and treated eyes. We have already demonstrated this fact by studying 
the effects of standard drugs, timolol and MK-927 on Kou  ^ value using the 
newly developed fluorescein dilution technique.
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The magnitude of inhibition of AH formation by timolol in the bovine perfused 
eye was rather small (about 13%). However, Vareilles et al. (1977) reported 
about 10.5% reduction of IOP in unanaesthetized rabbit with normal IOP. A 
timolol-induced suppression of AH formation ranging from 13% to 48% in 
normal human eye has been reported by Coakes and Brubaker (1978). In 
contrast, greater effects (52%) in the isolated arterially perfused rabbit eye 
(Kodama et al., 1985) and (about 70%) in human in vivo (Yablonski et al., 1978) 
have been reported. This may imply that this drug is less effective in the bovine 
than in other species tested, or that it has more than one mechanism of action in 
other species. It is also possible that its effect somehow cannot be fully 
expressed in an eye whose secretory function may have been compromised by 
non-blood perfusion and perhaps by anoxia. While MK-927 also induces a 
decrease in formation rate which is smaller than might be expected from 
experiments in rabbit and man (Sugrue et al., 1988; Wang et al., 1991), it is 
possible that doses greater than 100 nmol might have produced larger effects in 
our preparation. Topper and Brubaker (1985) showed that timolol and 
acetazolamide are effective in reducing AH formation during the day, while they 
are ineffective during the night when sympathetic tone and CNS activity is at a 
minimum. In the isolated perfused bovine eye preparation, the lack of 
sympathetic and CNS tone, may be responsible for the smaller drug effect.
The advantages offerred by this preparation as a model of AH dynamics lie in 
the convenience of easily obtained and inexpensive tissue. Bovine eyes from 
the abattoir afford the opportunity for research on ocular physiology and 
pharmacology without the necessity of killing animals for experimental 
purposes. Public concern over this issue was reported by Fox (1984) and has 
been growing ever since.
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In the case of the isolated arterially perfused eye, analysis of the 
pharmacological mechanism is simplified by the absence of systemic circulatory 
and neuronal effects and the absence of unpredictably fluctuating arterial and 
venous pressures. The standard topical route of administration of drugs to the 
eye is fraught with high and unpredictable losses to the general circulation, via 
the AH, and the conjunctival, scleral and nasal vasculature. The intra-arterial 
route of drug administration affords much more predictable delivery to the site 
of action and speed of drug response than does the topical route. If a known 
concentration of drug is perfused (instead of injecting a bolus dose) then the drug 
concentration in the vicinity of the target cells (CE) will be much more 
accurately known. This avoids the use of the large doses of drug which are 
required for corneal and conjunctival absorption, e.g. the standard ocular dose of 
timolol in man is approximately 1000 nmol. By comparing the concentration of 
drug required to alter AH formation with that required to alter biochemical 
parameters (such as cyclic nucleotide concentrations) we can advance our 
understanding of drug mechanisms.
The bovine perfused eye preparation therefore lends itself to studies of drug 
mechanisms on AH dynamics especially where the drug may have effects on the 
blood vessels or on the blood-aqueous barrier. The preparation has already 
provided data on the relationship between aqueous formation and ciliary cyclic 
AMP (Shahidullah and Wilson, 1992) and on the mechanisms by which 
atriopeptin and other vasodilator drugs lower IOP (Millar and Wilson, 1991)
The system gives experimental control over the perfusion medium and may 
allow study of the dependence of AH formation on individual ions etc. Also in 
this preparation both control and test data can be obtained from the same eye 
thus avoiding variation from eye to eye. In the present study, data obtained in
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two sets of experiments both using same-eye control and different-eye control 
shows that same-eye control data may be equally reproducible. However, 
before drawing a definite conclusion, further experimental evidence is necessary.
The preparation is also very suitable for isolating and culturing CE cells. In the 
present study, two new methods of isolating and culturing CE cells have been 
established using collagenase as the digesting enzyme.
The bovine perfused eye has also been used to analyse drug-induced changes in 
regional blood flow using labelled microspheres (Millar et al., 1992).
Mechanisms of Action of Timolol and Terbutaline
In the eye, p2 -adrenoeceptors ^  present predominantly in the CE, which is the 
tissue responsible for AH formation. Since timolol is a P-adrenergic blocker 
(McDevitt, 1979), it is reasonable to deduce that it may reduce AH formation 
and hence lower IOP through p-adrenergic blockade. It has been well 
documented that p-adrenoceptors in the CE are coupled to the adenylate cyclase 
system (Nathanson, 1980, 1981b; Cepelic and Cemohorsky, 1981; Elena et al., 
1984a; Palkama et al, 1986). The classical biochemical mechanism is that 
occupation of the receptor by an agonist causes its stimulation which in turn 
activates, via Gs protein, the membrane-bound enzyme adenylate cyclase. 
Adenylate cyclase then catalyzes the hydrolysis of ATP to produce cyclic AMP, 
widely recognised as a second messenger. On this basis the p-adrenergic 
antagonists will inhibit the agonist-induced tonic production of cyclic AMP in 
the CE. Hence it has been concluded that cyclic AMP in the CE is j  involved in
l
modifying AH dynamics and hence IOP (Nathanson, 1980; Cepelic and 
Cemohorsky, 1981; Mitttag and Tormay, 1985b).
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In the present study we have tried to explore the mechanism of action of timolol 
and terbutaline by relating cyclic AMP content of CE to the AH formation rate 
and IOP, using the isolated arterially perfused bovine eye as a model which has 
already been shown to be a very useful preparation for this sort of purpose 
(Wilson et al., 1993). It would appear from our data that the cyclic AMP 
content of CE has no relevance to the formation of AH. A preliminary 
communication of these results has been made (Shahidullah and Wilson, 1992). 
We used a number of drugs to achieve this conclusion. The drugs used were 
timolol, a beta-adrenergic antagonist, terbutaline, a beta-adrenergic agonist, 
forskolin, a potent non-adrenergic stimulator of adenylate cyclase and 8 -bromo 
cyclic AMP, a cell-permeable analogue of cyclic AMP. The various drugs were 
used either because they were known to decrease AH formation or because they 
were likely to alter cyclic AMP levels or both. For cyclic AMP estimation in 
CE we used three different types of tissue samples. These includes scraped 
ciliary processes obtained from a perfused eye challenged with the appropriate 
bolus doses of either drug or vehicle, excised ciliary processes and cultured CE 
incubated with drug or the vehicle.
The data shows that in our preparation either 10 nmol timolol or 30 nmol 
terbutaline produces a highly significant reduction of AH formation as measured 
by the fluorescein dilution technique. Reduction of AH formation by timolol 
has been reported in anaesthetized cat (Liu and Chiou, 1981), in unanaesthetized 
owl monkeys (Bartels, 1988), in normal human subjects (Coakes and Brubaker,
1978), in ocular hypertensive human subjects (Yablonski et al., 1978) and in 
patients with COAG (Brubaker et al., 1982). Although controversy exist as to 
the cellular mechanism of action, it is now established that timolol and other P- 
blockers, such as levobunolol (Yablonski et al., 1987), metipranolol (Sugrue et 
al., 1985a), carteolol (Araie and Takase, 1985), betaxolol (Reiss and Brubaker,
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1983) etc. produce their ocular hypotensive effect by reducing AH formation. 
Thus significant reduction of AH formation in isolated bovine eye is in the line 
of general agreement.
Surprisingly, terbutaline, a relatively selective [^-adrenoceptor agonist also 
reduced AH formation in our preparation. The literature on the effect of 
terbutaline and other p-adrenoceptor agonists on AH formation and IOP is 
conflicting. Nilsson et al. (1990) found 100% increase in AH formation by 
terbutaline in cynomolgus monkeys. Isoprenaline stimulates cyclic AMP 
synthesis and increases AH formation in the monkey eye (Nathanson, 1980; 
Miichi and Nagataki, 1983). The p-agonists salbutamol and metaproterenol 
have also been found to increase AH formation in man (Araie and Takase, 1981; 
Coakes and Siah, 1984) and monkeys (Miichi and Nagataki, 1983). In contrast, 
several investigations showed that terbutaline, salbutamol or soterenol reduce 
IOP in monkeys (Langham and Biggs, 1974) and humans (Paterson and 
Paterson, 1972; Wettrell et al., 1977). They postulated that the reduction in IOP 
was largely due to a reduction in AH formation. Using a number of selective pj 
and P2 -adrenoceptor agonists and antagonists, Colasanti and Trotter (1981) 
concluded that P2 stimulation is a especially effective way of lowering IOP. 
However, Brubaker and Gaasterland (1984) were unable to demonstrate either a 
lowering of IOP withj isoprenaline nor an effect of isoproterenol on the flow of 
AH in the normal eye.
The conflicting results described above may be, in part, due to species 
difference. There is marked species difference in the distribution of sympathetic 
nerves (Laties and Jacobowitz, 1966; Ehinger, 1971) as well as of a-and p- 
adrenergic receptors in the anterior segment of the eye (van Alphen et al., 1965). 
This anatomical variation makes it difficult to extrapolate results obtained in one
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species to another. However, some of these variable findings can not be 
accounted for by species difference. For example, terbutaline, isoproterenol, 
salbutamol and metaproterenol are all p-adrenergic agonists and expected to 
increase adenylate cyclase activity to stimulate cyclic AMP production and yet 
some of them cause increase (Araie and Takase, 1981; Coakes and Siah, 1982) 
and some of them cause a decrease (Paterson and Paterson, 1972; Wettrell et al., 
1977) in AH formation in man. At present there is no explanation of these 
variable effects.
As expected, 10 nmol bolus dose of timolol produced no effect on CE cyclic 
AMP content. Phylactos (1986) showed that timolol in moderate concentration 
(10-7 ^0 10"5 M) could not inhibit adenylate cyclase activity in rabbit iris-ciliary 
body membrane rich fraction but higher concentrations (10"2 to 10"4 M) had 
some inhibitory effect. An antagonist can abolish the effect of an agonist but 
itself does not usually produce any effect. Thus failure of a small dose of 
timolol to inhibit adenylate cyclase activity, particularly in a preparation which 
does not have any adrenergic tone, is quite understandable. The same dose 
produced a significant reduction of AH formation in the preparation indicating 
that a mechanism other than antagonism at p-adrenoceptor is involved.
More surprisingly, terbutaline also failed to raise ciliary cyclic AMP levels at the 
same dose of 30 nmol which produced a significant reduction of AH formation 
rate. Even at a higher dose level (100 nmol) terbutaline was entirely ineffective 
in stimulating ciliary cyclic AMP accumulation. It is, however, impossible to 
relate bolus doses to the concentrations with any accuracy. Perfusion of drug 
instead of bolus dose would answer this question. When excised ciliary 
processes from fresh eyes were incubated with terbutaline, it produced a 
concentration-dependent increase in cyclic AMP with concentrations of 10"6 ,
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10“5 and 10-4 M. The same concentrations also produced more pronounced and 
concentration-dependent increases in cyclic AMP in cultured 1st passage CE 
cells. With the largest concentration used (10"4 M), there occurred about 800% 
increase in ciliary cyclic AMP. As expected, the baseline value was also higher 
(48.9 pmol.mg'l protein) compared to the scraped and excised ciliary processes 
where the baseline values were 9.8 and 9.4 pmol.mg‘1 protein respectively. In 
the case of scraped and excised ciliary processes, the lower baseline value of 
cyclic AMP per unit of TCA-precipitated protein can be reasonably explained as 
the contamination of CE cells by the underlying connective tissue. Connective 
tissue is likely to have a higher proportion of proteins than epithelial cells. 
There is no published data regarding the cyclic AMP content of bovine CE. A 
baseline value of 9.4 pmol.mg’l of protein has been reported in excised ciliary 
processes of rabbit (Bausher et al., 1987). A basal value of 32.2 pmol.mg“l 
protein in rabbit, iris-ciliary body has been reported by Bartels et al. (1980). 
Thus the baseline values obtained in scraped and excised ciliary processes as 
well as in cultured CE of the present experiment are in good agreement with the 
reported values.
Bausher et al. (1987) found that isoprenaline, produced a biphasic dose-response 
curve for cyclic AMP accumulation; stimulation at low concentration (0.1 to 1.0 
pM) and inhibition at high concentration (10 to 1000 pM). A similar biphasic 
response was also observed with terbutaline, a relatively more p2 ’se e^cbve 
agonist, but the concentrations of agonist required for stimulation of and for 
inhibition of cyclic AMP production were shifted to higher values. Increase in 
aqueous cyclic AMP concentration in rabbit by terbutaline (Rowland and Potter,
1979) and isoprenaline (Bausher et al., 1987) and in bovine CE (Elena et al., 
1984a, b) has been reported. Stimulatory effects of salbutamol on adenylate 
cyclase in the rabbit iris-ciliary body homogenate and its suppression by timolol
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was also reported (Phylactos, 1986). On the basis of the presence of 
predominantly p2"ac^ renergic receptors in the CE of man and animals 
(Nathanson, 1980, 1981b; Mittag and Tormay, 1985a) including bovine (Elena et 
al., 1984a, b; Polansky et al., 1985), these increases in cyclic AMP by the p- 
adrenoceptor agonists and inhibition by the antagonist, timolol, seem quite 
straightforward and unsurprising. However, if we seek relevance of such 
changes in adenylate cyclase/cyclic AMP to IOP and AH formation then the 
picture suddenly becomes much more complex. The available literature in this 
respect is very conflicting. Some studies have shown that an increase in cyclic 
AMP is associated with a decrease in AH flow and IOP (Gregory et al., 1981; 
Caprioli et al., 1984; Sears, 1985; Bartels et al., 1987; Mittag et al., 1993); some 
showed an increase in cyclic AMP causes an increase in AH inflow and IOP 
(Nathanson, 1981; Miichi and Nagataki, 1983; Rowland et al., 1986; Larson and 
Brubaker, 1988; Nilsson et al., 1990; Yoshitomi et al., 1991) and still others 
showed no relevance (Rowland and Potter, 1979; Schmitt et al., 1981; Sears, 
1984; Liu and Dacus, 1991).
In the present experiments failure to stimulate cyclic AMP accumulation in 
perfused eyes with 30 and 100 nmol of terbutaline, might be due to inadequate 
drug concentration. However, in the bovine excised ciliary processes and 
cultured CE the minimum concentration of terbutaline required to stimulate 
cyclic AMP accumulation was 10-^M compared to 10"^M in the case of excised 
ciliary processes of rabbit (Bausher et al.,1987). Because bolus doses of 
terbutaline were used in the perfused eye, we did not know the exact 
concentration of drug in the vicinity of the CE. However, the lower dose (30 
nmol), also in bolus injection, produced marked reduction in AH formation. 
Thus it appears that terbutaline can stimulate cyclic AMP production quite 
efficiently in higher concentration, but the concentration which is needed to
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reduce AH formation is much less. This indicates that there is no causal 
relationship between terbutaline's effect on AH formation and its ability to 
stimulate ciliary cyclic AMP production in the bovine perfused eye.
Forskolin has been shown to cause marked increase in cyclic AMP concentration 
in the AH, prolonged reduction of IOP and decreased AH formation in vivo in 
rabbit (Bartels et al., 1987). Decreased AH formation was also reported in 
cynomolgus monkeys (Lee et al., 1984a) and in human (Burstein et al.,1984). 
In vitro forskolin activates adenylate cyclase of crude particulate homogenates 
prepared from cultured human CE or from dissected CE processes of rabbit or 
human eyes (Caprioli et al., 1984). In the isolated bovine eye preparation it 
produced a highly significant increase in ciliary cyclic AMP in a bolus dose of 
30 nmol. The same dose, however, completely failed to affect the AH 
formation rate in the preparation thus providing further evidence that cyclic 
AMP content of CE has no relevance to the AH formation rate in the bovine 
perfused eye. To confirm this result, we used a 100 nmol bolus dose of 8- 
bromo cyclic AMP in an effort to influence AH formation. It also failed to 
influence the AH formation rate in the preparation.
Timolol, a classic p-adrenoceptor antagonist, which is well known for its ocular 
hypotensive effect, and powerful p-antagonistic effect, also produced a 
significant reduction of AH formation in the isolated perfused bovine eye. 
Timolol, as would be expected, was found to have no effect on CE cyclic AMP 
content. Thus in the present study we manipulated either AH formation or 
ciliary cyclic AMP by using four different drugs, yet found no correlation 
between the AH formation and ciliary cyclic AMP content.
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In the isolated eye preparation there is no endogenous P-adrenergic agonist, such 
as noradrenaline or adrenaline, which are released from the sympathetic nerve 
endings and adrenal medulla in vivo. By definition, an antagonist would be 
expected to have no effect in the absence of an agonist. Thus timolol 
suppression of AH flow in the isolated eye preparation is further evidence of a 
mechanism other than antagonism of the conventional p-adrenoceptor. There is 
a considerable body of evidence that timolol decreases AH formation by some 
mechanism other than p-adrenergic blockade (Liu and Chiou, 1981; Watanabe 
and Chiou, 1983; Keats and Stone, 1984; Chiou et al., 1985; Yorio, 1985; Mills 
et al., 1988). Studies with specific Pi and P2 -adrenergic agonists and 
antagonists (Chiou et al., 1985) showed that the adrenergic receptor mechanism 
does exist in the eye tissue but that it does not control IOP or AH formation. 
Recent studies in rabbits by Liu and Dacus (1991) also refute the involvement of 
p-adrenoceptor activity and of cyclic AMP in the circadian fluctuation of IOP. 
Santafe et al. (1993) showed that in the conscious rabbit, both isoprenaline and 
timolol reduced IOP independently by reducing AH formation. When they used 
different doses of isoprenaline in the presence of a fixed concentration of 
timolol, the dose-response curve for isoprenaline showed a synergistic action of 
the two drugs. This strongly supports the view that timolol and isoprenaline 
both act, wholly or at least in part, through mechanisms unrelated to 
conventional p-adrenoceptors in the ciliary processes.
The above discussion makes it clear that there is no simple causal relationship 
between the ability of these various drugs to alter gross cyclic AMP levels in the 
CE and their ability to decrease AH formation in the bovine eye.
In contrast to this conclusion, when we used the specific inhibitors of cyclic 
AMP-dependent protein kinase (PK^) to blunt the AH and IOP-reducing effect
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of terbutaline we got results which suggest that cyclic AMP-stimulated protein 
kinase is involved in the mechanism by which terbutaline lowers AH formation 
and IOP. When a 30 nmol dose of terbutaline and a 10 nmol dose of the 
specific PKa  inhibitor (KT-5720) were used together, terbutaline failed to 
reduce both AH formation and IOP. On the other hand when we tried specific 
cyclic GMP-dependent protein kinase inhibitor (PKq , KT-5823) with 
terbutaline, we found that PKq  inhibitor had no effect on terbulatine's IOP- 
lowering effect. This suggests that terbutaline does not reduce AH formation 
and IOP by increasing cyclic GMP levels in CE, which is in contrast to the 
report by Rowland and Potter (1979) who found a significant increase in cyclic 
GMP in AH. However, they admitted that due to experimental error, they could 
only estimate cyclic GMP in 4 of their samples. Thus their experimental data is 
not very reliable. Also cyclic GMP levels in the AH may not necessarily reflect 
the cyclic GMP levels in the CE cells. Nevertheless, our finding that terbutaline 
can still lower IOP in the presence of PKq  inhibitor, constitutes a form of 
control result which strengthens the inpact of the experiment in which the 
terbutaline's effect was blocked by the PK^ inhibitor. Thus, in the present 
investigation, only inhibition of PK^ was effective in blocking terbutaline's 
effect on AH formation and IOP. However, in view of the number of 
experimental results which show no relevance of cyclic AMP to AH formation, 
this single piece of experimental evidence cannot be used to reverse the 
conclusion. Further experiments to this end are necessary.
There may be other explanations for the effect of the PK^ inhibitor on the 
terbutaline response. It may be that the increase in cyclic AMP by terbutaline 
which is capable of influencing AH dynamics is so tiny that it could not me 
measured by the RIA used in the present experiments. There is also possibility 
of the existence of functional compartmentalization of cyclic AMP in bovine CE,
as reported in other tissues. For example, although it is generally accepted that 
activation of steroid synthesis in Leydig cells is mediated through the 
accumulation of intracellular cyclic AMP in response to j luteinizing 
hormone/chorionic gonadotropin, there are discrepancies in the dose required to 
stimulate steroid biosynthesis or to activate the accumulation of cyclic AMP 
(Hunzicker-Dunn and Bimbaumer, 1985; Themmen et al., 1985; Sullivan and 
Cooke, 1986). It has also been demonstrated that there was no association 
between cyclic AMP accumulation and steroid synthesis in response to low 
levels of adrenocorticotropic hormone in isolated adrenal cells (Beall and Sayers, 
1972; Sayers et al., 1972). Thus steroid accumulation can be increased by 
levels of tropic hormone which results in no increase in intracellular cyclic 
AMP. It was postulated that a functional compartmentalization or coupling of 
cyclic AMP generated through tropic hormone receptors to specific cyclic AMP 
dependent protein kinases occurs in the cells (Mendelson et al., 1975; Dufau et 
al., 1978) Douglas and Chaudhary (1990) showed in mouse Leydig tumour cells 
that cyclic AMP generated via human chorionic gonadotropin stimulation, 
whilst able to generate similar amounts of progesterone, does not stimulate the 
synthesis of the same proteins as does cyclic AMP added exogenously or 
generated through indiscriminate activation of adenylate cyclase. Similar 
functional compartmentalization of cyclic AMP has been reported in rat 
hepatocytes (Yamatani et al., 1987), where two types of hormone-sensitive 
(glucagon and secretin sensitive) adenylate cyclase were demonstrated and the 
suppressive effect of insulin is specific only for the glucagon-sensitive adenylate 
cyclase. It may be that in the bovine CE the cyclic AMP synthesis stimulated 
by forskolin or the exogenous cyclic AMP analogue has no effect on AH 
secretion whereas the cyclic AMP stimulated by terbutaline, although not 
detectable in the present experiment, is an important modulator of AH formation.
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It is also possible that there is a critical area within the CE cell which controls 
the function of the ion-transport mechanism upon which AH production relies; 
one might postulate that a significant change in cyclic AMP level within those 
critical areas may be enough to alter AH formation, yet may be so small in 
relation to the total cyclic AMP content of the cell that no overall rise in cyclic 
AMP is measurable.
It has long been known that cyclic AMP modulates cell function in various 
tissues by activating specific protein kinases. Attempts to identify the proteins 
phosphorylated in CE have not yielded information about how AH flow might be 
modified via protein kinases. It is known by histochemical studies that both 
adenylate cyclase and Na,K-ATPase are located in the same membrane 
component of the rabbit ciliary processes (Palkama and Uusitalo, 1970; Uusitalo 
and Palkama, 1970; Tsukahara and Maezawa, 1978; Sweadner and Goldin, 
1980; Palkama et al., 1981) and both enzymes participate in the formation of AH 
(Bonting and Becker, 1964; Simon et al., 1962; Uusitalo et al., 1982). The 
interdependence of the enzymes has been emphasized by Uusitalo et al. (1985) 
who observed that the activity of adenylate cyclase in the iris-ciliary body was 
stimulated, whereas that of Na,K-ATPase was reduced, in response to 
intravenous injection of ouabain. This has been strongly supported by the 
recent findings that Na,K-ATPase activity was reduced by more than 50% by the 
catalytic subunit of PK^ (Delamere et al., 1990). The same study also showed 
that neither cyclic AMP nor the enzyme alone altered Na,K-ATPase activity. 
Subsequently, it has been shown that preincubation of CE with forskolin plus 
isobutylmethylxanthine also reduced ouabain-sensitive ATPase activity 
(Delamere and King, 1992). Indirect immunofluorescence (Coca-Prados and 
Lopez-Briones, 1987) as well as histochemical and ultrahistochemical 
(Eichhom et al., 1990) studies showed that basolateral surfaces of both non-
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pigmented and pigmented CE cells of bovine eye contain Na,K-ATPase. 
Adenylate cyclase activity in the bovine pigmented and non-pigmented CE cells 
has been demonstrated (Elena at al., 1984a). Thus similar interdependence of 
adenylate cyclase and Na,K-ATPase may also play a role in the bovine eye.
These findings are compatible with the idea that terbutaline may decrease AH 
formation via a cyclic AMP-mediated mechanism involving PK^, though it 
would seen that in the bovine eye this occurs at concentrations of terbutaline too 
low to induce any measurable change in cyclic AMP content of the ciliary 
processes.
The above conclusion still leaves a large question mark over the mechanism of 
timolol.
Atriopeptin and AH Formation
Previous studies showed that atriopeptin (AP) lowered IOP in rabbits (Mittag et 
al., 1987a; Nathanson, 1987), glaucoma patients (Diestelhorst and Krieglstein, 
1989) and in the bovine arterially perfused eye (Millar et al., 1990). AP- 
activated guanylate cyclase activity has been demonstrated in the ciliary 
processes of the eye (Nathanson, 1987; Nathanson et al., 1987; Fawcett and 
Wilson, 1989). Activators of soluble guanylate cyclase such as nitroglycerine, 
sodium nitroprusside etc. have been shown to reduce IOP (Nathanson, 1988b, 
1992). Topical application of 8-bromo cyclic GMP, a membrane permeable 
cyclic GMP analogue, also lowers IOP in rabbits (Becker, 1990), although Busch 
et al. (1992) found that subconjunctival, but not topical, cyclic GMP reduced 
IOP in the rabbit. Evidence that this fall in IOP is due to a reduction in AH 
formation is scanty. Neither the reported increase in cyclic GMP in iris-ciliary
134
body (Korenfeld and Becker, 1989) nor in the ciliary process homogenates 
(Nathanson, 1987) localizes this effect to the secretory epithelium. The 
guanylate cyclase involved could have been located in the vascular tissues within 
the ciliary process.
In the present study we showed that in the bovine perfused eye, AP lowers IOP 
by reducing AH formation. We also showed that AP increases cyclic GMP 
levels in cultured CE cells in a concentration-dependent manner. Culture of CE 
offers the opportunity to localize receptors. Thus the present investigation 
advances our knowledge of AP that it acts directly to reduce AH formation to an 
extent which is consistent with its much-reported ability to lower IOP; that AP 
receptors are present on cultured CE cells; and that these AP receptors are 
coupled to the guanylate cyclase/cyclic GMP system.
In the isolated bovine eye preparation, a very moderate dose of AP (50 pmol) 
produces a marked reduction (38%) in AH formation over a period of 60 min. 
This finding confirms the observation of Korenfeld and Becker (1989) in the 
living anaesthetized rabbit, who found a 20% reduction in AH formation 
following intravitreal injection of APIII, over a period of 80 min. The decreased 
response in their experiment may be due to intravitreal administration of drug. 
Intra-arterial administration in our preparation is probably the more 
physiological, since AP that reaches the eye most likely originates in the atrial 
myocytes. Although extra-atrial production of AP has been reported, such as in 
the kidney, adrenal medulla, pituitary (McKenzie et al., 1985; Gardner et al., 
1986) no mRNA transcripts of AP were found in the anterior uvea (Stone, 1987). 
The quantifiable levels of AP found in anterior uvea (Stone and Glembotski, 
1986) probably represent ocular tissue binding of cardiac APs. Decreased 
response may also be due to the markedly depressed baseline AH formation in
135
animals after systemic anaesthesia. A species difference could also account for 
the greater response in the bovine eye. For example, in the cynomolgus monkey 
AP causes an increase rather than a decrease in AH formation (Samuelsson- 
Almenetal., 1991).
It has been reported that intravenous infusion of AP in the living animal causes a 
fall in mean arterial blood pressure (Samuelsson-Almen et al.,1991) which may 
trigger an activation of the sympathetic nervous system. An effect of AP on AH 
dynamics in the living animal thus may be secondary to p-adrenoceptor 
activation and hence an increase in cyclic AMP levels in the target tissue. In the 
isolated eye preparation the ciliary body is devoid of sympathetic nervous tone 
and other systemic effects. Thus a decrease in AH formation in the isolated eye 
supports the theory that activation of ciliary guanylate cyclase is the main 
mechanism of AP in lowering IOP.
Several investigators (Bianchi et al., 1986; Sugrue and Vlader, 1986) suggested 
that AP receptors in the rabbit ciliary process are negatively coupled to adenylate 
cyclase. Negative coupling of AP receptors has also been demonstrated in other 
tissues, such as in adrenal cortical membrane (Anand-Srivastava et al., 1985) and 
in pituitary tissue (Anand-Srivastava et al., 1985). Bianchi et al. (1986) argued 
that the decrease in IOP is due to decreased levels of cyclic AMP which is 
effected secondary to increased cyclic GMP in response to AP. In contrast to 
their result, Mittag et al. (1987a) were unable to demonstrate any effect of AP on 
ciliary process adenylate cyclase activity in the same homogenates or particulate 
preparations where it activated guanylate cyclase. They showed that particulate 
cyclic AMP phosphodiesterase activity was stimulated by low doses ( 1 - 5  pM) 
of cyclic GMP in the ciliary process. Thus, AP, acting via a guanylate cyclase, 
has the potential to regulate phosphodiesterase activity and indirectly decrease
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cyclic AMP levels in ciliary process. However, in the bovine eye, we have 
convincingly shown that cyclic AMP levels in the CE bear no relationship with 
AH formation. So a decrease in ciliary cyclic AMP is unlikely to be the cause 
of reduction of AH formation in the bovine isolated eye in response to AP. 
Increased cyclic GMP production by AP appears to be the most likely mediator 
of reduction in AH secretion. Also the concentration-dependent increase in 
cyclic GMP in cultured CE cells suggest that AP may act locally on the secretory 
cells to modify AH secretion via a cyclic GMP pathway perhaps by activating 
cyclic GMP-dependent protein kinase, particularly in view of the evidence 
involving azide and the selective inhibition of PKq  (see below).
Sodium Azide, IOP and AH Formation
In the isolated bovine eye preparation Millar and Wilson (1991) showed that a 
10 nmol bolus dose of sodium azide caused a significant increase in ciliary 
cyclic GMP and a significant reduction in IOP. The same dose was shown to 
have no effect upon the ciliary vasculature (Millar and Wilson, 1991). They 
postulated that sodium azide might have reduced IOP by direct reduction in AH 
formation and that the ocular effect did not bear any relationship to its vascular 
effect. Other nitrovasodilators, such as nitroglycerin and sodium nitroprusside, 
which stimulate cyclic GMP synthesis by a family of soluble NO-activated 
guanylate cyclases (Chinkers and Garbers, 1992; Yuen and Garbers, 1992; Wong 
and Garbers, 1992) have also been shown to lower IOP (Nathanson, 1988b,
1992). That 8 -bromo cyclic GMP, a membrane-permeable analogue, lowers 
IOP (Becker, 1990) suggests that cyclic GMP mediates the ocular hypotensive 
effect irrespective of whether its accumulation in the target tissue is stimulated 
either by AP receptors, which results in hormonally stimulated particulate 
guanylate cyclase or by activators of soluble guanylate cyclase, such as by
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nitrovasodilators. Despite this apparent concordance, there are conflicting data 
in the literature, e.g. Nathanson (1992) concluded that nitroglycerin’s site of 
action was at the outflow apparatus, not the ciliary process.
To address this, we investigated sodium azide for its effect on AH formation as 
well as on IOP. A specific inhibitor of cyclic GMP-dependent protein kinase 
(PKq ) was also used to blunt the IOP-lowering effect of sodium azide. Sodium 
azide is reported to directly stimulate an intracellular soluble guanylate cyclase 
as opposed to particulate guanylate cyclase stimulated by AP. It also promotes 
the release of the endothelial derived relaxing factor - EDRF (Furchgott and 
Zawadski, 1980). EDRF was subsequently identified as nitric oxide (Palmer et 
al., 1987). EDRF also stimulates an intracellular soluble guanylate cyclase.
A 10 nmol bolus dose of sodium azide produced a marked decrease in AH
r
formation (46%) and IOP.j A 10 nmol dose of PKq inhibitor completely abolished 
the IOP-lowering effect of 10 nmol of sodium azide. To our satisfaction, when 
we used a 10 nmol bolus dose of specific PK^ inhibitor, we found that it 
completely failed to abolish the IOP-lowering effect of sodium azide. Thus it 
appears that activation specifically of PKq is the mechanism of the reduction in 
IOP and AH formation in the isolated bovine eye.
Thus all experiments using AP and sodium azide indicate that they lower IOP by 
reduction of AH formation. This contradicts the previous findings that the 
physiological effects of AP and nitrovasodilator drugs in the eye differ in their 
mode of action - AP causes a decrease in secretion (Steardo and Nathanson, 
1987; Korenfeld and Becker, 1989) with little effect on outflow, whereas the 
nitrovasodilators cause only a small effect on AH formation but a definite 
enhancing effect on outflow (Nathanson, 1992). A 46% reduction of AH flow
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by 10 nmol sodium azide over a 60 min period undoubtedly proves that it lowers 
IOP by affecting secretion of AH. This difference in finding is very difficult to 
explain. It may reflect the difference of distribution of nitrovasodilator-sensitive 
guanylate cyclase in ocular tissues in different species. Predominant occurrence 
of such guanylate cyclase in the bovine CE cells may be the cause of marked 
reduction in AH formation due to sodium azide. Similarly predominant 
distribution of nitrovasodilator-sensitive guanylate cyclase in the rabbit 
trabecular epithelium may underly their effect on outflow of AH.
Verapamil and IOP
In the present study, intra-arterial administration of verapamil, a widely used 
Ca2+-channel blocker, produced a dose-dependent decrease in IOP in the 
isolated perfused bovine eye. Reduction of IOP by topical application of 
verapamil in untreated ocular hypertensive volunteers has been reported 
(Abelson et al., 1988; Goyal et al., 1989). Topical verapamil and nifedipine 
lower IOP in conscious normotensive rabbits (Segarra et al., 1986). Intravenous 
perfusion of verapamil reduces IOP in anaesthetised rabbits and recently 
intravenous verapamil and nifedipine have been shown to lower IOP in 
conscious rabbits (Payne et al., 1990). All these findings are in agreement with 
our results. In contrast, the results of Beatty et al. (1984) in conscious rabbit 
and human suggest that topical verapamil, diltiazem and nifedipine increase IOP 
in both species. Monica et al., (1983) reported that oral nifedipine reduces IOP 
in the human, but Kelly and Wally (1988) found no effect of either oral or 
intravenous nifedipine on IOP in normal subjects. Schnell (1975) also showed 
that intravenous and oral nifedipine had no effect on IOP in normal volunteers or 
glaucomatous patients. Thus, the literature on ocular effects of verapamil and 
other Ca2+-channel blockers is conflicting as well as scarce. Part of this
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variability may result from the variable doses and routes of administration 
utilized by different workers. With such conflicting data in the literature, a 
dose-dependent reduction in IOP in the isolated eye preparation by small doses 
(1 to 100 nmol) of verapamil, is interesting and deserves further work to 
determine whether the effect is on AH formation.
The mechanism of ocular hypotensive effect of verapamil is, however, very 
difficult to explain, since the ocular effects of Ca^+-channel blockers on AH 
formation is lacking and on outflow is scanty.
Recently it has been demonstrated that sympathetic nerve terminals in the rabbit 
ciliary body contain verapamil-sensitive channels which contribute to 
neurotransmitter release (Jumblatt, 1988), and thus suggesting an indirect means 
by which these drugs may influence IOP. In the isolated eye preparation such 
release of neurotransmitter would be very limited and can not account for a 
sustained reduction of IOP over a period of 2  h in response to a bolus dose used.
So far, the only important pharmacological effects of Ca^+-channel blockers are 
confined to the cardiac and smooth muscles. The primary mechanism of action 
of this class of drugs is the blockade of membrane-bound calcium channels and 
an inhibition of extracellular Ca^+ influx. Ca^+ is an important intracellular 
messenger, often interacting with cyclic nucleotides to control a broad spectrum 
of physiological functions (Berridge, 1975) and is critical to many biological 
processes including muscle contraction, neurotransmitter release, enzyme 
activation and cellular secretion. For example, decreased intracellular free Ca^+ 
causes relaxation of smooth muscle and in vascular smooth muscle this causes 
vasodilatation and improved blood flow (Piepho, 1983).
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Extrapolating from the action of Ca2+ in smooth muscle, we can argue that in 
the eye verapamil may cause relaxation of the ciliary muscle as a result of a 
reduction in intracellular Ca2+. Relaxation of ciliary muscle should have 
produced relative closure of the trabecular meshwork, and thus hindered the AH 
drainage through the trabecular route. Decreased drainage and normal or 
increased AH formation can in no way produce decreased IOP. Thus it seems 
that the dose-dependent decrease in IOP in the isolated bovine eye is likely to be 
due to a reduction of AH inflow. Direct measurement of AH flow using 
verapamil and other Ca2+-channel blockers might confirm this hypothesis (see 
future work).
There is little information available on the possible roles of Ca2+ in the CE. But 
presence of a calcium signalling system has been confirmed in the cultured 
nontransformed human and rabbit non-pigmented CE cells (Ohuchi et al., 1992). 
Although little information is available, preliminary data on the regulatory role 
of Ca2+ in the ciliary processes point to the possibility that the drugs which 
influence Ca2+ mobilization might affect the AH inflow by acting on electrolyte 
transport. For example, gap junctions have been described between non- 
pigmented and pigmented CE cells (Green et al., 1985). AH formation possibly 
could be modified by ion transport through the gap junctions between CE cells, 
which are known to be regulated by calcium ions (Loewenstein, 1981). Abelson 
et al. (1988) suggested that verapamil may interfere with these gap junctions, 
altering cellular permeability of the CE, and thus inhibiting the normal AH 
inflow.
It has been demonstrated that rabbit ciliary process membranes contain a 
calcium/calmodulin-regulated adenylate cyclase which is different from the 
adenylate cyclase regulated by stimulatory GTP-binding proteins, and thus
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receptors which affect calcium mobilization may have the potential to regulate 
cyclic AMP levels in the ciliary processes and ciliary processes transport 
function (Tormay et al., 1987; Mittag et al., 1993). Therefore, calcium channel 
blockers may also alter the cyclic AMP content via an effect on calcium in the 
CE cells, and in this way decrease both AH inflow and IOP.
Compared to the cyclic AMP-dependent system, relatively little attention has 
been paid to calcium signal regulation with regard to electrolyte transport in the 
CE. However, Yoshimura et al (1989) has shown that rabbit ciliary process 
membranes contain a much higher activity of protein kinase C than of PK^ or 
other protein kinases. Although the physiological role of calcium-dependent 
protein phosphorylation has not been fully elucidated, the data of Yoshimura et 
al. (1989) suggest that drugs acting via calcium-dependent signal systems may 
exert a significant degree of control on cellular function in the ciliary process.
In conclusion, it appears that verapamil and other Ca2+-channel blockers may 
have multiple sites and mechanisms of action in the eye through which they 
could affect AH dynamics. Thus extensive studies on this group of drugs is 
desirable to ascertain accurately their mechanism of action (see future work).
FUTURE WORK
FUTURE WORK
From our experimental data on IOP, AH formation and CE cyclic GMP, we 
postulated that both AP and sodium azide lower IOP by reducing AH formation 
and that these drugs act through cyclic GMP/guanylate cyclase system. Further 
work with other nitrovasodilators, such as sodium nitroprusside, nitroglycerine 
on both physiological (IOP, AH formation etc.) and biochemical (cyclic GMP 
levels of CE) parameters may confirm our hypothesis.
Results of experiments with timolol, terbutaline, forskolin, 8 -bromo cyclic AMP 
and specific inhibitors of cyclic nucleotide-dependent protein kinases, on their 
effects on IOP, AH formation and cyclic AMP levels in CE cells, using three 
different types of tissue preparations (perfused eye, excised ciliary processes 
from fresh eyes and cultured CE), made it clear that there is no direct 
relationship between CE cyclic AMP content and AH formation or IOP. Our 
results suggest a functional compartmentalization of cyclic AMP in CE cell 
function. Further work in this respect with a large variety of agents which can 
activate the enzyme adenylate cyclase, such as catecholamines, glycoprotein 
hormones, organic fluorides, griseolic acid etc. might help to confirm this 
hypothesis.
We have confirmed, by incubating cultured CE cells with terbutaline and 
atriopeptin, that these cells retain their surface receptors. Jacob (1991) 
identified T-type Ca^+-channel in bovine CE cells. Yoshimura et al (1989) 
showed that rabbit ciliary process membranes contain much higher activity of 
PKc than PK^\ and other kinases. We found a dose-dependent decrease in IOP 
by moderate bolus doses (1 to 100 nmol) of verapamil in the isolated arterially 
perfused eye. Thus Ca^+ may play an important role in CE function of AH
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secretion. Future work involving microscale measurement of intracellular free 
Ca2+, using a sensitive method, such as the fura-2  technique, described by 
Morgan and Morgan (1982) or Buchan and Martin (1992), would be a logical 
extension of the present work. Measurement of intracellular free Ca^+ in 
response to different Ca^+ channel blockers and other drugs having Ca^+ 
mobilizing ability, in cultured CE cells, and relating these biochemical events to 
their physiological effect, such as IOP and AH formation, would provide precise 
information about the role of Ca2+ in CE cell function.
More precise information concerning the concentration of drug actually present 
at the site of action, i.e. in the vicinity of CE, which is responsible for 
modulating physiological functions, would be obtained by administering the 
ocular hypotensive drugs at a fixed concentration in the perfusate, instead of 
bolus doses.
The CE appears to be a very complex functional entity and a site for a number of 
biochemical systems operating to modulate its function, such as the presence of 
cyclic AMP, cyclic GMP, Ca2+ messenger systems, serotonergic (Barnett and 
Osborne, 1993) and purinergic receptors (Wax et al., 1993) etc. Identification of 
calmodulin-activated adenylate cyclase in rabbit ciliary process (Mittag et al.,
1993) and potentiation of agonist-induced stimulation of cyclic AMP by 
activation of PKC in cultured rat retinal PE (Nash et al., 1994), which is 
embryologically a close relative of CE, indicates some sort of cross-talk between 
different systems. Thus a future approach in studying the cross-talk between 
and among different biochemical systems could provide important information 
about the complex and poorly understood mechanisms of modulation of AH 
dynamics.
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APPENDIX
Appendix I
List of Abbreviations used in this thesis:
Abbreviation Definition
ADP Adenosine Diphosphate
AH Aqueous Humour
ANOVA Analysis of Variance
AP Atriopeptin
ATP Adenosine Triphosphate
ATPase Adenosine Triphosphatase
BSA Bovine Serum Albumin
CA Carbonic Anhydrase
CAG Closed-angle glaucoma
CE Ciliary Epithelium
CO AG Chronic Open-angle Glaucoma
Cyclic AMP 3'5' Cyclic Adenosine
Monophosphate
Cyclic GMP 3'5 Cyclic Guanosine
Monophosphate
°C Degrees Celcius
DAG Diacylglycerol
DMEM Dulbecco's Modification of Eagle's
Medium
DMSO Dimethyl Sulphoxide
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DNA Deoxyribonucleic Acid
EDTA Ethylene Diamine Tetraacetic Acid
EGTA Ethylene Glycol Tetraacetic Acid
ER Endoplasmic Reticulum
FCS Foetal Calf Serum
fmol femtomoles
g Grammes
G-protein Guanine Nucleotide-Binding Protein
GABA Gamma Amino Butyric Acid
GDP Guanosine Diphosphate
GTP Guanosine Triphosphate
h Hours
IgE Immunoglobulin E
IgG Immunoglobulin G
IOP Intraocular Pressure
IP3 Inositol 1,4,5-Trisphosphate
Iu International Unit
KDa Kilodalton
M Molar
mg Milligrammes
min Minutes
ml Millilitres
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mm Millimetres
mM Millimolar
mmH2 0  Millimetres of Water
mmHg Millimetres of Mercury
mol Moles
mV Millivolts
jig Microgrammes
|il Microlitres
NCS Newborn Calf Serum
ng Nanogrammes
nmol Nanomoles
NPE Non-pigmented Ciliary Epithelium
OAG Open-angle Glaucoma
PA Phosphatidic Acid
pA Picoamperes
PC Phosphatidylcholine
PE Pigmented Ciliary Epithelium
PIP Phosphatidyl inositol 4-phosphate
PIP2  Phosphoinositol 4,5-bisphosphate
PKa  Cyclic AMP-dependent Protein
Kinase
PKc Protein Kinase C
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PKq  Cyclic GMP-dependent Protein
Kinase
PLA2  Phospholipase A2
PLC Phosphilipase C
pmol Picomoles
PPI Polyphosphoinositides
RIA Radioimmunoassay
RNA Ribonucleic Acid
s Seconds
SEM Standard Error of Mean
TCA Trichloroacetic Acid
TNO Tri-n-Octylamine
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Appendix II
Materials Used:
Material
Atriopeptin II (Rat sequence)
KT-5720 (PKa  inhibitor)
KT-5823 (PKq  inhibitor)
Collagenase A 
Gentamycin
Dimethyl Sulfoxide(DMSO)
Foetal Calf Serum
Newborn Calf Serum
Trypsin EDTA solution (IX)
DMEM
Verapamil Hydrochloride 
Timolol Maleate 
MK-927
Sodium Azide 
Terbutaline Hemi-sulphate 
Cyclic AMP and cyclic GMP RIA Kit 
Forskolin
8-bromo Cyclic AMP
Source
Sigma Chemical company
Calbiochem Corporation
Calbiochem Corporation
Boehringer Mannheim
Sigma (Cell Culture)
Sigma Chemical Company
GIBCO, Life Technologies 
Ltd.
GIBCO, Life Technologies 
Ltd.
GIBCO
GIBCO
Sigma Chemical Company
Sigma Chemical Company
Merk Sharp and Dohme Res. 
Lab.
BDH Chemicals Ltd.
Sigma Chemical Company 
DuPont, New England Nuclear 
Sigma Chemical Company 
Sigma Chemical Company
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Appendix III
Solutions Used:
1. Solutions for Protein Assay
Solution C 98 parts of Solution A
2 parts of Solution B
These are prepared fresh and mixed just before use.
Solution A
Sodium Carbonate 2 g
Sodium Hydroxide (0.1 N) add 100 ml.
Solution B
Cupric Sulphate 0.5 g
Sodium-potassium T artrate 1.0 g
Distilled water add 100 ml.
2. Buffers Used for Cell Culture
(a) X 10 Concentration of Ca^+-free buffer
41.5 gNaCl 
2.5 g KC1
12.0 g Hepes, dissolved in 500 ml of distilled water, pH adjusted to 7.4.
(b) X 10 Concentration of Collagenase Buffer
9.75 gNaCl 
1.25 gKCl
6.00 g Hepes, dissolved in 250 ml distilled water, pH adjusted to 7.6 
Add 12 ml of 1M Ca2 Cl, check pH again.
